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Relationship	  between	  Brucella	  melitensis	  and	  the	  associated	  
immune	  response	  after	  intranasal	  infection	  in	  mice	  	  
	  




Brucella	  melitensis	   is	  a	  facultative	   intracellular	  bacterium	  responsible	  for	  one	  of	  the	  
most	  common	  zoonosis	  in	  the	  world,	  mainly	  transmitted	  by	  oral	  ingestion	  of	  contaminated	  
food	   and	   aerosol.	   Infected	   humans	   usually	   have	   an	   undulant	   fever	   that	   can	   become	   a	  
chronic	  disease	  if	  it	  is	  not	  treated.	  Abortion	  and	  sterility	  are	  the	  major	  symptoms	  in	  domestic	  
and	   wild	   animals.	   The	   classical	   intraperitoneal	   (i.p.)	   model	   of	   infection	   in	   mice	   has	   been	  
useful	  for	  discovering	  virulence	  factors	  of	  Brucella	  and	  characterizing	  effectors	  of	  protective	  
host	   immunity.	   But	   this	  model	   is	   not	   representative	   of	   the	   natural	   route	   of	   infection	   and	  
much	   remains	   unknown	   regarding	   the	   immune	   response	   and	   mechanisms	   developed	   by	  
Brucella	   to	   persist	   in	   the	   host.	   Consequently,	   we	   decided	   to	   develop	   an	   intranasal	   (i.n.)	  
model	   of	   infection	   to	   study	   the	   immune	   response	   of	   mice	   against	   Brucella	   melitensis	  
infection.	  
	  
In	  the	  first	  part	  of	  the	  study,	  using	  wild	  type	  and	  genetically	  deficient	  C57BL/6	  mice,	  
we	  analyzed	  the	  nature	  and	  the	  function	  of	  immune	  cellular	  populations	  controlling	  Brucella	  
infection,	   including	  the	  action	  of	  specific	  components	  of	  mucosal	   immunity.	  We	  confirmed	  
the	  crucial	  role	  of	  IFN-­‐γ-­‐producing	  CD4	  Th1	  cells	  in	  the	  control	  of	  the	  primary	  i.n.	  infection	  by	  
Brucella	  melitensis.	  We	  also	  observed	  an	  early	  role	  for	  	  γδ	  T	  lymphocytes	  and	  production	  of	  
IL-­‐17A	  in	  the	  control	  of	  the	  bacterial	  load	  in	  lungs.	  We	  showed	  that	  B	  lymphocyte	  deficiency	  
does	  not	  affect	  the	  efficiency	  of	  the	  primary	  or	  secondary	  immune	  response	  against	  Brucella.	  	  
In	  the	  second	  part	  of	  the	  work,	  using	  susceptible	  IL12p40-­‐deficient	  BALB/c	  mice,	  we	  
characterized	  the	  preferential	  cellular	  niche	  for	  Brucella	   in	  the	  spleen	  during	  the	  persistent	  
phase	  of	  infection.	  We	  confirmed	  that	  Brucella	  melitensis	  exhibits	  a	  tropism	  for	  the	  myeloid	  
lineage	   in	   susceptible	   IL12p40-­‐deficient	   BALB/c	   mice.	   The	   large	   majority	   of	   infected	   cells	  
expressed	   CD11c	   and	   CD205	  markers,	   which	   are	   specific	   for	   dendritic	   cells.	   But	   they	   are	  
lipid-­‐rich	   and	   they	   display	   high	   levels	   of	   arginase1,	   a	   typical	   marker	   of	   IL-­‐4-­‐induced	  
alternatively	   activated	  M2	  macrophages.	   To	   determine	   if	   these	   cells	   are	   Th2-­‐induced	  M2	  
macrophages,	  we	   analysed	   the	   impact	   of	   IL-­‐4/STAT6	   signaling	   deficiency	   on	   the	   course	   of	  
infection	   and	   the	   phenotype	   of	   infected	   cells	   in	   IL12p40-­‐deficient	  mice.	  We	   observed	   no	  
differences	   between	   IL-­‐12p40	   and	   IL-­‐12p40/STAT6	   deficient	   mice,	   demonstrating	   that	  
infected	  cells	  are	  not	  dependent	  on	  IL-­‐4	  and	  cannot	  be	  considered	  as	  alternatively	  activated	  
M2	  macrophages	  induced	  by	  the	  Th2	  response.	  
	  
In	   conclusion,	   this	   work	   provides	   a	   better	   understanding	   of	   the	   immune	   response	  
induced	  by	  Brucella	  melitensis	  in	  an	  i.n.	  model	  of	  infection,	  and	  describes,	  for	  the	  first	  time,	  
the	  phenotype	  of	  a	  preferential	  cellular	  niche	  of	  the	  pathogen	  in	  susceptible	  mice	  during	  the	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AAM/M2	  	   Alternatively	  activated	  macrophage	  
AID	  	   Activation	  Induced	  cytidine	  deaminase	  
Ab	   Antibody	  
Ag	   Antigen	  
APC	   Antigen	  presenting	  cell	  
Arg1	   Arginase1	  
ATP	   Adenosine	  tri-­‐phosphate	  
BALT	   Bronchus	  associated	  lymphoid	  tissue	  
BCR	   B	  cell	  receptor	  
BCV	   Brucella	  containing	  vacuole	  
BMDM	   Bone	  marrow	  derived	  macrophage	  
BTP1	   Brucella	  TIR	  containing	  protein	  
CAM/M1	  	   Classically	  activated	  macrophage	  
CARKL	   Carbohydrate	  kinase-­‐like	  
CCR2	   Chemokin	  receptor	  2	  
CD	   Cluster	  of	  differentiation	  	  
CFU	   Colony	  forming	  unit	  
CpG	   Cytosine	  phosphate	  guanosine	  
DALIS	  	   Dendritic	  cells	  aggresome-­‐like	  induced	  structures	  
DAMPS	   Damage	  associated	  molecular	  patterns	  
DC	   Dendritic	  cell	  
DC	  SIGN	   Dendritic	  cell-­‐	  specific	  icam3-­‐grabbing	  non	  integrin	  
DOK2	   docking	  protein	  2	  
DTH	   Delayed-­‐type	  hypersensitivity	  
EE	   Early	  endosome	  
ER	   Endoplasmic	  reticulum	  
ERK	   extracellular	  signal-­‐regulated	  kinase	  
FA	   Fatty	  acid	  
FasL/R	   Fas	  ligand/receptor	  
FIZZ	   Found	  in	  inflammatory	  zone	  






i.n.	   Intranasal	  
i.p.	   intraperitoneal	  
IC	   Immune	  complex	  
IFN	   Interferon	  
Ig	   Immunoglobulin	  
IL	   Interleukin	  
INOS	   Inducible	  nitric	  oxyde	  synthase	  
JAK1	   Janus	  kinase	  1	  
JNK	   JUN	  N-­‐terminal	  kinase	  
LE	   Late	  endosome	  
LN	   Lymph	  node	  
LPS	   Lipopolysoccharide	  
MALT	   Mucosal	  associated	  lymphoid	  tissue	  
MAPK	   Mitogen-­‐activated	  protein	  kinase	  
MARCO	   Macrophage	  receptor	  
MD2	   Myeloid	  differenciation	  2	  
MHC	   Major	  histocompatibility	  complex	  
MLN	   Mesenteric	  lymph	  node	  
MMM	   Metallophilic	  macrophage	  
MOMA	   Monocyte/Macrophage	  
MR	   Mannose	  receptor	  
MuMT	   μM	  mutation	  (B	  cell	  deficient	  mice)	  
MyD88	   Myeloid	  differentiation	  factor	  88	  
MZ	   Marginal	  zone	  	  
MZM	   Marginal	  zone	  macrophage	  
NFκB	   activation	  of	  nuclear	  factor-­‐κB	  
NK	   Natural	  Killer	  
NKT	   Natural	  Killer	  T	  (cell)	  
NLR	   Nod	  like	  receptor	  
NO	   Nitric	  oxyde	  
NOD	   Nucleotide	  oligomerization	  domain	  
NOHA	   NG-­‐hydroxy-­‐L-­‐arginine	  	  






OAT	   Ornithine	  aminotransferase	  	  
OCR	   Oxygen	  consumption	  rate	  
ODC	   	  Ornithine	  decarboxylase	  
Omp	   Outer	  membran	  protein	  
PAMP	   Pathogen	  associated	  molecular	  pattern	  
PPAR	   Peroxisome	  proliferator	  activated	  receptors	  
PPP	   Pentose	  phosphate	  pathway	  
PRR	   Pattern	  recognition	  receptor	  
PTX	   Pentaxin	  
r.p.	   red	  pulp	  
RAG	   Recombination	  associated	  gene	  
RASA2	   RAS	  GTPase-­‐activating	  protein	  
RhoA	   Ras	  homolog	  gene	  family,	  member	  A	  
RLR	   Rig	  like	  receptor	  
RNS	   Reactive	  nitrogen	  species	  
ROS	   Reactive	  oxygen	  species	  
SCV	   Salmonella	  containing	  vacuole	  
SH	  domain	   Small	  hydrophobic	  domain	  
SIRPα	   signal-­‐regulatory	  protein-­‐α	  
SLAM	   Signaling	  lymphocytic	  activation	  molecule	  
SMAD	   Sma	  and	  mad	  related	  proteins	  
SOCS	  3	   suppressor	  of	  cytokine	  signaling	  3	  
SP	   Pulmonary	  surfactant-­‐associated	  protein	  
STAT6	   Signal	  tranducer	  and	  activator	  of	  transcription	  6	  
SR	   Scavenger	  Receptor	  
ssRNA	   single	  strand	  RNA	  (Ribonucleic	  acid)	  
TAP-­‐1	   Transporter	  associated	  with	  antigen	  procession	  
TcpB	   TIR	  domain	  containing	  protein	  
TCR	   T	  Cell	  Receptor	  
TGF	   Transforming	  growth	  factor	  
Th	   T	  helper	  
TIR	   Toll/Interleukin-­‐1	  Receptor	  






TNF	   Tumor	  necrosis	  factor	  
Treg	   T	  regulator	  
TREM2	   Triggering	  receptor	  expressed	  by	  myeloid	  cells	  2	  
TRIF	   Toll/Interleukin-­‐1	  Receptor	  domain-­‐containing	  adapter	  inducing	  IFNβ	  
w.p.	   white	  pulp	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1. Foreword:	  Relationship	  between	  microorganisms	  and	  their	  hosts	  
Host-­‐parasite	  relationship	  is	  a	  phenomenon	  that	  appeared	  on	  earth	  at	  the	  same	  time	  as	  
life	  emerged	  around	  3.8	  billion	  years	  ago.	  The	  evolution	  is	  based	  on	  constant	  intra	  and	  inter-­‐
specific	   interactions	   in	   which	   each	   partner	   devotes	   its	   life	   to	  meet	   its	   own	   needs	   and	   to	  
replicate.	   It	   gave	   rise	   to	   extremely	   diversified	   and	   dynamic	   interactions	   between	  
microorganisms	   and	   their	   hosts.	   These	   relationships	   can	   lead	   to	   peaceful	   coexistence	  
(mutualism),	   as	   it	   is	   the	   case	   for	   the	   intestinal	   flora	   and	   its	   host,	   but	   it	   is	   far	   from	   being	  
always	   the	   case:	   microorganisms	   can	   prosper	   to	   the	   detriment	   of	   their	   host.	   They	   are	  
termed	  “pathogen”	  and	  generally	  induce	  damage	  to	  their	  host	  (parasitism)	  (Montgomery	  &	  
McFall-­‐Ngai,	   1994).	   It	   is	   noteworthy	   that	   an	   invasion	   by	   a	   pathogen	   can	   also	   result	   in	   a	  
chronic	  or	  a	  latent	  infection	  without	  detectable	  clinical	  symptoms,	  but	  following	  any	  changes	  
in	  the	  environment,	  the	  host	  or	  the	  parasite	  can	  modify	  the	  equilibrium	  and	  the	  disease	  can	  
take	   place	   (Araújo	   et	   al.,	   2013).	   The	   battle	   between	   host	   and	   parasite	   refers	   to	   the	   “Red	  
Queen’s	   hypothesis”,	   derived	   from	   the	   animation	   Alice	   in	   Lewis	   Carroll’s	   “Through	   The	  
Looking	  Glass”,	  and	  used	  by	  Leigh	  Van	  Valen	  in	  1973	  to	  illustrate	  the	  law	  of	  extinction	  and	  
co-­‐evolution	  between	  competing	   species.	   It	  proposes	   that	  organisms	  continuously	  have	   to	  
adapt,	  evolve	  and	  proliferate	  to	  have	  reproductive	  advantage	  and	  survive	  against	  competitor	  
organisms	   in	   a	   changing	   environment	   (Van	  Valen,	   1973).	   The	   outcome	  of	   the	   relationship	  
will	  depend	  on	  the	  competition	  of	  the	  host’s	  immune	  system	  and	  the	  escape	  mechanisms	  of	  
the	  pathogen	  (Araújo	  et	  al.,	  2013).	  	  
	  
This	   thesis	   will	   focus	   on	   the	   pathogenic	   aspect	   of	   chronic	   bacterial	   infection,	   and	   the	  
immune	  defenses	   implemented	  by	  animals.	  We	  are	  particularly	   interested	   in	  the	  pathogen	  
Brucella	  melitensis	  and	  its	  ability	  to	  deal	  with	  the	  immune	  responses	  of	  mice.	  














2. Brucella,	  the	  agent	  of	  brucellosis	  
2.1. Historical	  overview	  of	  the	  pathogen	  
Skeletal	   remains	   from	   the	   Ancient	   Albanian	   city	   from	   10th	   to	   13th	   centuries	   AD	   revealed	  
circular	   lytic	   lesions	  on	  the	  thoracic	  and	  lumbar	  vertebrae.	  They	  are	  similar	  to	   lesions	  from	  
present	   pathologies	   known	   to	   affect	   these	   skeletal	   regions	   such	   as	   tuberculosis	   or	  
brucellosis.	  Genetic	   screening	  and	  DNA	  sequencing	   revealed	   the	  presence	  of	  Brucella	  DNA	  
and	  suggests	  that	  brucellosis	  has	  been	  present	  in	  this	  region	  at	  least	  since	  the	  Middle	  Ages	  
(Mutolo	  et	  al.,	  2012).	  Before	  this	  period,	  clue	  of	  the	  presence	  of	  brucellosis	  stays	  indirect.	  In	  
August	  79	  AD,	  a	  catastrophic	  volcanic	  eruption	  of	  Mount	  Vesuvius	  was	  responsible	   for	   the	  
sudden	   death	   of	   thousands	   of	   Roman	   residents.	   Examination	   of	   the	   skeletons	   revealed	  
typical	   lesions	  of	  brucellosis	   in	  more	  than	  17	  %	  of	  the	   inhabitants.	   It	   is	  consistent	  with	  the	  
fact	   that	   the	   population	   had	   the	   habit	   to	   consume	   sheep’s	   milk	   and	   its	   derivatives.	   A	  
carbonized	   cheese	   found	   in	   the	   ruins	   reinforced	   this	   conclusion	   when	   it	   revealed	   the	  
presence	   of	   coccobacilli-­‐like	   forms	   morphologically	   and	   dimensionally	   similar	   to	   Brucella	  
(Capasso,	  2002).	  The	  examination	  of	  Egyptian	  bones	  that	  revealed	  osteoarticular	  lesions	  is	  a	  
clue	   that	  brucellosis	  was	  present	   in	  Africa	  around	  750	  BC	   (Pappas	  &	  Papadimitriou,	  2007).	  
More	   recently,	   scientists	   have	   analyzed	   partial	   skeleton	   of	   an	   Australopithecus	   from	   the	  
hominid	   side	   of	   Sterkfontain	   South	   Africa	   (Australopithecus	   africanus).	   The	   lesions	   are	  
consistent	   with	   the	   one	   developed	   in	   case	   of	   brucellosis.	   It	   would	   coincide	   with	   the	  
hypothesis	   that	  Australopithecus	   africanus	   began	   to	   include	  meat	   in	   its	   diet	   and	   it	  moves	  
back	  the	  potential	  origin	  of	  brucellosis	  to	  about	  2.5	  million	  years	  ago.	  (D’anastio	  et	  al.,	  2009).	  	  
	  
One	  became	  aware	  of	  the	  disease	  in	  Malta	  during	  the	  Crimean	  War	  in	  1850	  for	  the	  first	  
time.	   And	   it	   is	   only	   in	   1887	   that	   David	   Bruce	   identified	   Micrococcus	   melitensis	   as	   the	  
pathogen	  responsible	   for	   the	  “Malta	   fever”	   in	  a	  British	  soldier	  who	  died	   from	  the	  disease.	  
The	  genus	  “Brucella”	  was	  given	  in	  honor	  of	  David	  Bruce	  when	  a	  close	  species	  was	  discovered	  
in	   cattle.	   But	   the	   zoonotic	   nature	  of	  Malta	   fever	  was	  only	   discovered	   in	   1905	  by	   isolating	  
Brucella	  melitensis	  from	  goat’s	  milk	  	  (Seleem	  et	  al.,	  2010).	  	  






Table	  1	  :	  Currently	  described	  Brucella	  species	  and	  host	  associated.	  
Species	   Preferential	  host	  
B.	  melitensis	   Sheep,	  goats,	  camels	  
B.	  abortus	   Cattle,	  buffalo,	  elk,	  yaks,	  camels	  
B.	  suis	   Domestic	  pigs,	  wild	  boar,	  reindeer,	  caribou,	  rodents	  
B.	  canis	   Canines	  
B.	  ovis	   Sheep	  
B.	  neotomae	   Rodents	  
B.	  ceti	   Porpoises,	  dolphins,	  whales	  
B.	  pinnipedialis	   Seals	  
B.	  microti	   Red	  foxes,	  common	  voles	  (also	  isolated	  from	  soil)	  
B.	  inopinata	   Unknown	  
B.	  papionis	   Baboons	  
	   	  








2.2. 	  Epidemiology	  in	  humans	  
To	  date,	  11	  species	  of	  Brucella	  have	  been	  identified	  (Table	  1),	  but	  it	  seems	  that	  6	  species	  are	  
able	   to	   generate	   a	   disease	   in	   humans	   (B.	   melitensis,	   B.	   abortus,	   B.	   suis	   and,	   to	   a	   lesser	  
extent,	  B.	  canis,	  B.	  ceti	  and	  B.	  pinnipedialis).	  Brucellosis	  is	  one	  of	  the	  most	  common	  bacterial	  
zoonosis	   in	   the	   world	   with	   more	   than	   500	   000	   new	   reported	   cases	   each	   year.	   However,	  
epidemiological	   data	   underestimate	   the	   disease	   incidence	   for	   various	   reasons,	   such	   as	  
barriers	   to	   accessing	   health	   care	   and	  misdiagnosis.	   Global	   distribution	   of	   the	   disease	   has	  
changed	   over	   the	   last	   decade	   and	   is	   still	   in	   constant	   evolution,	   due	   to	   sanitary,	   socio-­‐
economic	   and	   political	   reasons	   (Pappas	   et	   al.,	   2006).	   Figure	   1	   shows	   the	   most	   recent	  
representation	  of	  the	  worldwide	  incidence	  of	  brucellosis	  (between	  2000	  and	  2006)	  (Pappas	  
et	   al.,	   2006).	   The	   disease	   is	   eradicated	   in	   many	   developed	   countries	   but	   remains	   highly	  
prevalent	   in	  the	  developing	  world.	  Central	  and	  South	  America,	  The	  Middle	  East,	  Africa	  and	  
west	  of	  Asia	  are	  the	  most	  affected	  regions	  in	  the	  world	  (Dean	  et	  al.,	  2012;	  Medzhitov,	  2007;	  
Pappas	  et	  al.,	  2006).	  
	  
2.3. Pathology	  and	  transmission	  
Human	  brucellosis	  is	  mainly	  associated	  with	  an	  undulant	  fever	  during	  the	  acute	  phase.	  If	  
the	  disease	  is	  not	  treated,	  human	  can	  suffer	  from	  multiple	  complications,	  depending	  on	  the	  
site	   of	   infection.	  Direct	   cutaneous	   contact,	   ingestion	   of	   animal	   products	   and	   inhalation	   of	  
airborne	   agents	   are	   the	   main	   routes	   of	   transmission	   in	   humans.	   (Acha	   &	   Szyfres,	   2001).	  
Encephalitis,	   meningitis,	   spondylitis,	   arthritis,	   endocarditis,	   orchitis,	   prostatitis	   or	   even	  
abortion	  can	  be	  the	  symptoms	  of	  the	  chronic	  disease	  in	  humans	  (Acha	  &	  Szyfres,	  2001).	  
	  
The	   pathology	   in	   animals	   is	  mainly	   characterized	   by	   abortion	   in	   pregnant	   females	   but	  
males	  can	  also	  become	  sterile.	  Most	  of	  the	  females	  abort	  only	  once	  even	  if	  the	  placenta	  is	  
highly	   infected	   in	  subsequent	  normal	  calvings	   (Morgan,	  1969;	  Saenz	  et	  al.,	  2008).	   It	  seems	  
that	   60	   to	   70	  %	   of	   the	   fetuses	   born	   to	   infected	  mothers	   carry	   the	   disease	   (Díaz	   Aparicio,	  
2013).	  Horizontal	  transmission	  of	  the	  disease	  is	  frequent	  and	  is	  usually	  ensured	  by	  inhalation	  
of	  the	  bacterium	  during	  the	  birth,	  or	  ingestion	  of	  food	  or	  water	  contaminated	  with	  secretion	  
or	   aborted	   fetal	   remains	   from	   infected	   animals.	   Juveniles	   are	   often	   infected	   by	  
contaminated	  milk.	  Milking	  healthy	  females	  after	  the	  infected	  ones	  with	  the	  same	  teat	  cups	  















is	  endemic,	  animal	  production	  is	  disturbed	  because	  of	  the	  reduction	  of	  milk	  production,	  the	  
abortion	  and	  delayed	  conception.	  The	  slaughter	  of	  contaminated	  animals	  and	  the	  decrease	  
in	  productivity	  generates	  extensive	  economic	  losses	  estimated	  to	  several	  hundreds	  of	  million	  
dollars	  (Seleem	  et	  al.,	  2010).	  
	  
Brucella	  species	  are	  classified	  according	  to	  their	  preferential	  host	  but	  cross-­‐infections	  can	  
also	   occur	   between	   species.	   For	   example,	  Brucella	   abortus,	   the	   etiologic	   agent	   for	   bovine	  
brucellosis,	  can	  infect	  goats	  that	  share	  pasture	  and	  facilities	  with	  cattle,	  or	  dogs	  coming	  from	  
the	  same	  farm	  (E.	  Diaz	  Aparicio,	  2013;	  B.	  K.	  Baek	  et	  al.,	  2003).	  Brucella	  melitensis,	  normally	  
associated	  with	  infection	  in	  goats	  and	  sheep,	  can	  also	  be	  responsible	  for	  brucellosis	  in	  dogs,	  
cattle	   and	   camels	   (Acha	  &	   Szyfres,	   2001).	   Cross-­‐infection	   can	   become	   an	   important	   issue,	  
like	   in	   The	   Middle	   East	   where	   B.	   melitensis	   regularly	   infects	   cattle	   while	   it	   is	   the	   most	  
frequently	  reported	  species	  infecting	  human	  (Corbel,	  2006).	  	  
	  
2.4. Diagnosis	  of	  Brucellosis	  
Diagnosis	  of	  brucellosis	  in	  humans	  can	  be	  achieved	  by	  the	  isolation	  of	  Brucella	  from	  
samples	  such	  as	  blood,	  cerebrosplinal	  or	  synovial	  fluid.	  Unfortunately,	  the	  detection	  of	  the	  
pathogen	  in	  the	  sample	  is	  far	  from	  being	  a	  frequent	  success.	  Serological	  tests	  are	  therefore	  
often	  necessary	   for	   the	  diagnosis	  of	   the	   infection.	   In	  Belgium,	  CODA-­‐CERVA	   is	   the	  national	  
reference	   laboratory	   for	   brucellosis	   in	   humans.	   Two	   serological	   tests	   are	   done:	   (I)	   Rose	  
Bengal	  test,	  based	  on	  the	  agglutination	  of	  the	  serum	  in	  presence	  of	  Brucella	  antigen,	  and	  (II)	  
ELISA	   (Enzyme-­‐Linked	   Immunosorbent	   Assay),	   which	   reveals	   the	   presence	   of	   anti-­‐LPS	  
antibodies	   from	   the	   serum	  by	   an	  enzymatic	   reaction.	   The	   combination	  of	   the	   two	   tests	   is	  
required	   because	   their	   sensitivity	   is	   not	   optimal.	   It	   is	   also	   important	   to	   know	   that	   cross-­‐
reaction	  with	  other	  pathogens	  like	  Yersinia	  enterolitica	  or	  Francisella	  tularensis	  is	  possible.	  In	  
Belgium,	  brucellosis	   is	   rare	   in	  humans:	   there	  are	  only	  5	   to	  10	  cases	  of	  brucellosis	  per	  year	  
and	  patients	  are	  generally	  allochtons,	  coming	  from	  countries	  where	  brucellosis	   is	  endemic.	  
Therefore,	  if	  a	  patient	  has,	  for	  example,	  an	  undulent	  fever,	  diagnosis	  can	  take	  times	  before	  
thinking	  about	  brucellosis.	  
	  
Brucellosis	  is	  not	  endemic	  in	  livestock	  in	  Belgium	  but	  the	  presence	  of	  the	  bacterium	  
in	   wildlife	   is	   not	   excluded.	   Its	   transmission	   to	   the	   livestock	   is	   therefore	   possible	   and	  












brucellosis	   in	   animals	   is	   abortion	   at	   the	   first	   gestation.	   In	   case	   of	   abortion	   in	   bovine,	  
bacteriology	   is	   systematically	  made.	   if	  Brucella	   is	   responsible	   for	   the	   event,	   it	   is	   detected	  
without	   any	   problem.	  However,	   serological	   tests	   are	   essential	   if	   there	   is	   no	   symptoms.	   In	  
Belgium,	   seroagglutination	   test	   (SAT)	   and	   commercial	   ELISA	   are	   done	   in	   regional	  
laboratories.	  If	  the	  sample	  is	  positive,	  it	  is	  sent	  to	  the	  CODA-­‐CERVA	  where	  a	  more	  effective	  
non-­‐commercial	  ELISA	  test	  is	  done	  to	  confirm	  the	  results	  before	  make	  a	  decision	  about	  the	  
animal.	  
	  
2.5. Treatment	  and	  vaccination	  
Contaminated	  humans	  have	  to	  be	  treated	  by	  antibiotics	  to	  avoid	  chronic	  complications.	  
The	  intracellular	  localization	  of	  Brucella	  and	  its	  ability	  to	  replicate	  in	  cells	  specialized	  in	  the	  
destruction	  of	  pathogens	  explain	  that	  treatment	  failure	  and	  relapse	  rate	  are	  relatively	  high	  
and	  depend	  on	  drug	  combination	  and	  patient	  compliance.	  A	  combination	  of	  two	  antibiotics	  
is	   necessary	   to	   avoid	   relapse	   and	   to	   prevent	   multiplication	   of	   intracellular	   bacteria.	  
Presently,	   the	   Food	   and	   Agriculture	   Organisation	   of	   the	   United	   Nation	   and	  World	   Health	  
Organization	   (FAO/WHO)	   Expert	   Committee	   consider	   the	   combination	   of	   high	   doses	   of	  
doxycycline	  with	  rifampicin	  during	  six	  weeks	  as	  the	  optimal	  treatment	  (Seleem	  et	  al.,	  2010).	  
	  
Infected	   animals	   are	   not	   treated;	   they	   have	   to	   be	   eliminated.	   In	   countries	   where	   the	  
zoonosis	  is	  endemic,	  vaccination	  of	  healthy	  livestock	  is	  important	  to	  limit	  the	  infection	  from	  
contaminated	   ones	   and	   wildlife:	   “Strain	   19”	   is	   the	   vaccine	   with	   proven	   efficacy	   against	  
bovine	   brucellosis,	   and	   the	   vaccine	   “Rev1”	   controls	   the	   ovine	   and	   caprine	   brucellosis.	  
Nevertheless,	  these	  live	  attenuated	  vaccines	  are	  not	  fully	  effective;	  they	  can	  trigger	  abortion	  
and	   be	   infectious	   for	   humans.	  Moreover,	   “Rev1”	   is	   resistant	   to	   streptomycin,	  which	   is	   an	  
antibiotic	   that	   could	   be	   used	   in	   the	   treatment	   of	   brucellosis,	   and	   induces	   antibodies	   that	  
interfere	  with	  diagnosis	  of	  the	  real	  disease	  (Moriyón	  et	  al.,	  2004).	  Consequently,	  an	  effective	  
vaccine	  that	  would	  (i)	  not	  interfere	  with	  diagnosis,	  (ii)	  not	  induce	  abortion,	  (iii)	  not	  resist	  to	  
antibiotics	  used	  for	  treatment	  and	  (iv)	  would	  be	  safe	  enough	  for	  human	  still	  has	  to	  be	  found.	  






TABLE	  2:	  PRRs	  of	  the	  innate	  immunity	  and	  their	  PAMPS	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Carbohydrates	  (e.g.	  bacterial	  capsules)	  
	  
	   	  
Figure	   2:	   Schematic	   structure	   of	   LPS	   from	   Brucella.	   It	   is	   composed	   of	  
three	  domains	  :	   a	  polysaccharidic	  O	   chain	   in	  «	  smooth	  »	   strains,	  a	   core	  







3. Brucella	  and	  the	  immune	  response	  
3.1. Innate	  immune	  vigilance	  facing	  Brucella	  
Classically,	  the	  innate	  immune	  system	  is	  able	  to	  recognize	  an	  invading	  pathogen	  through	  
specific	  signatures:	  the	  pathogen	  associated	  molecular	  patterns	  (PAMPS).	  This	  recognition	  is	  
mediated	   by	   pattern-­‐recognition	   receptors	   (PRRs)	   (Table	   2).	   The	   consequence	   of	   this	  
recognition	   is	   the	   inflammation	  and	   the	  development	  of	  an	   immune	  response	   to	  clear	   the	  
infection	   through	   the	   activation	  of	   effector	  mechanisms	  deleterious	   for	   the	   pathogen	   (for	  
more	  details	  see	  Box	  1).	  However,	  some	  pathogens,	  as	  Brucella,	  have	  developed	  strategies	  
to	  escape	  and	  resist	  to	  the	  immune	  response	  (Gorvel,	  2008).	  Brucella	  has	  developed	  furtive	  
characteristics	   by	   losing,	   modifying	   or	   hiding	   PAMP-­‐bearing	   molecules,	   ensuring	   low	  
stimulatory	  activity	  of	  host	  cells:	  
-­‐ The	  bacterium	  does	  not	  display	  many	  classical	  structures	   involved	   in	  virulence	  such	  
as	  pili,	   fimbriae	  and	  capsules.	  The	  absence	  of	   these	  PAMP-­‐bearing	  molecules	   limits	  
the	  detection	  of	  the	  pathogen	  by	  immune	  effectors	  (Martirosyan	  et	  al.,	  2011).	  
-­‐ The	  unconventional	  structure	  of	  Brucella	  lipopolysaccharide	  (LPS)	  molecule	  (Figure	  2)	  
protects	  the	  bacterium	  from	  the	  innate	  immunity.	  The	  lipid	  A	  displays	  a	  low	  number	  
of	  anionic	  groups,	  leading	  to	  a	  reduced	  binding	  of	  bactericidal	  cationic	  peptides.	  The	  
long	   O-­‐chains	   of	   LPS	   in	   smooth	   species	   (such	   as	   B.	   melitensis,	   B.	   suis,	   B.	   abortus)	  
provoke	  steric	  barriers	  that	  contribute	  to	  the	  protection	  against	  bactericidal	  products	  
and	   prevent	   deposition	   of	   complement	   at	   the	   surface	   of	   Brucella	   (Lapaque	   et	   al.,	  
2005).	  Moreover,	   the	   structure	   of	   Brucella	   LPS	   has	   reduced	   endotoxic	   properties	  
because	   of	   a	   reduced	   TLR4	   agonist	   activity,	   which	   is	   expected	   to	   stimulate	  
neutrophils,	  monocytes	   and	  macrophages	   to	  produce	  adhesion	  molecules	   and	  pro-­‐
inflammatory	  cytokines	  (de	  Jong	  et	  al.,	  2010;	  Ko	  &	  Splitter,	  2003).	  
-­‐ Other	   molecules	   of	   the	   cell	   envelope,	   such	   as	   phospholipids,	   lipoproteins	   and	  
ornithine-­‐containing	   lipids	   also	  display	   reduction	  of	   negative	   charges	   and	  are	  weak	  
inducers	   of	   pro-­‐inflammatory	   molecules	   (such	   as	   Tumor	   Necrosis	   Factor	   (TNF)α,	  
Interleukin	  (IL)-­‐1β	  and	  IL-­‐6)	  (Barquero-­‐Calvo	  et	  al.,	  2007;	  Gorvel,	  2008).	  
	  






Box	  1:	  overview	  of	  the	  innate	  immune	  system	  
	  
The	   innate	   immune	  system	   is	   composed	  of	   soluble	  effectors,	   such	  as	   the	  complement,	  and	  a	  
diverse	   set	   of	   cells	   of	   haematopoeietic	   origin,	   including	   tissue-­‐residing	   cells	   (macrophages	   and	  
dendritic	   cells)	   and	   cells	   that	   patrol	   throughout	   the	   body	   via	   blood	   and	   lymphatic	   vessels	  
(neutrophils,	   eosinophils	   and	   monocytes).	   The	   system	   constitutes	   the	   first	   line	   of	   the	   immune	  
defense:	   innate	   cells	   are	   rapidly	   activated	   in	   contact	   of	   pathogens	   thanks	   to	   receptors	   called	  
pattern-­‐recognition	   receptors	   (PRRs)	   that	   recognize	   highly	   conserved	   foreign	   structures	   called	  
pathogen-­‐associated	  molecular	  patterns	  (PAMPs).	  Table	  2	  enumerates	  PRRs	  that	  recognize	  bacterial	  
PAMPs	  (from	  Doughty,	  2011;	  Takeuchi	  &	  Akira,	  2010).	  	  
	  
The	  reaction	  of	   innate	   immunity	   is	  particularly	   rapid,	  but	   the	  response	   is	  not	  specific	  and	  the	  
repertoire	  of	  PRRs	  is	  limited	  and	  invariant.	  This	  global	  system	  lacks	  long	  term	  and	  specific	  memory	  
and	  does	  not	  have	  any	  ability	  to	  enhance	  the	  response	  in	  case	  of	  a	  second	  contact	  with	  the	  foreign	  
structure.	   However	   it	   is	   noteworthy	   that	   some	   cell	   types	   such	   as	   Natural	   Killer	   (NK)	   cells	   and	  
monocytes/macrophages,	   classified	   as	   innate	   immune	   cells,	   display	   a	   form	   of	   memory	   (termed	  
trained	  immunity)	  against	  some	  antigens	  (Kleinnijenhuis	  et	  al.,	  2012;	  Quintin	  et	  al.,	  2012;	  Sun	  et	  al.,	  
2014).	  
	  
Three	  major	  effector	  mechanisms	  can	  be	  attributed	  to	  the	   innate	   immune	  response	  against	  a	  
pathogen:	  	  
-­‐ Phagocytosis:	  phagocytic	  cells	  engulf	  and	  internalize	  the	  pathogen	  in	  order	  to	  destroy	  it	  by	  a	  
set	  of	  digestive	  enzymes	  and	  reactive	  oxygen	  species,	  among	  others.	  	  
-­‐ Inflammation:	  damaged	  tissues	  and	  resident	   immune	  cells	  secrete	  chemokines	  that	  attract	  
phagocytes	  from	  the	  circulation	  to	  the	  infected	  site.	  Activated	  resident	  cells	  and	  phagocytes	  
produce	   soluble	   mediators	   called	   cytokines	   and	   interleukins	   that	   further	   increase	   the	  
phagocytic	  function	  of	  the	  cells.	   Increasing	  secretion	  of	  chemokines	  and	  cytokines	   leads	  to	  
the	   recruitment	   of	   cells	   and	   plasma	   proteins	   in	   tissues	   through	   increased	   vessel	  
permeability,	   triggering	   the	   classical	   signs	   of	   inflammation	   (swelling,	   redness,	   pain	   and	  
heat).	   The	   inflammatory	   response	   is	   also	   essential	   for	   the	   healing	   process	   of	   the	   injured	  
tissue.	  (Bellanti,	  2012;	  Moser	  &	  Leo,	  2010).	  
-­‐ Cytotoxicity:	  cytotoxic	  cells,	  such	  as	  NK	  cells,	  recognize	  infected	  cells	  and	  use	  a	  combination	  
of	  mechanisms	   to	   lyse	   them.	   These	   include	   (i)	   the	   release	   of	   cytotoxic	  molecules	   such	   as	  
perforin,	  which	  polymerizes	  to	  form	  a	  pore	  in	  target	  membrane,	  and	  granzymes,	  which	  are	  
serine	  proteases	  that	  use	  the	  pore	  to	  reach	  the	  cytoplasm	  of	  target	  cell,	  (ii)	  Fas	  ligand	  (FasL),	  
constitutively	   expressed	  or	   induced	  by	   interaction	  with	   aberrant	   cells,	   and	   (iii)	  membrane	  
bound	  or	  secreted	  cytokines	  Tumor	  Necrosis	  Factor	  (TNF)α.	  These	  mechanisms	  activate	  the	  
apoptosis,	  a	  non-­‐inflammatory	  programmed	  cell	  death	  (Topham	  &	  Hewitt,	  2009).	  
	  
When	   the	   defenses	   of	   the	   innate	   immunity	   are	   not	   sufficient	   to	   destroy	   the	   invader,	   the	  
efficiency	  of	  the	  response	  is	  improved	  by	  the	  activation	  of	  the	  adaptive	  immune	  response.	  Globally,	  
after	   the	   contact	   and	   the	   recognition	   of	   the	   pathogen,	   the	   innate	   immune	   cells,	   and	   more	  
particularly	  professional	  antigen-­‐presenting	  cells	  (APCs),	  can	  migrate	  to	  secondary	  lymphoid	  organs	  
and	   present	   antigens	   associated	   with	   a	   major	   histocompatibility	   complex	   (MHC)	   molecule	   to	   T	  
lymphocytes.	   The	   antigen	   presentation,	   added	   to	   co-­‐receptors	   and	   soluble	   signals,	   activates	   T	  
lymphocytes	  and	  initiate	  the	  adaptive	  immune	  response	  (Medzhitov,	  2007).	  For	  more	  details	  on	  the	  







-­‐ Usually,	   flagellin	   is	   recognized	   by	   TLR5.	   In	  Brucella,	   its	   amino	   acid	   sequence	   is	   not	  
well	   detected	   by	   this	   receptor	   because	   it	   does	   not	   have	   its	   agonist	   domain.	  
Nevertheless,	   its	   recognition	   by	   at	   least	   the	   NOD-­‐like	   receptor	   IPAF	   limits	   the	  
persistence	  of	  Brucella	  in	  mice	  (Terwagne	  et	  al.,	  2013).	  
	  
Thanks	  to	  the	  characteristics	   listed	  above,	  Brucella	   is	  able	  to	  partially	  escape	  the	   innate	  
immune	  system	  and	  reduces	   immuno-­‐stimulatory	  properties	  of	  dendritic	  cells	   (DCs).	  Other	  
mechanisms	  actively	  suppress	  DCs	  both	  at	  the	  cytokine	  production	  level	  (such	  as	  TNFα)	  and	  
at	  the	  antigen	  processing	  and	  presentation	  level	  (de	  Jong	  et	  al.,	  2010;	  Salcedo	  et	  al.,	  2008)	  :	  	  
-­‐ Btp1	   (Brucella	   Tir-­‐containing	   protein)	   in	   Brucella	   abortus	   (homologous	   of	   TcpB	   in	  
Brucella	   melitensis)	   is	   a	   bacterial	   protein	   with	   significant	   sequence	   similarity	   to	  
Toll/interleukin	   receptor	   (TIR)	   domain	   family	   which	   interferes	   with	   the	   signaling	  
pathway	   of	   TLR2	   and	   TLR4.	   Thanks	   to	   this	   particularity,	   it	   is	   responsible	   for	   the	  
decrease	  of	  the	  maturation	  of	  Brucella-­‐infected	  DCs:	  it	  reduces	  the	  expression	  of	  DCs	  
maturation	  marker	  such	  as	   the	  Cluster	  of	  Differentiation	  CD80	  and	  DALIS	   (dendritic	  
cells	   aggresome-­‐like	   induced	   structures),	   the	   production	   of	   TNFα,	   IL-­‐12	   and	  
Interferon	   (IFN)	   β,	   and	   the	   level	   of	   surface	   expression	   of	  MHCII	   (Cirl	   et	   al.,	   2008;	  
Salcedo	  et	  al.,	  2008).	  
-­‐ The	   atypical	   Brucella	   LPS	   is	   recycled	   to	   the	   cell	   surface	   and	   forms	   stable	  
macrodomains	   that	   sequester	   MHCII	   molecules.	   The	   complex	   between	   LPS	   and	  
MHCII	   is	   non-­‐functional	   and	   is	   not	   able	   to	   stimulate	   T	   lymphocytes	   properly	  
(Forestier	  et	  al.,	  2000).	  
-­‐ Brucella	   is	  also	  responsible	  for	  retention	  of	  MHCI	  in	  the	  Golgi	  apparatus,	  decreasing	  










	   	  
Box	  2:	  Brucella	  trafficking	  in	  its	  host	  cell	  
	  
Following	   phagocytosis,	   even	   if	   the	   host	   cell	   kills	  most	   of	   the	  Brucella,	   a	   small	   percentage	   of	  
bacteria	  survive	  and	  replicate.	  To	  succeed,	  the	  pathogen	  controls	  the	  trafficking	  and	  maturation	  of	  
its	  Brucella	  containing	  vacuole	  (BCV).	  The	  BCV	  starts	  normal	  trafficking	  with	  a	  transient	  association	  
with	   early	   endosome.	   Next,	   the	   presence	   of	   markers	   such	   as	   LAMP1,	   Rab7	   and	   Rab	   interacting	  
lysosomal	  protein	   (RILP)	  on	  the	  BCV	  suggests	   that	   its	   trafficking	  undergoes	  temporary	   interactions	  
with	  late	  endosome	  and	  even	  lysosome	  (Starr	  et	  al.,	  2008).	  These	  fusions	  are	  accompanied	  with	  an	  
increased	  acidification	  that	  turns	  out	  to	  be	  essential	  for	   intracellular	  surviving	  of	  Brucella	  (Porte	  et	  
al.,	  1999).	  Then,	   the	  trafficking	  of	   the	  vacuole	  becomes	  atypical	   for	   the	  host	  cell	  because	  the	  BCV	  
begins	   to	   interact	   with	   endoplasmic	   reticulum	   (ER).	   There,	   it	   acquires	   ER	   markers	   including	  
chaperones	   calreticulin,	   calnexin	   and	   the	   translocator	   sec61.	   The	   ER-­‐like	   compartment	   containing	  
Brucella	   constitutes	   the	   preferential	   location	   that	   ensures	   its	   replication	   and	   its	   virulence	  
(Martirosyan	   et	   al.,	   2011).	   The	   control	   of	   intracellular	   trafficking	   and	   the	   maturation	   of	   the	  
phagosome	  is	  essential	  for	  the	  pathogen	  and	  involves	  specific	  Brucella	  factors,	  including	  virB	  type	  IV	  
secretion	  system	  (Comerci	  et	  al.,	  2001;	  Delrue	  et	  al.,	  2001),	  two-­‐component	  (bvrR-­‐bvrS)	  regulatory	  
system	   (Sola-­‐Landa	   et	   al.,	   1998),	   LPS	   O	   chain	   (Porte	   et	   al.,	   2003)	   and	   β-­‐cyclic	   glucan	   (Arellano-­‐
Reynoso	  et	  al.,	  2005).	  To	  survive	  during	  the	  trafficking	  and	  in	  its	  replicative	  niche,	  Brucella	  possesses	  
features	   to	  deal	  with	  encounter	   stresses,	   such	  as	   reactive	  oxygen	  species	   (ROS),	   reactive	  nitrogen	  
species	  (RNS),	  acidic	  environment,	  deprivation	  of	  nutrients	  and	  transient	  exposure	  to	  antimicrobial	  
peptides.	  For	  more	  details	  on	  these	  features,	  see	  the	  following	  articles	  (Kohler	  et	  al.,	  2003;	  Roop	  et	  






Despite	   these	   escape	   strategies,	   some	   of	   PRRs	   finally	   recognize	   the	   pathogen	   and	  
activate	   the	  host	   innate	   immune	   response.	   Indeed,	   some	  studies	  using	   the	   intraperitoneal	  
(i.p.)	  model	  have	  shown	  a	  role	  for	  TLR9,	  that	  recognizes	  DNA	  of	  Brucella	  (Copin	  et	  al.,	  2007;	  
Oliveira	  et	  al.,	  2008).	  TLR9-­‐deficient	  mice	  are	  more	  susceptible	  and	  show	  a	  reduction	  of	  IL-­‐12	  
production	   by	   macrophages	   and	   DCs	   and	   a	   decrease	   in	   IFNγ and	   nitric	   oxide	   synthase	  
(NOS2/INOS)	  positive	  cells	  in	  the	  spleen	  (Copin	  et	  al.,	  2007;	  Macedo	  et	  al.,	  2008).	  A	  possible	  
collaboration	  between	  TLR4	  and	  TLR9	  has	  even	  been	  proposed	  since	  TLR4-­‐deficient	  mice	  are	  
slightly	   susceptible	   (Copin	  et	  al.,	  2007).	   It	   is	   recognized	   that	  other	  PRRs	   recognize	  Brucella	  
because	  MyD88,	  which	  is	  the	  adaptor	  molecule	  for	  several	  TLRs,	  contributes	  significantly	  to	  
the	   control	   of	   Brucella	   infection	   in	   mice.	   Indeed,	   MyD88-­‐deficient	   mice	   are	   highly	  
susceptible	   to	  Brucella,	  maturation	  of	  DCs	   is	   reduced,	   IL-­‐12	  and	  TNFα	  are	   less	   induced	  and	  
IFNγ,	  and	  INOS	  production	  is	  altered	  (Macedo	  et	  al.,	  2008;	  Pei	  et	  al.,	  2012).	  	  
	  
To	  conclude,	  all	  the	  strategies	  used	  by	  Brucella	  impair	  the	  ability	  of	  the	  host	  immunity	  to	  
rapidly	  identify	  Brucella	  as	  a	  Gram-­‐negative	  pathogenic	  bacterium.	  The	  consequence	  is	  that	  
classical	   anti-­‐bacterial	   host	   response	   appears	   reduced	   and	   delayed.	   It	   allows	   Brucella	   to	  
reach	   its	   intracellular	   niche	   (Box2)	   and	   establish	   infection	   before	   effective	   immune	  
activation	  (de	  Jong	  et	  al.,	  2010).	  	  
	  
3.2. Brucella	  facing	  the	  adaptive	  immune	  response	  
Once	  activated,	   specialized	   innate	   immune	  cells	  named	  Antigen-­‐presenting	  cells	   (APCs)	  
(e.g:	   DCs,	  Macrophages,	   B	   lymphocytes)	   are	   able	   to	   induce	   the	   activation	   of	   the	   adaptive	  
immunity	   to	   organize	   and	   reinforce	   the	   immune	   defenses	   against	   pathogens	   (for	   more	  
details	  on	  adaptive	  immunity,	  see	  Box	  3	  and	  Box	  4).	  As	  explained	  before,	  Brucella	   limits	  its	  
detection	   by	   the	   innate	   immune	   cells,	   reduces	   the	   maturation	   of	   DCs	   and	   impairs	   the	  
antigen	  presentation	  to	   the	  adaptive	   immunity	   to	  ensure	   its	  establishment,	  but	   the	   innate	  
immune	   cells	   finally	   manage	   to	   activate	   lymphocytes	   that	   initiate	   a	   T	   helper	   immune	  
response.	  The	  use	  of	  RAG1-­‐deficient	  mice	  that	  do	  not	  display	  mature	  B	  and	  T	   lymphocytes	  
has	  shown	  that	  the	  adaptive	  immune	  response	  plays	  an	  important	  role	  in	  the	  control	  of	  the	  
infection	  by	  Brucella	  (Copin	  et	  al.,	  2012;	  Izadjoo	  et	  al.,	  2000;	  Vitry	  et	  al.,	  2012).	  









Box	  3:	  Adaptive	  immune	  populations	   	  
	  
Adaptive	  immunity	  is	  composed	  of	  T	  and	  B	  lymphocytes	  and	  can	  reinforce	  the	  immune	  defenses	  
initiated	  by	  innate	  immunity.	  Lymphocytes	  have	  the	  ability	  to	  recognize	  a	  wide	  range	  of	  molecular	  
structures	  with	  specific	  receptors	  because	  during	  their	  maturation,	  a	  process	  of	  DNA	  recombination	  
gives	   rise	   to	   random	   formation	   of	   a	   large	   panel	   of	   antigenic	   receptors.	   Then,	   selections	   are	  
necessary	  to	  eliminate	  lymphocytes	  that	  recognize	  self-­‐antigens.	  For	  T	  lymphocytes,	  the	  recognition	  
of	  self-­‐MHC	  molecules	  is	  also	  an	  essential	  selection.	  	  
	  
Class Structure Properties 
IgA Dimeric and 
monomeric 
Found in gastrointestinal, respiratory and 
urogenital tract mucosa. Prevents the 
colonization by pathogens. Also present in 
saliva, tears and milk. 
IgD Monomeric Membran immunoglobulin. It is part of the 
membrane receptor of naïve B lymphocytes 
(BCR). 
IgE Monomeric Involved in allergic and parasitic processes. 
Its interaction with basophils and 
mastocytes causes histamine release. 
IgG Monomeric Main immunoglobulin of acquired 
immunity. It has the capacity to cross the 
placental barrier in certain animals such as 
carnivores, rodents and primates. 
IgM Monomeric and 
Pentameric 
It is part of the membrane receptor of naïve 
B lymphocytes (BCR). Form found in the 
serum, secreted early in acquired immune 
response. 
Once	  mature,	  naive	  T	   lymphocytes	  generally	  need	   to	   recognize	  an	  antigen	  presented	  by	  APCs	  
(e.g.:	  DCs,	  macrophages)	  or	  infected	  cells,	  engage	  their	  co-­‐receptor	  and	  receive	  soluble	  signals	  (such	  
as	  cytokines)	  to	  be	  activated.	  Then,	  they	  undergo	  a	  clonal	  amplification	  before	  participating	   in	  the	  
control	  of	   the	   infection.	   It	   is	  mainly	  because	  of	   this	   amplification	   that	   lymphocytes	   constitute	   the	  
second	  line	  of	  defense	  against	  a	  pathogen.	  T	  lymphocytes	  can	  have	  a	  cytotoxic	  effect	  by	  killing	  the	  
infected	   cells	   (e.g.:	   T	   CD8+	   cells)	   or	   produce	   cytokines	   that	   activate	   other	   cells	   to	   destroy	   or	  
neutralize	   the	   pathogen	   (e.g.:	   T	   helper	   CD4+	   cells).	   Some	   of	   them	  will	   differentiate	   to	   ensure	   an	  
immunological	   memory	   that	   provides	   a	   long-­‐lasting	   protection	   against	   further	   contact	   with	   the	  
pathogen.	  	  
	  
Naive	  B	  cells	   require	   two	  distinct	  signals	   to	  be	  activated:	   the	   first	  one	   is	   the	  recognition	  of	  an	  
antigen	  thanks	  to	  their	  receptors	  (BCRs).	  The	  second	  signal	  can	  be	  T-­‐cell	  dependent	  or	  independent.	  
The	  activation	  of	   some	  B	   cells	  needs	   interaction	  with	  T	   cells:	   in	   this	   case,	  B	   cells	   act	   as	  APCs:	   the	  
recognized	  antigen	  by	  BCR	  is	  internalized	  by	  endocytosis,	  digested	  and	  associated	  with	  MHCII	  on	  B	  
cell	  surface.	  The	  presentation	  of	  the	  antigen	  with	  MHCII	  triggers	  the	  activation	  of	  T	  cells	  that	  then	  
give	  the	  second	  signal	  to	  the	  B	  cells	  thanks	  to	  a	  variety	  of	  cytokines.	  Alternatively,	  B	  cells	  can	  directly	  
receive	   the	   second	   signal	   by	   certain	   type	   of	   antigens,	   such	   as	   LPS	   or	   flagellin	   (T	   cell	   independent	  
activation).	   Once	   activated,	   B	   cells	   proliferate	   and	   form	   germinal	   centers	   in	   secondary	   lymphoid	  
organs	  where	  they	  differentiate	  into	  plasma	  cells	  or	  memory	  B	  cells.	  Plasma	  cells	  produce	  antibodies	  
that	   are	   particularly	   effective	   to	  
fight	  extracellular	  pathogens	  into	  
the	   blood	   and	   the	   lymph.	  
Globally,	   antibodies	   bind	   foreign	  
antigens	   that	   become	   inactive	  
and/or	   are	   better	   recognized	   by	  
phagocytic	   cells	   for	   destruction	  
(Bellanti,	   2012).	   The	   table	  
opposite	   summarizes	   the	  
characteristics	   of	   the	   different	  
classes	   of	   immunoglobulins	  
(modified	   from	   Mesquita	   Júnior	  








3.2.1. Brucella	  and	  T	  lymphocytes	  
3.2.1.1. Conventional	  T	  cell	  populations	  
Several	   research	   groups	   have	   investigated	   the	   role	   of	   the	   different	   T	   lymphocytes	  
subsets	   in	   the	  defense	  against	  Brucella.	   IFNγ	   is	  often	   linked	   to	   the	  control	  of	   the	   infection	  
because	  its	  production	  is	  crucial	  to	  ensure	  the	  survival	  of	   infected	  mice	  (Baldwin	  &	  Parent,	  
2002;	   Murphy	   et	   al.,	   2001).	   Moreover,	   transfer	   of	   T	   lymphocytes	   has	   a	   protective	   effect	  
partially	  dependent	  on	  IFNγ	  because	  an	  inhibition	  of	  the	  cytokine	  by	  antibodies	  reduces	  the	  
resistance	   of	   the	   receiver	   mice	   (Zhan	   &	   Cheers,	   1993).	   Therefore,	   the	   protective	   role	   of	  
lymphocytes	  have	  been	  associated	  to	  their	  ability	  to	  produce	  IFNγ.	  	  
	  
In	  the	   ip.	  model,	   it	   is	  known	  that	  CD4+	  and	  CD8+	  T	  cells	  produce	   IFNγ	  during	  a	  Brucella	  
infection	   (Baldwin	  &	  Goenka,	  2006;	  Copin	  et	  al.,	   2007).	  However,	  CD4+	  T	   lymphocytes	  are	  
the	  main	  IFNγ-­‐producers	  after	  10	  days	  of	  infection	  by	  Brucella	  melitensis	  (Copin	  et	  al.,	  2007).	  
The	   comparison	   between	   Tap1-­‐deficient	  mice,	   that	   do	   not	   have	  mature	   CD8+	   T	   cells,	   and	  
MHCII-­‐deficient	  mice,	   that	   do	   not	   have	  mature	   CD4+	   T	   cells,	   showed	   that	   IFNγ-­‐producing	  
CD8+	  T	  cells	  are	  not	  sufficient	  to	  control	  Brucella;	  IFNγ	  must	  be	  produced	  by	  CD4+	  T	  cells	  for	  a	  
late	   control	   of	   Brucella	   infection	   (Goenka	   et	   al.,	   2011;	   Vitry	   et	   al.,	   2012).	   The	   cytotoxic	  
function	  of	  CD8+	  T	  cells	   is	  neither	  effective	  against	   the	  bacterium	  probably	  because	  the	  B.	  
melitensis	  derived	  protein	  TcpB	   inhibits	  specific	  activity	  of	   these	  cells	  against	   infected	  cells	  
(Durward	  et	  al.,	  2012).	  The	  role	  of	  CD4+	  T	  cells	  against	  intracellular	  bacteria	  is	  not	  limited	  to	  
their	  ability	  to	  produce	  IFNγ	  and	  regulate	  a	  Th1	  immune	  response;	  Indeed,	  it	  is	  known	  that	  
Th17	  can	  play	  a	  major	  role	  against	  intracellular	  pathogens	  (Bai	  et	  al.,	  2009;	  Conti	  et	  al.,	  2009;	  
Tsai	  et	  al.,	  2013).	  The	  research	  team	  of	  Muraille	  and	  Letesson	  has	  used	  IL17Rα-­‐	   IL21R-­‐	  and	  
IL22-­‐deficient	  mice	  to	  check	  the	  function	  of	  Th17	  in	  the	  protection	  against	  Brucella	  infection.	  
The	  group	  concluded	  to	  a	  minor	  role	  of	  Th17	  because	  they	  only	  observed	  a	  slightly	  higher	  
CFU	  count	   in	   the	  spleen	  of	   these	  deficient	  mice	  12	  days	  post-­‐infection	   (Vitry	  et	  al.,	  2012).	  
Recently,	   a	   cytotoxic	   function	   of	   CD4+	   T	   cells	   has	   been	   identified	   in	   a	  mouse	  model	   of	  B.	  
abortus	   infection.	  If	  early	  stage	  of	  the	  infection	  is	  characterised	  by	  a	  Th1	  adaptive	  immune	  
response	  with	  the	  production	  of	  IFNγ,	  it	  seems	  that	  an	  increasing	  percentage	  of	  CD4+	  T	  cells	  
also	   produce	   granzymes	   B	   and	   have	   a	   cytolytic	   activity	   against	   infected	   phagocytes	   by	  B.	  
abortus.	  So	  far,	   little	   is	  known	  about	  the	  phenotype,	  function	  and	  transcriptional	  profile	  of	  






Box	  4:	  T	  cell	  immune	  responses	  
	  
T	   CD4+	   lymphocytes	   activated	   by	   APCs	   with	   MHCII	   molecules	   can	   induce	   three	   major	   well-­‐
described	  sub-­‐classes	  of	  immune	  responses,	  depending	  on	  the	  type	  of	  detected	  pathogen:	  Th1,	  Th2	  
and	   Th17	   immune	   response	   (Kaiko	   et	   al.,	   2008).	   Globally,	   Th1	   is	   adapted	   to	   fight	   intracellular	  
pathogens,	   Th2	   limits	   the	   invasion	  
by	   extracellular	   macro-­‐parasites	  
such	   as	   helminthes	   (Mosmann	   &	  
Coffman,	   1989),	   and	   Th17	   is	  
generally	   observed	   as	   a	   response	  
against	   extracellular	   bacteria	  
(Harrington	   et	   al.,	   2006)(Figure	  	  
opposite).	   It	   is	   however	   important	  
to	  note	  that	  there	  are	  exceptions	  of	  
these	   generalities,	   depending	   on	  
the	   situation	   and	   location	   of	   the	  
infection.	   It	   has	   been	   reported,	   for	   example,	   that	   Th17	   confers	   partial	   protection	   against	  
intracellular	  bacteria	   such	  as	  Mycobacterium	  tuberculosis	   in	   lungs	   (Okamoto	  Yoshida	  et	  al.,	  2010).	  
These	   last	   years,	   the	   knowledge	   on	   immune	   responses	   has	   evolved	   and	   new	   T	   helper	   subsets	   of	  
lymphocytes	  have	  been	  discovered	  but	  still	  have	  to	  be	  investigated:	  Th9	  lymphocytes	  produce	  IL-­‐9	  
and	   seem	   to	   play	   a	   role	   in	   inflammatory	   diseases	   such	   as	   asthma	   (Kaplan,	   2013),	   and	   T	   helper	  
follicular	   lymphocytes	   (Thf)	   are	   important	   for	   the	   establishment	   of	   germinal	   centers	   and	   the	  
differentiation	  of	  B	  lymphocytes	  into	  plasma	  cells	  and	  memory	  B	  cells	  (Crotty,	  2011).	  	  
	   	  
APCs	  and	  non-­‐immune	  infected	  cells	  can	  also	  activate	  T	  CD8+	  lymphocytes	  by	  the	  presentation	  
of	   antigens	  with	  MHCI	  molecules.	   It	   is	   generally	   the	   case	  when	   the	  pathogen	   is	  mainly	   located	   in	  
intra-­‐cytoplasmic	  compartment.	  Activated	  T	  CD8+	  cells	  have	  a	  cytotoxic	  effect	  on	  the	  infected	  cells:	  
they	   induce	   apoptosis	   in	   target	   cells	   by	   the	   release	   of	   lytic	   granules	   containing	   effector	   proteins.	  
Perforins	  and	  granzymes	  are	  the	  two	  main	  types	  of	  cytotoxic	  proteins	  that	  induce	  the	  death	  of	  the	  
target	  cells	  (Box1)	  (Murphy,	  2011).	  
	  
Other	  T	  cell	  types	  can	  take	  part	  in	  the	  immune	  response.	  Natural	  Killer	  (NK)	  T	  cells	  are	  activated	  
by	   one	   particular	   PAMP	   (glycolipid)	   presented	  with	   a	   complex	   structurally	   close	   to	  MHCI,	   named	  
CD1.	  NKT	  cells	  produce	  a	   large	  panel	  of	   cytokines,	   such	  as	   IFNγ,	   IL-­‐4	  and	   IL-­‐13,	   few	  minutes	  after	  
antigenic	   stimulation	   that	   rapidly	  modulate	   the	   immune	   response	   (Godfrey	  et	  al.,	  2010).	   γδT	  cells	  
are	  generally	  compared	  to	  innate	  immune	  cells	  because	  they	  are	  directely	  activated	  by	  non-­‐peptidic	  
antigens	   and	   are	   present	   in	   cutaneous	   epithelium	   and	   mucosal	   surfaces.	   They	   are	   an	   important	  
source	  of	   inflammatory	   cytokines	   such	  as	   IFNγ	   and	   IL-­‐17	   (Roark	  et	  al.,	   2008).	   These	   cells	   can	  also	  
ensure	  an	  immunological	  memory	  (Sheridan	  et	  al.,	  2013).	  
	  
After	  immune	  activation,	  a	  particular	  type	  of	  T	  CD4+	  cells,	  named	  regulatory	  T	  (reg)	  cells,	  is	  able	  
to	  ensure	  the	  end	  of	  the	  stimulatory	  activities	  of	  T	  cells	  to	  suppress	  potentially	  deleterious	  effects	  
that	   would	   generate	   immunopathology.	   They	   produce	   regulatory	   cytokines,	   such	   as	   IL-­‐10	   and	  
transforming	   growth	   factor	   (TGF)-­‐β,	   to	   feedback	   control	   the	   pro-­‐inflammatory	   immune	   response	  







3.2.1.2. Non	  conventional	  T	  cell	  populations	  
γδ	   T	   lymphocytes	   :	   The	   lymphoid	   tissues	   of	   mice	   contains	   a	   small	   number	   of	   γδ	   T	  
lymphocytes.	  These	  cells	  are	  mainly	  abundant	  in	  barrier	  surfaces	  such	  as	  lungs,	  intestine	  and	  
skin,	   and	   play	   an	   important	   role	   against	   infection	   of	   intracellular	   bacteria,	   such	   as	  
Mycobacterium	  tuberculosis	  (Janis	  et	  al.,	  1989;	  McGill	  et	  al.,	  2014),	  Listeria	  monocytogenes	  
(Tramonti	  et	  al.,	  2008)	  and	  Salmonella	  choleraesuis	  (Emoto,	  1992).	  It	  has	  also	  been	  proposed	  
that	   these	   non	   conventional	   lymphocytes	   could	   alter	   the	   response	   against	   Gram-­‐negative	  
bacteria	  such	  as	  Klebsiella	  pneumoniae	  (Moore	  et	  al.,	  2000).	  The	  role	  of	  γδ	  T	  lymphocytes	  in	  
brucellosis	  has	  not	  been	  deeply	   investigated.	   It	   is	  known	  that	  these	  cells	  are	  activated	  and	  
proliferate	   in	  the	  blood	  of	  humans	   infected	  with	  Brucella	  melitensis	  (Bertotto	  et	  al.,	  1993).	  
Human	  γδ	  T	  cells	  (Vc9Vd2	  T	  cells)	  activated	  by	  a	  “fraction”	  of	  B.	  suis	  produce	  TNFα	  and	  IFNγ,	  
which	  reduces	  bacterial	  multiplication	  inside	  infected	  cells	  (Ottones	  et	  al.,	  2000).	  It	  has	  been	  
demonstrated	   that	   bovine	   γδ	   T	   cell	   rapidly	   respond	   to	   Brucella	   abortus	   infection	   of	   co-­‐
cultured	   autologous	   macrophages	   and	   could	   impair	   the	   intracellular	   replication	   of	   the	  
pathogen	   thanks	   to	   the	   production	  of	   IFNγ	   (Skyberg	  et	   al.,	   2011).	   Experiments	  with	   intra-­‐
peritoneal	  infection	  of	  mice	  with	  Brucella	  abortus	  have	  demonstrated	  that	  γδ	  T	  cell-­‐deficient	  
mice	  are	  slightly	  more	  susceptible	  than	  wild-­‐type	  (wt)	  mice	  during	  the	  first	  week	  of	  infection.	  	  
It	   is	   translated	   into	   a	   splenomegaly	   and	   a	   higher	   bacterial	   load	   in	   the	   spleen.	   These	   cells	  
produce	  IFNγ	  and	  IL17,	  and	  their	  ability	  to	  confer	  protection	  seems	  also	  to	  be	  linked	  to	  the	  
production	   of	   TNFα	   by	   splenocytes.	   However,	   their	   role	   seems	   to	   be	   limited	   because	   the	  
bacterial	  load	  decreases	  rapidly	  to	  similar	  levels	  as	  the	  wt	  mice	  (Skyberg	  et	  al.,	  2012).	  	  
	  
NK	  T	  lymphocytes	  :	  The	  role	  of	  these	  cells	  during	  an	  infection	  of	  Brucella	  suis	  has	  been	  
investigated	   in	  vitro	  by	  the	  research	  team	  of	  Lafont.	  One	  population	  of	  NKT	  cells,	  the	  CD4+	  
invariant	   NKT	   cells,	   limit	   the	   growth	   of	  Brucella	   in	  macrophages	   thanks	   to	   their	   cytotoxic	  
function.	  They	  trigger	  apoptosis	  of	  infected	  cells	  by	  a	  FAS-­‐FASL	  interaction	  and	  by	  the	  release	  
of	  lytic	  granules	  (Bessoles	  et	  al.,	  2009).	  In	  vivo	  investigations	  would	  be	  necessary	  to	  confirm	  
a	  potential	  role	  of	  these	  cells.	  





















3.2.2. Brucella	  and	  B	  lymphocytes	  
It	  is	  now	  agreed	  that	  B-­‐lymphocytes	  do	  not	  contribute	  to	  the	  control	  of	  primary	  infection	  
by	  Brucella.	  On	  the	  contrary,	  in	  the	  i.p.	  model	  of	  infection,	  B	  cell-­‐deficient	  mice	  are	  better	  at	  
clearing	   the	   bacteria	   from	   the	   spleen	   thanks	   to	   the	   absence	   of	   the	   regulatory	   function	   of	  
these	  cells.	  B-­‐lymphocyte	  production	  of	  TGF-­‐β	  in	  BALB/c	  mice	  and	  IL-­‐10	  in	  C57BL/6	  mice	  at	  
the	  early	  stage	  of	  the	  contamination	  dampens	  the	  pro-­‐inflammatory	  Th1	  response	  and	  thus	  
improves	   the	  ability	  of	  Brucella	   to	  establish	   the	   infection	   (Goenka	  et	  al.,	  2011;	  Vitry	  et	  al.,	  
2012).	   Moreover,	   Baldwin’s	   research	   team	   has	   demonstrated	   that	   B-­‐lymphocytes	   can	  
provide	   an	   intracellular	   niche	   for	   Brucella	   and	   could	   participate	   in	   the	   chronic	   infection	  
(Goenka	  et	  al.,	  2012).	  	  
	  
3.3. Granuloma:	  a	  strategy	  of	  the	  immune	  system	  against	  Brucella	  
Granulomas	   are	   organized	   dynamic	   structures	   mainly	   composed	   of	   activated	   monocytes	  
surrounded	  by	  T	   lymphocytes	   (figure	  3).	  Granuloma	   formation	   is	   generally	  presented	  as	   a	  
fighting	  mechanism	  against	  a	  pathogen	  and	  its	  dissemination.	  But	  it	  has	  also	  been	  observed	  
that	   this	   host	   strategy	   can	   be	   exploited	   by	   the	   pathogen	   to	   ensure	   its	   expansion	   and	  
dissemination	   (Davis	   &	   Ramakrishnan,	   2009;	   Ottones	   et	   al.,	   2000;	   Ramakrishnan,	   2012).	  
Granuloma	   and	   their	   contradictory	   role	   in	   the	   disease	   are	   often	   described	   for	   chronic	  
infection	  induced	  by	  Mycobacterium	  tuberculosis	  (Co	  et	  al.,	  2004).	  Our	  group	  has	  described	  
the	   formation	   of	   granulomas	   in	   spleen	   of	   mice	   intraperitoneally	   infected	   with	   Brucella	  
melitensis	   (Copin	   et	   al.,	   2012)	   (see	   appendix	   1).	   One	  week	   post-­‐infection	   granulomas	   are	  
located	   in	   red	   pulp	   of	   the	   spleen	   and	   are	   composed	   of	   mature	   activated	   monocytes,	  
surrounded	  by	  T	  lymphocytes	  and	  granulocytes.	  After	  twelve	  days,	  their	  phenotype	  is	  similar	  
but	   we	   observe	   a	   re-­‐localization	   of	   granulomas	   into	   the	   white	   pulp	   (Copin	   et	   al.,	   2012).	  
During	  brucellosis,	  their	  formation	  seems	  to	  be	  necessary	  to	  control	  the	  bacterial	  load	  and	  it	  
seems	  to	  be	  dependent	  on	  the	  Th1	  immune	  response	  since	  MyD88-­‐,	  IL12-­‐	  and	  IFNγ-­‐deficient	  
mice	  display	  altered	  granuloma	  structure	  and	  are	  highly	  susceptible	  to	  the	  infection	  (Copin	  














3.4. Secondary	  infection	  and	  immunity	  
When	  Brucella	  infects	  an	  animal,	  immune	  mechanisms	  of	  the	  host	  are	  set	  up	  to	  fight	  the	  
pathogen	   and	   some	   immune	   cells	   differentiate	   to	   ensure	   an	   immunological	  memory	   that	  
provides	  a	  long-­‐lasting	  protection	  against	  further	  contact	  with	  the	  pathogen.	  	  
	  
Most	  of	  the	  data	  known	  on	  immune	  memory	  against	  Brucella	  come	  from	  the	  I.P.	  model	  
of	  infection.	  If	  humoral	  immunity	  does	  not	  positively	  contribute	  to	  the	  control	  of	  a	  primary	  
infection	  (Goenka	  et	  al.,	  2011;	  Vitry	  et	  al.,	  2012),	  our	  group	  has	  shown	  that	  humoral	  defense	  
is	   essential	   to	   limit	   early	   blood	   dissemination	   of	   a	   challenge	   (second	   infection).	   This	   step	  
seems	  to	  be	   important	   to	  ensure	  clearance	  of	   the	  spleen,	  as	  B	  cell-­‐deficient	   (MuMT)	  mice	  
are	  not	  able	  to	  avoid	  bacteria	  persistence	  in	  the	  spleen	  in	  comparison	  with	  wild-­‐type	  mice.	  
AID-­‐deficient	  mice	   that	   only	   produce	   IgM	   isotype	   of	   antibodies	   are	   as	   resistant	   as	   the	  wt	  
mice;	   it	   suggests	   that	   IgM	   are	   sufficient	   to	   guarantee	   the	   protection.	   It	   is	   important	   to	  
highlight	  that	  injection	  of	  live	  as	  well	  as	  heat-­‐killed	  bacteria	  induces	  the	  development	  of	  B-­‐
cell	  memory	   population	   able	   to	   produce	   specific	   circulating	   IgM	   fighting	   against	   a	   second	  
bacterial	  dissemination	  (Vitry	  et	  al.,	  2014a)	  (see	  appendix	  2).	  
	  
Cellular	   immunity	   also	   plays	   a	   key	   role	   into	   the	   fighting	   of	   a	   secondary	   infection.	   Our	  
group	  has	  shown	  that,	  as	  for	  the	  control	  of	  a	  primary	  infection,	  IFNγ-­‐producing	  CD4+	  T	  cells	  
are	  crucial	  for	  the	  control	  of	  a	  challenge.	  More	  precisely,	  CD4+	  T	  cells	  are	  not	  important	  to	  
control	   early	   blood	   dissemination	   but	   later	   to	   eradicate	   Brucella	   from	   the	   spleen.	   It	   was	  
proven	  by	  the	  use	  of	  mice	  deficient	  for	  activated	  CD4+	  T	  cells	  and	  IFNγ-­‐inducing	  pathways:	  
MHCII-­‐,	  MyD88-­‐	  and	   IL-­‐12-­‐deficient	  mice,	  associated	  with	  a	  drastic	  reduction	  of	   IFNγ,	  have	  
serious	  impairment	  of	  protective	  immunity	  in	  the	  spleen.	  It	  is	  also	  essential	  to	  point	  out	  that	  
cellular	  protection	  is	  only	  ensured	  following	  live	  vaccine	  administration.	  Heat	  killed	  Brucella	  
does	  not	   induce	  the	  development	  of	  CD4+	   lymphocyte	  memory	  population	  able	   to	   rapidly	  
produce IFNγ in case of re-infection. It means that the dynamics of Brucella’s intracellular 
cycle is critical to induce this effector mechanism (Vitry et al., 2014a) (see appendix 2). 
	  	  






	   	  
Figure 4: Histology of a lung section in mouse. Terminal bronchiols (TB) lead to alveolar 






4. Mucosal	  environment,	  first	  interface	  with	  microorganisms	  
4.1. Overview	  
The	   mucosal	   surfaces	   of	   the	   respiratory,	   gastrointestinal	   and	   urogenital	   tracts	   are	   in	  
direct	   contact	   with	   a	   large	   collection	   of	   foreign	   antigens	   from	   the	   external	   environment.	  
These	   tissues	   must	   maintain	   a	   barrier	   to	   avoid	   infection	   and	   ensure	   survival	   of	   the	   host	  
because	   they	   are	   the	   preferred	   entry	   routes	   for	  most	   of	   the	   pathogens.	   In	   parallel,	   these	  
surfaces	   have	   to	   preserve	   a	   peaceful	   relationship	   with	   diverse	   beneficial	   microbial	  
communities	  (Noora	  Ottman,	  2012)	  (Ichinohe	  et	  al.,	  2011)	  and	  be	  tolerant	  to	  a	  large	  panel	  of	  
innocuous	  environmental	  stimuli.	  Therefore,	  the	  challenge	  of	  mucosal	  surfaces	  is	  to	  protect	  
the	   body	   against	   invading	   pathogens	   while	   maintaining	   symbiosis	   with	   commensal	  
microbiota	  and	  not	  responding	  to	  innocuous	  antigen	  (Belkaid	  &	  Artis,	  2013).	  
	  
4.2. Respiratory	  tract	  
4.2.1. Anatomy	  and	  functions	  
The	  respiratory	  tract	  can	  be	  divided	  into	  two	  main	  parts:	  (i)	  the	  upper	  respiratory	  tract,	  
composed	   of	   the	   nasal	   cavity,	   the	   mouth	   and	   the	   nasopharynx,	   mainly	   involved	   in	   the	  
filtration,	  humidification	  and	  temperature’s	  adjustment	  of	  the	  inhaled	  air	  and	  (ii)	  the	  lower	  
respiratory	  tract,	  also	  named	  the	  broncho-­‐pulmonary	  apparatus,	  which	  is	  responsible	  for	  the	  
conduction	   of	   the	   air	   and	   the	   gaseous	   exchanges.	   The	   latter	   begins	   by	   the	   larynx	   and	  
continues	  with	  the	  trachea	  that	  is	  divided	  into	  two	  primary	  bronchi.	  They	  are	  then	  divided	  in	  
secondary	   and	   tertiary	   bronchi	   before	   splitting	   into	   many	   small	   ducts,	   the	   bronchioles.	  
Terminal	  bronchioles	  mark	  the	  end	  of	  the	  conducting	  airway	  and	  lead	  to	  the	  alveolar	  ducts,	  
increasingly	  implicated	  into	  gas	  exchange	  (Figure	  4).	  They	  end	  in	  dilated	  spaces,	  named	  the	  
alveolar	  sacs,	  opening	  with	  alveoli	  (Wheather	  et	  al.,	  2001;	  Scudamore,	  2014)	  	  
	  
The	   respiratory	   tract	   is	   drained	   by	   cervical,	   mediastinal	   and	   tracheobronchial	   lymph	  
nodes	  (LNs)	   (Gueirard	  et	  al.;	  Van	  Den	  Broeck,	  2006).	   	  They	  are	  secondary	   lymphoid	  organs	  
containing	  B	  cells,	  T	  cells	  and	  other	  immune	  cells	  such	  as	  DCs	  and	  macrophages,	  and	  act	  as	  
filters	   by	   trapping	   aberrant	   cells	   and	   pathogens	   traveling	   through	   the	   lymph.	   It	   is	   a	   site	  
where	   T	   lymphocytes	   are	   activated	   by	   APCs	   before	   their	   migration	   to	   the	   infected	   site	  







	   	  
Figure	   5:	   Schematic	   representation	   of	   the	   main	   constituents	   of	   an	   alveolus	   and	   the	   interalveolar	   wall.	  









4.2.2. Histology	  of	  the	  mucous	  membrane	  
	   The	   upper	   respiratory	   tract	   is	   covered	   by	   a	   pseudostratified	   cylindrical	   epithelium	  
and	  many	  caliciform	  cells	   that	   secrete	  mucus.	  The	  epithelium	   is	   rested	  on	  a	   loose	   layer	  of	  
collagen,	  named	  chorion	  or	   lamina	  propria.	  The	  epithelium	  and	   the	  chorion	  constitute	   the	  
airway	  mucosa	  (	  Conti	  et	  al.,	  2004;	  Wheater	  et	  al.,	  2001).	  	  
	  
The	   epithelium	  of	   the	   airway	  progressively	   evolves	   from	  a	   ciliated	  pseudostratified	  
cylindric	   type	   in	   the	   larynx	   and	   trachea,	   to	   a	   non	   ciliated	   simple	   cubic	   type	   in	   the	   distal	  
airways.	   There	   are	   a	   lot	   of	   caliciform	   cells	   in	   the	   trachea	   and	   their	   number	   decreases	  
progressively	   so	   that	   they	   are	   absent	   in	   the	   terminal	   bronchioles	   (Conti	   et	   al.,	   2004).	  
Endocrinian	   cells	   are	   scattered	  among	   the	  epithelium	  and	  are	   responsible	   for	   secretion	  of	  
mediators	   such	   as	   serotonin,	   calcitonin	   and	   bombesin.	   Immune	   cells,	   such	   as	   DCs	   and	  
macrophages,	   are	   particularly	   abundant	   into	   the	   mucosa	   and	   ensure	   the	   immune-­‐
surveillance	   within	   and	   beneath	   the	   surface	   of	   the	   epithelium.	   CD8+	   T	   cells,	   that	   have	   a	  
cytotoxic	   effect	   on	   infected	   cells,	   are	   mainly	   located	   among	   epithelial	   cells	   while	   CD4+	   T	  
lymphocytes,	   which	   ensure	   development	   of	   the	   proper	   immune	   response	   to	   fight	   the	  
entering	  pathogen,	  are	  preferentially	  located	  in	  the	  lamina	  propria	  (Harbeck,	  1998).	  We	  can	  
also	   find	   clusters	   of	   immune	   cells,	   part	   of	   the	  mucosa-­‐associated	   lymphoid	   tissue	   (MALT),	  
named	   BALT	   for	   «Bronchus-­‐Associated	   Lymphoid	   Tissue	  ».	   Typically,	   it	   is	   a	   place	   where	  
antigen	   sampling	  occurs	   and	   immune	   responses	  are	   initiated.	   It	   seems	   that	   in	  human	  and	  
mice,	  BALT	  develop	  mainly	   in	   response	   to	  microbial	   stimulation	  or	   inflammation.	  They	  are	  
located	  throughout	  the	  lung,	  usually	  between	  bronchi	  and	  pulmonary	  arteries.	  The	  center	  is	  
composed	  of	  a	  B	  follicule	  and	  a	  T	  zone,	  and	  DCs	  and	  macrophages	  are	  scattered	  throughout	  
the	  BALT	  (Cesta,	  2006;	  Randall,	  2010).	  Finally,	  deeper	  in	  the	  mucous	  membrane	  we	  can	  find	  
a	  smooth	  muscle	  layer	  that	  increases	  progressively	  to	  be	  maximal	  in	  the	  distal	  airways.	  It	  is	  
important	  to	  control	  the	  air	  flow	  all	  along	  the	  tract	  (Wheater	  et	  al.,	  2001).	  If	  we	  focus	  on	  the	  
alveoli	   and	   their	   environment	   (figure	   5),	   they	   are	   composed	   of	   two	   cell	   types	  :	   type	   I	  
pneumocytes,	  which	  are	  flat	  cells	  that	  consitute	  most	  of	  the	  surface	  of	  the	  alveoli,	  and	  type	  
II	  pneumocytes,	  which	  are	  cells	  that	  produce	  the	  surfactant1.	  Each	  alveolus	  is	  surrounded	  by	  	  
	   	  
                                                
 
1	  Surfactant	  :	  a	  complex	  of	  lipoproteins	  that	  increases	  the	  ability	  of	  lung	  to	  expand	  and	  prevent	  the	  













a	  network	  of	  capillaries,	  and	  type	  I	  pneumocytes	  are	  in	  close	  contact	  with	  endothelial	  cells	  
for	   the	   gaseous	   exchanges.	   The	  wall	   between	   alveoli	   can	   be	   extremely	   thin	   to	   let	   the	   air	  
through,	  or	  thicker	  and	  display	  conjunctive	  tissue	  with	  collagen,	  elastic	   fibers	  or	   fibroblast.	  
This	   interstitial	   space	   is	   also	   endowed	  with	   few	   interstitial	  macrophages,	   DCs	   and	   T	   cells.	  
Alveolar	  macrophages,	   also	   called	   «	  dust	   cells	  »	   are	   located	   in	   alveolar	   space	   and	   capture	  
foreign	   particles	   reaching	   the	   alveoli.	   They	   are	   coming	   into	   the	   lungs	   from	   blood	   and	  
differentiate	  into	  effective	  cleaner	  (Gartner	  &	  Hiatt,	  2004).	  
	  
4.2.3. Immunity	  of	  the	  broncho-­‐pulmonary	  apparatus	  
4.2.3.1. In	  steady	  state	  
Almost	   two-­‐thirds	   of	   microbial	   agents	   enter	   the	   body	   through	   the	   respiratory	   tract	  
(Bellanti,	   2012).	   It	   is	   then	   easy	   to	   understand	   that	  mammals	   have	   developed	   an	   immune	  
system	   specifically	   dedicated	   to	   this	   particular	   surface.	   In	   steady	   state,	   a	   combination	   of	  
mechanisms	  limits	  inflammatory	  reaction	  to	  frequent	  innocuous	  environmental	  antigens	  and	  
allows	  the	  symbiotic	  relation	  with	  favorable	  commensal	  bacteria:	  
-­‐ Mucus	  produced	  by	  caliciform	  cells	  and	  the	  submucosal	  glands	  traps	  foreign	  particles	  
that	   enter	   into	   the	   airways	   during	   respiration,	   and	   contains	   antimicrobial	   peptides	  
secreted	  by	  epithelial	  cells	  and	  immune	  cells,	  such	  as	  defensins	  or	  cathelicidins,	  that	  
kill	  bacteria	  by	  compromising	  cell	  wall	  integrity	  or	  inhibit	  their	  growth.	  The	  cilia	  of	  the	  
epithelial	  cells	  beat	  to	  move	  the	  secreted	  mucus	  toward	  the	  laryngopharynx	  where	  it	  
will	  be	  expectorated	  or	  swallowed	  to	  the	  stomach	  (Beisswenger	  et	  al.,	  2005;	  Lillehoj	  
et	  al.,	  2002).	  	  
-­‐ Another	  mechanism	  involves	  dimeric	  immunoglobulin	  A	  (IgA).	  They	  are	  produced	  as	  
monomers	  by	  plasma	  cells	  from	  the	  lamina	  propria,	  they	  are	  dimerized	  during	  their	  
transcytosis	   across	   the	   epithelium	   and	   are	   secreted	   from	   the	   apical	   surface	   of	  
epithelial	   cells.	   They	   guard	   the	   epithelium	   from	   microbial	   entry,	   and	   transport	  
antigens	  or	  microorganisms	  that	  penetrate	  the	  barrier	  back	  into	  the	  lumen	  (Nagler-­‐
Anderson,	  2001).	  	  
-­‐ Immune	   receptors	   of	   the	   mucosal	   membrane	   seem	   to	   be	   down	   regulated	   or	  
modified	   to	   avoid	   an	   inappropriate	   immune	   response	   against	   non-­‐pathogenic	  






	   	  
Figure	   6:	   Negative	   regulation	  of	   alveolar	  macrophages	   by	   soluble	  mediators	   and	   by	  
cell–cell	   interactions	   with	   bronchial	   and	   alveolar	   epithelial	   cells.	   (1)	   Pulmonary	  
surfactant-­‐associated	  protein	  A	  (SPA)	  and	  SPD	  are	  abundant	  in	  the	  airways	  and	  block	  
TLR2	  and	  TLR4	   interactions	  with	   their	   ligands,	  as	  well	   as	  with	   the	  co-­‐receptors	  MD2	  
and	  CD14,	   thereby	  stopping	  the	   initiation	  of	  the	   inflammatory	   response	   through	   the	  
activation	   of	   nuclear	   factor-­‐κB	   (NF-­‐κB).	   (2)	   Attachment	   of	   SPA	   and	   SPD	   to	   signal-­‐
regulatory	   protein-­‐α	   (SIRPα)	   recruits	   SH2	   domain-­‐containing	   protein	   tyrosine	  
phosphatase	   1	   (SHP1)	   and	   activates	   RHOA,	   which	   inhibits	   phagocytosis.	   (3)	  
Interleukin-­‐10	   (IL-­‐10)	   is	   abundant	   in	   lung	   and	   induces	   the	   expression	   of	   negative	  
regulators	  such	  as	  suppressor	  of	  cytokine	  signaling	  3	  (SOCS3)	  and	  the	  microRNA	  miR-­‐
146b	  through	  Janus	  kinase	  1	  (JAK1)–signal	  transducer	  and	  activator	  of	  transcription	  3	  
(STAT3)	   pathway.	   SOCS3	   inhibits	   the	   expression	   of	   pro-­‐inflammatory	   cytokines.	   (4)	  
The	  CD200	  receptor	   (CD200R)	   interacts	  with	  CD200	  on	   the	   respiratory	  epithelium.	  It	  
blocks	   the	  extracellular	   signal-­‐regulated	   kinase	   (ERK),	   p38	  mitogen-­‐activated	  protein	  
kinase	   (MAPK)	   and	   JUN	   N-­‐terminal	   kinase	   (JNK)	   inflammatory	   pathways	   through	  
recruitment	   of	   docking	   protein	   2	   (DOK2)	   and	  RAS	  GTPase-­‐activating	   protein	  RASA2.	  
(5)	   The	   αvβ6	   integrin,	   expressed	   on	   bronchial	   and	   alveolar	   epithelial	   cells,	   binds	  
transforming	   growth	   factor-­‐β	   (TGFβ),	   and	   facilitates	   access	   of	   the	   TGFβ	   receptor	  
(TGFβR)	   on	   alveolar	   macrophages.	   It	   controls	   inflammation	   through	   both	   SMAD-­‐
dependent	   and	   SMAD-­‐independent	   signaling	   pathways.	   (6)	   Triggering	   receptor	  
expressed	   by	   myeloid	   cells	   2	   (TREM2)	   limits	   inflammation	   in	   macrophages	   by	   an	  
unknown	   mechanism.	   (7)	   The	   mannose	   receptor	   (CD206)	   blocks	   TLR4	   and	   inhibits	  







-­‐ dependent	  ligands	  of	  gram-­‐positive	  bacteria;	  it	  correlates	  with	  a	  low	  expression	  level	  
of	   TLR2	   and	  missing	   expression	   of	   co-­‐receptor	   CD36	   (Mayer	  et	   al.,	   2007).	   Another	  
example	  is	  TLR4	  that	  seems	  to	  be	  only	  expressed	  in	  the	  intracellular	  compartment	  of	  
epithelial	  cells	   to	  avoid	  an	   inappropriate	  activation	  due	  to	   frequent	  exposure	   to	  air	  
containing	  small	  amounts	  of	  LPS	  (Guillot	  et	  al.,	  2004).	  	  
-­‐ Resident	  alveolar	  macrophages	  are	  negatively	  regulated	  by	  many	  soluble	  mediators	  
and	  interaction	  with	  epithelial	  cells	  (figure	  6).	  Thus,	  in	  steady	  state,	  their	  phagocytic	  
activity	  is	  used	  to	  sequester	  the	  antigens	  reaching	  the	  alveoli	  to	  protect	  local	  tissues	  	  
from	  the	  development	  of	  specific	   immune	  response	  (Hussell	  &	  Bell,	  2014;	  MacLean	  
et	  al.,	  1996).	  	  
-­‐ There	   are	  different	   subsets	  of	   resident	   lung	  DCs	   the	   role	  of	  which	  depends	  on	   the	  
location	  and	  the	  context	  of	  the	  lung	  environment	  but	  it	  seems	  that	  during	  the	  steady	  
state,	  DCs	  have	  an	  “immature”	  status	  where	  they	  protect	  the	  lung	  from	  inflammation	  
and	  damages	  (Plantinga	  et	  al.,	  2010;	  Kushwah	  et	  al.,	  2011).	  
-­‐ By	   default,	   the	   immune	   response	   in	   lungs	   is	   non-­‐inflammatory;	   T-­‐cell	   mediated	  
tolerance	  (Holt,	  1994).	  The	  mechanisms	  ensuring	  this	  “default”	   immune	  response	  is	  
not	  well	  understood	  but	  it	  seems	  that	  immature	  DCs	  participate	  to	  the	  tolerance	  by	  
the	  induction	  of	  regulatory	  T	  (Treg)	  cell	  populations	  (Kushwah	  et	  al.,	  2011).	  Treg	  then	  
regulate	  T-­‐cell	  responses	  thanks	  to	  mechanisms	  such	  as	  the	  production	  of	  IL-­‐10	  and	  
TGF-­‐β	  (Strickland	  et	  al.,	  2008).	  
	  
4.2.3.1. During	  infection	  
In	  case	  of	  imbalance	  in	  the	  system	  like	  after	  tissue	  injury	  induced	  by	  physical	  agents	  or	  
because	  of	  impairment	  of	  the	  immune	  system,	  some	  commensals	  can	  overgrow	  and	  invade	  
the	   tissues;	   they	   become	  pathogens	   and	   are	   named	  pathobionts.	  Other	   bacteria	   are	   non-­‐	  
commensal	  but	  need	  a	  host	  for	  their	  life	  cycle	  and	  display	  mechanisms	  to	  get	  into	  the	  tissues	  
despite	  physical	  and	   immunological	  barriers.	  Directly	  after	   invasion,	  PAMPs	  are	  recognized	  
by	   PRRs,	   expressed	   on	   epithelial	   cells,	   sentinel	   alveolar	  macrophages	   and	   DCs.	   The	   latter	  
migrate	   to	   the	   draining	   lymph	   nodes	   to	   activate	   naive	   T	   cells	   and	   initiate	   the	   immune	  
response.	   Despite	   the	   fact	   that	   alveolar	  macrophages	   are	   able	   to	  migrate	   to	   the	   draining	  
lymph	  node	  (Kirby	  et	  al.,	  2009),	  they	  do	  not	  seem	  to	  have	  a	  significant	  role	  of	  APC	  (Hussell	  &	  
Bell,	  2014).	  But	  they	  can	  be	  activated	  by	  stimuli,	  such	  as	  cytokines	  or	  microorganisms.	  They	  












this	  activated	  condition,	  macrophages	  phagocyte,	  kill,	  produce	  cytokines	  and	  coordinate	  the	  
innate	  immune	  response	  (Holt	  et	  al.,	  2008;	  Hussell	  &	  Bell,	  2014).	  
	  
Effector	  “Th”	  responses	  are	  extremely	  complex	  and	  heterogeneous.	  However,	  we	  can	  
highlight	   the	   importance	  of	  Th17	  cells	  at	  mucosal	  surfaces,	  and	  particularly	   in	   the	   lungs.	   It	  
has	  been	  demonstrated	  that	  Th17	  cytokines,	  such	  as	  IL-­‐17A,	  play	  a	  key	  role	  for	  effective	  host	  
defense	  against	  extracellular	  or	  intracellular	  pulmonary	  pathogens	  (Tsai	  et	  al.,	  2013;	  Way	  et	  
al.,	  2013).	   Interestingly,	  Th17	  and	  Treg	  cells	  seem	  to	  be	  mutually	  exclusive.	   In	  mice,	  TGF-­‐β	  
induces	  Th17	  and	  Treg	  but	  TLR	  activation	  also	  induces	  IL-­‐6	  and	  the	  resultant	  is	  the	  action	  of	  
Th17	  cells.	  IL-­‐21	  also	  participates	  in	  the	  differentiation	  of	  Th17	  cells	  that	  produce	  IL-­‐17,	  IL-­‐22	  
and	  IL-­‐23.	  This	  response	  ensures	  the	  recruitment	  of	  neutrophils	  and	  cytotoxic	  molecules	  to	  
the	   lungs.	  Neutrophils	  produce	  ROS,	  proteolytic	  enzymes	  and	  other	  antimicrobial	  peptides	  
to	   kill	   foreign	   pathogens	   in	   the	   infection	   site	   (Way	   et	   al.,	   2013).	   CD4+T	   lymphocytes,	  
producing	  Th17	  cytokines,	  are	  essential	  in	  the	  adaptive	  phase	  of	  the	  host	  defense.	  However,	  
innate	   immune	  cells,	   such	  as	  γδ	   T	   cells,	  NK	  cells	  and	  NKT	  cells,	  are	  able	   to	  produce	   IL-­‐17A	  
earlier	   in	   the	   lungs	  and	  make	   the	   link	  between	   the	   innate	  and	  adaptive	   immune	  response	  
(Way	  et	  al.,	  2013).	  For	  example,	  γδ	  T	  cells	  are	  the	  major	  source	  of	  early	  production	  of	  IL-­‐17A	  
in	  response	  to	  infections	  like	  K.	  pneumonia	  (Price	  et	  al.,	  2012),	  M.	  tuberculosis	  (Peng	  et	  al.,	  
2008)	   or	  M.	   bovis	   (Okamoto	   Yoshida	   et	   al.,	   2010).	   Rapid	   production	   of	   IL-­‐17A	   can	   even	  
promote	  the	  adaptive	  immune	  response	  Th1	  into	  the	  lungs	  to	  improve	  pathogen	  clearance	  
(Umemura	  et	  al.,	  2007;	  scurlock	  et	  al.,	  2011).	  In	  some	  cases,	  however,	  the	  function	  of	  Th17	  
can	   become	   pathogenic	   and	   IL-­‐17A	   have	   deleterious	   effect	   when	   the	   production	   of	  
neutrophils	   does	   not	   improve	   the	   clearance	   of	   the	   pathogen,	   leading	   to	   a	   prolonged	  
inflammation	  and	  damage	  in	  the	  tissue	  generating	  pathologies	  such	  as	  cystic	  fibrosis	  (Way	  et	  
al.,	  2013;	  Jin	  et	  al.,	  2013).	  
	  
4.2.4. Infection	  with	  inhaled	  Brucella…	  what’s	  going	  on?	  
Intranasal	  or	  aerosol	   infection	  by	  Brucella	  melitensis	  has	  not	  been	  deeply	   investigated.	  
Intranasal	   infection	   by	   Brucella	   leads	   to	   the	   infection	   of	   lungs	   followed	   by	   progressive	  
dissemination	  into	  the	  spleen	  and	  the	  liver.	  In	  the	  i.p.	  model,	  however,	  the	  dissemination	  is	  
immediately	  systemic.	   It	  highlights	  the	  fact	  that	  the	  way	  of	   infection	  could	  have	  significant	  
impact	   on	   the	   immune	   response.	   The	   research	   team	   of	   Gorvel	   has	   shown	   that	   alveolar	  






	   	  
Figure 7:	   Schematic	   representation	   of	   persister	   cells.	   When	   the	   bacterial	  
population	   undergoes	   	   a	   lethal	   stress,	   such	   as	   immune	   defense	   or	   antibiotic	  
treatment,	  a	  	  fraction	  of	  the	  cells	  survives.	  After	  the	  stress,	  the	  cells	  give	  birth	  to	  







for	   2	   to	   5	   days	   after	   intranasal	   infection	   (Archambaud	  et	   al.,	   2010).	   A	   recent	   study	  made	  
with	  an	  aerosol	  infection	  has	  shown	  that	  TLR2	  and	  TLR4	  play	  a	  role	  to	  clear	  lung	  infection	  but	  
do	  not	  have	  significant	  contribution	  in	  spleen	  and	  liver	  (Pei	  et	  al.,	  2012).	  The	  research	  team	  
of	   Hoover	   did	   not	   find	   any	   gross	   or	   microscopic	   indication	   of	   inflammation	   all	   along	   the	  
infection	  in	  the	  lungs,	  in	  opposition	  to	  what	  it	  is	  happening	  in	  deep	  organs	  such	  as	  the	  spleen	  
and	   liver	  where	   recruitments	   and	   granulomas	   are	   detected	   (Mense	  et	   al.,	   2001).	   Another	  
group	  has	  shown	  the	  importance	  of	  T	  and	  B	  lymphocytes	  thanks	  to	  Rag1-­‐deficient	  mice	  that	  
do	  not	   control	   the	   infection	  and	  have	  persistence	   in	   lungs,	  whereas	  wt	  mice	  progressively	  
eliminate	   the	   bacteria	   from	   this	   organ	   (Izadjoo	   et	   al.,	   2000).	   Brucella	   is	   progressively	  
eliminated	  from	  the	  lungs	  but	  it	  is	  able	  to	  reach	  other	  organs	  like	  the	  spleen	  where	  it	  persists	  
for	  a	  long	  time.	  The	  next	  chapter	  will	  discuss	  the	  ability	  of	  intracellular	  bacteria	  to	  persist	  in	  
the	  host	  and	  to	  take	  advantage	  of	  the	  host	  cells.	  
	  
5. Persistence	  of	  bacteria	  in	  the	  host	  
5.1. Overview	  
Innate	   and	   adaptive	   immunity	   usually	   eliminates	   the	   acute	   infection	   caused	   by	  
pathobionts	  or	  strict	  pathogens.	  In	  some	  cases,	  however,	  bacteria	  are	  able	  to	  survive	  in	  the	  
host.	  The	  prolonged	  presence	  of	  bacteria	  in	  the	  host,	  or	  persistence,	  is	  possible	  thanks	  to	  	  
strategies	  that	  can	  be	  divided	  in	  two	  categories	  (i)	  the	  invader	  is	  adapted	  to	  the	  environment	  
and/or	  (ii)	  it	  must	  induce	  a	  local	  reconfiguration	  of	  the	  environment.	  	  
	  
The	  adaptation	  of	  bacteria	  to	  the	  environment	  can	  be	  achieved	  by	  multiple	  mechanisms.	  
For	   example,	  Neisseria	  meningitidis,	   a	   human	   commensal	   that	   can	   be	   responsible	   for	   the	  
acute	   inflammation	   meningitis	   and	   occasionally	   chronic	   infection	   (stephens,	   2009),	   has	   a	  
major	  defense	  system:	  a	  capsule	  made	  of	  homopolymers	  of	  α2-­‐8-­‐linked	  sialic	  acid.	  The	  steric	  
conformation	   of	   this	   sialic	   acid	   seems	   to	   prevent	   the	   antimicrobial	   peptides	   to	   reach	   the	  
outer	  membrane	   (Gasparini	   et	   al.,	   2012)	   and	   it	   is	   poorly	   immunogenic	   because	   it	  mimics	  
human	  neural	  cell	  adhesion	  molecule	  (Lo	  et	  al.,	  2009).	  The	  bacterium	  is	  also	  equipped	  with	  
other	  surface	  structures	  of	  which	  the	  composition	  is	  close	  to	  the	  host’s	  ones.	  It	  is	  the	  case	  of	  
its	   LPS:	  one	  epitope,	   the	  Lacto-­‐N-­‐neotetraose,	   is	  a	   close	  copy	  of	  a	   red	  blood	  cells	  antigen.	  
This	  bacterium	  also	  displays	  an	  extremely	  variable	  genome	  and	   is	  able	  to	  acquire	  genes	  of	  







	   	  
Figure	   8:	   Schematic	   sporulation	   cycle	   under	   a	   stress	   condition,	   such	   as	   starvation,	  
the	  bacterium	  (e.g.	  Bacillus	   subtilis)	  produces	  a	   spore	   to	  survive.	  The	  spore	   is	   then	  
able	   to	   give	   rise	   to	   a	   bacterium	   (germination)	   when	   the	   stress	   is	   ended.	   (source:	  
http://ezines.tifn.nl/intouch/october2013/eijlander_sporeweb.html).	  
Figure	  9:	  Hijacking	  of	  host	  cell	  trafficking	  by	  pathogens.	  (1)	  Separation	  from	  the	  
endocytic	  route	  and	  interaction	  with	  Golgi-­‐derived	  vesicles	  to	  form	  an	  inclusion	  
vacuole.	   (2)	  Segregation	  from	  the	  endocytic	   route	  at	  the	  early	  endosome	  (EE)	  
stage	  and	  formation	  of	  an	  endoplasmic	  retuculum-­‐like	  compartment.	  (3)	  Arrest	  
of	  the	  maturation	  at	  EE	  stage.	  (4)	  Transient	  arrest	  of	  the	  bacterium-­‐containing	  
vacuole	   at	   the	   EE	   and	   late	   endosome	   (LE)	   stages.	   SCV=Salmonella	   containing	  












bacterium	   to	   avoid	  microbicidal	   immune	  defenses	   and	   to	   establish	   a	   preferential	   niche	   to	  
replicate.	   The	   adaptation	   can	   also	   be	   achieved	   by	   a	   small	   number	   of	   bacteria,	   named	  
persister	   cells,	   that	   are	   dormant	   variants	   of	   regular	   bacteria	   formed	   randomly	   in	   the	  
population,	   as	   it	   is	   the	   case	   for	   Pseudomonas	   aeruginosa,	   a	   pathobiont	   responsible	   for	  
nosocomial	   infections	  (Lewis,	  2010)	  (Figure	  7).	  Persister	  cells	  are	  highly	  tolerant	  to	  harmful	  
conditions,	   allowing	   long-­‐term	   surviving	   in	   the	   host.	   In	   Bacillus	   anthracis,	   responsible	   for	  
anthrax	   infection,	   it	   is	   dormant	   spore	   that	   can	   be	   recovered	   in	   lungs	   months	   after	  
inhalational	   infection	  (Jenkins	  &	  Xu,	  2013).	  Spores	  are	  produced	  by	  bacteria	   in	  detrimental	  
conditions	   and	   display	   a	   hard	   protective	   coating	   that	   contains	   key	   elements	   of	   the	  
bacterium.	  These	  resistant	  structures	  turn	  into	  cells	  back	  when	  the	  conditions	  become	  more	  
favorable	  (figure	  8).	  
	  
Bacteria	   can	   also	   display	   mechanisms	   that	   modify	   the	   environment	   to	   generate	   a	  
favorable	  condition	  for	  their	  survival.	  Chlamydia,	  Legionella,	  Mycobacterium	  or	  Salmonella,	  
deviate	   the	   host’s	   intracellular	   trafficking	   to	   prevent	   the	   fusion	   of	   their	   vacuole	   with	  
lysosomes	   and	   to	   create	   a	   specialized	   organelle	   favorable	   for	   replication	   (Figure	   9).	   To	  
achieve	  the	  deviation	  of	  the	  host	  trafficking,	  they	  translocate	  effectors	  across	  the	  vacuolar	  
membrane	   thanks	   to	   a	   secretion	   system.	   Then	   the	   effectors	   manipulate	   host	   proteins	  
located	   in	   the	   cytoplasm	   or	   on	   cellular	   organelles	   (Alix	   et	   al.,	   2011).	   Another	   example	  
involves	   the	   diarrheagenic	   enteropathogenic	   Escherichia	   coli.	   It	   limits	   the	   host	   cell	   death	  
because	   it	   is	   able	   to	   interfere	   with	   apoptotic	   pathway	   of	   infected	   enterocytes	   (intestinal	  
epithelial	  cells)	  early	  after	  infection.	  It	  is	  also	  the	  secretion	  of	  at	  least	  one	  effector	  (EspZ)	  and	  
its	  interaction	  with	  host	  proteins	  that	  ensure	  the	  survival	  of	  the	  cell	  (Roxas	  et	  al.,	  2012).	  
	  
5.1. Reservoir	  cells	  for	  pathogens	  	  
Various	   bacterial	   pathogens	   have	   their	   own	   strategies	   to	   overcome	   the	   immune	  
defenses	  of	  the	  host.	  Intracellular	  life	  is	  a	  way	  in	  itself	  to	  avoid	  a	  series	  of	  defenses	  such	  as	  
complement	   and	   antibodies.	   Different	   cell	   types	   are	   targeted	   by	   bacteria	   to	   constitute	   a	  
niche	  on	  the	  long	  term.	  Infection	  of	  DCs	  are	  particularly	  strategic	  for	  bacteria	  because	  these	  
cells	   have	  many	   functions	   in	   the	   immune	  defense.	   It	   is	  well	   described	   for	  Mycobacterium	  
tuberculosis	  that	  suppress	  maturation	  and	  migration	  of	  DCs,	  causing	  a	  delay	  of	  the	  adaptive	  
immune	   response	   (Urdahl	   et	   al.,	   2011).	   Salmonella	   enterica	   reduces	   the	   antigen	  






	   	  
BOX	  5	  :	  correlation	  between	  T	  helper	  immune	  responses	  and	  polarization	  of	  macrophages	  	  
Scientists	  have	  initially	  discovered	  that	  macrophages	  activated	  by	  the	  Th1	  cytokine	  IFNγ,	  and	  LPS,	  
display	  a	  phenotype	  and	  a	  metabolism	  different	  from	  macrophages	  activated	  by	  Th2	  cytokines	  (IL-­‐4	  
and	   IL-­‐13).	   Therefore	   Th1-­‐induced	  macrophages	   and	   Th2-­‐induced	  macrophages	   were	   named	  M1	  
(classically	   activated	   macrophages)	   and	   M2	   (alternatively	   activated	   macrophages)	   respectively	  
(Martinez	   et	   al.,	   2014).	   Subsequently,	   Th17	   immune	   response	   has	   been	   discovered	   and	   it	   is	   now	  
admitted	   that	  M1	  macrophages	   are	   not	   always	   only	   associated	   to	   Th1	   but	   also	   to	   Th17	   immune	  
response.	   Inflammatory	   M1	   macrophages	   can	   produce	   TNFα,	   IL-­‐6	   and	   IL-­‐12	   that	   promote	   the	  
expansion	   and	   the	   activation	  of	   IFNγ-­‐producing	   CD4+	   cells	   (Th1);	   but	   these	  macrophages	   can	   also	  
produce	   IL-­‐23,	  which	   is	  an	   important	  cytokine	  that	  acts	   through	   its	   receptor,	   IL-­‐23R,	  expressed	  on	  
CD4+	   T	   cells,	   to	   promote	   the	   development	   of	   IL-­‐17-­‐producing	   cells	  
(Th17)	  (Krausgruber	  et	  al.,	  2011).	  It	  has	  also	  been	  demonstrated	  that	  IL-­‐
23	   can	   give	   rise	   to	   an	   IL-­‐17+IFNγ+	   population	   of	   T	   cells.	   This	  
phenomenon	   supports	   the	   idea	   of	   a	   close	   relationship	   between	   Th1	  
and	   Th17	   cells.	   M1-­‐induced	   Th1/17	   cells	   can	   produce	   GM-­‐CSF	   that	  
facilitates	   the	   differentiation	   of	   M1	   macrophages.	   Opposite	   figure	  
shows	   this	   positive	   feedback	   loop,	   generally	   associated	   with	  
inflammation	  in	  autoimmune	  diseases	  (Li	  et	  al.,	  2013).	  	  
However,	   it	   is	   important	  to	  mention	  that	  Th17	  immune	  response	  is	  
not	   always	   associated	   with	   M1	   macrophages:	   for	   example,	  
mycobacterial-­‐infection-­‐induced	   suppressor	   macrophages	   (MIS-­‐MΦ)	  
down	  regulate	  T	  cell	  production	  of	  Th1	  and	  Th2	  cytokines	  but	  up-­‐regulate	  Th17	  cells	  expansion	  that	  
increase	  production	  of	  IL-­‐17A	  and	  IL-­‐22	  cytokines.	  This	  population	  of	  macrophages	  express	  markers	  
of	  M1	  such	  as	  IL-­‐12	  or	  iNOS	  but	  they	  	  also	  display	  M2	  markers,	  such	  as	  IL-­‐10	  or	  Ym1.	  This	  phenotype	  
is	  distinguishable	  from	  Th1-­‐induced	  M1	  and	  Th2	  -­‐induced	  M2	  macrophages	  subsets	   (Tatano	  et	  al.,	  
2014).	   These	   observationes	   reinforce	   the	   concept	   of	   plasticity	   of	   macrophages	   described	   in	   the	  
point	  5.2.1.	  	  
Figure	   10:	   Infection	   strategy	  of	  Bartonella.	   (a)	   Insect	   vectors	   transmit	  
the	   bartonellae	   to	   human.	   (b)	   Bacteria	   are	   probably	   transported	   by	  
migratory	   cells	   before	   (c)	   reaching	   vascular	   endothelium.	   (d)	  
Bartonellae	   then	   spread	   into	   the	   bloodstream	   where	   they	   invade	  
erythrocytes,	  (e)	  replicate	  and	  (f)	  	  persist	  in	  the	  erythrocytes	  before	  (g)	  






environment	   and	   particularly	   to	  mesenteric	   lymph	   nodes	   (MLNs)	   (Cheminay	   et	   al.,	   2005).	  
The	  uropathogenic	  Escherichia	  coli,	  responsible	  for	  the	  urinary	  tract	  infection,	  is	  able	  to	  get	  
into	  the	  superficial	  epithelial	  cells	  of	  the	  bladder	  thanks	  to	  a	  filamentous	  adhesive	  organelle	  
named	  Type	  1	  pili.	  Once	  in	  the	  cell,	  it	  persists	  and	  can	  multiply	  before	  invading	  neighboring	  
cells	   (Martinez,	   2000).	   Bartonella	   baciliformis	   and	   B.	   quitana,	   causing	   human	   disease	  
transmitted	  by	  insect	  vectors,	  have	  a	  tropism	  for	  erythrocytes.	  Actually,	   it	  seems	  that	  from	  
the	  dermis	  penetration,	  they	  get	  into	  a	  first	  niche,	  probably	  including	  vascular	  endothelium,	  
before	   spreading	   in	   the	   red	   blood	   cells	  where	   they	   cause	   a	   long	   lasting	   intra-­‐erythrocytic	  
bacteraemia	  (Eicher	  &	  Dehio,	  2012)	  (Figure	  10).	  Macrophages	  are	  another	  cell	  type	  regularly	  
targeted	   by	   intracellular	   bacteria,	   such	   as	   Francisella	   tularensis,	   Salmonella	   sp.	   or	  
Mycobacterium	  tuberculosis.	  The	  next	  point	  describes	  these	  cells	  and	  the	  reasons	  why	  they	  
are	  particularly	  appreciated	  by	  pathogens.	  	  
	  
5.2. Focus	  on	  macrophages	  
5.2.1. Macrophage	  plasticity	  	  
Macrophages	   are	   innate	   immune	   cells	   that	   perform	   a	   large	   panel	   of	   functions,	   in	  
health	  but	  also	   in	  response	  to	   infection.	  Phagocytosis,	   to	  kill	  pathogens	  or	  eliminate	  tissue	  
debris	   and	   apoptotic	   cells,	   was	   the	   first	   function	   discovered	   by	   Elie	   Metchnikoff	   at	   the	  
beginning	   of	   the	   20th	   century	   (Martinez	   et	   al.,	   2009).	   It	   was	   later	   admitted	   that	   their	  
functions	  are	  much	  more	  diversified.	   Indeed	  macrophages	  also	  make	  the	   link	  between	  the	  
innate	   and	   the	   adaptive	   immunity	   by	   activities	   such	   as	   presentation	   of	   antigens	   and	  
secretion	   of	   cytokines,	   and	   they	   take	   part	   in	   the	   repairing	   of	   wounded	   tissue	   and	   tissue	  
remodeling	   (Shapiro	   et	   al.,	   2011).	   The	   ability	   of	   resident	   and	   recruited	   macrophages	   to	  
perform	  distinct	   functions	  depends	  on	  environmental	   signals,	   such	  as	   cytokines,	   pathogen	  
derived	   molecules	   and	   lipid	   mediators	   (Kiss	   et	   al.,	   2013).	   These	   stimuli	   give	   rise	   to	  
macrophages	  with	  a	  large	  variety	  of	  phenotypes	  and	  different	  functional	  states.	  	  
	  
Since	   the	   discovery	   of	   macrophage	   diversity,	   macrophages	   have	   been	   classified	   in	  
two	  groups:	  classically	  (M1)	  and	  alternatively	  activated	  (M2)	  macrophages	  (Mantovani	  et	  al.,	  
2004).	  This	  division	  follows	  the	  lymphocyte	  terminology:	  Th1	  and	  Th2	  subsets	  (to	  have	  more	  
information	  about	  the	  correlation	  between	  T	  helper	  immune	  responses	  and	  the	  polarization	  









	   	  
Figure	  11:	   Induction	  and	  functional	  properties	  of	  polarized	  	  macrophages.	  The	  environmental-­‐derived	  
signal	   is	   responsible	   for	   the	   acquisition	   of	   different	   functional	   properties	   of	   macrophages.	   M1	  
macrophages	  have	  antimicrobial	  and	  antitumoral	  properties	  and	  are	  induced	  by	  IFNγ	  and	  LPS,	  while	  M2	  
macrophages	  are	  more	  prone	   to	   immunoregulatory	   and	  protumoral	   activities.	   IL4	   and	   IL13	   exposure	  
drive	   to	   M2a	   polarization,	   and	   combined	   exposure	   to	   immune	   complexes	   and	   TLR	   or	   IL1R	   agonist	  
differenciate	   macrophages	   into	   M2b.	   These	   types	   have	   immunoregulatory	   functions	   and	   drive	   Th2	  
immune	   response.	   IL-­‐10	   induces	  M2c	   phenotype	  whereby	  macrophages	   adopt	   an	   anti-­‐inflammatory	  
and	  wound	  healing	  profile.	  DTH,	  delayed-­‐type	  hypersensitivity;	   IC,	   immune	  complexes;	  MR,	  mannose	  
receptor;	   PTX3,	   the	   long	   pentraxin	   PTX3;	   RNI,	   reactive	   nitrogen	   intermediates;	   ROI,	   reactive	   oxygen	  
intermediates;	  SLAM,	  signaling	  lymphocytic	  activation	  molecule;	  SRs,	  scavenger	  receptors;	  TLR,	  Toll-­‐like	  






in	   presence	   of	   IFNγ	   and	   pathogen	   pattern	   such	   as	   lipopolysaccharide	   (LPS).	   In	   this	   case,	  
macrophages	  have	  anti-­‐microbicidal	  and	  pro-­‐inflammatory	  properties.	  M1	  are	  the	  first	   line	  
of	  defense	  against	  intracellular	  microbes	  and	  ensure	  Th1	  polarization	  of	  CD4+	  T	  cells.	  On	  the	  
contrary,	   if	   macrophages	   are	   activated	   by	   Th2	   cytokines	   IL-­‐4	   and	   IL-­‐13,	   they	   become	  
alternative	  activated	  M2	  macrophages.	  These	  cytokines	   trigger	   the	  phosphorylation	  of	   the	  
transcription	  factor	  STAT6	  that	  translocates	  to	  the	  nucleus	  where	  it	   induces	  the	  expression	  
of	   genes,	   including	  M2	  markers	   like	  Arg1	   (Arginase	   1)	  and	   regulators	   such	   as	   peroxisome	  
proliferator	  activated	  receptors	  (PPARγ	  and	  δ)	  that	  are	  useful	  to	  maintain	  the	  M2	  phenotype	  
(Chawla,	   2010).	   These	   macrophages	   participate	   to	   the	   immune	   response	   against	  
extracellular	  parasites	  like	  helminths.	  They	  can	  also	  help	  with	  the	  resolution	  of	  inflammation	  
and	  tissue	  repair	  (Kiss	  et	  al.,	  2013;	  Noora	  Ottman,	  2012;	  Shapiro	  et	  al.,	  2011)..	  
	  
Subsequently,	   other	   research	   has	   shown	   that	   cytokines	   and	   factors	   non-­‐associated	  
with	  Th1	  or	  Th2,	  such	  as	  IL-­‐10,	  TGF-­‐β	  or	  immune	  complexes,	  are	  able	  to	  elicit	  macrophages	  
with	  a	  similar	  function	  to	  IL-­‐4-­‐induced	  M2	  macrophages	  (Anderson	  et	  al.,	  2002).	  Moreover,	  
despite	  that	  some	  proteins	  such	  as	  Arg1,	  Fizz1	  (for	  “Found	  in	  Inflammation	  Zone”)	  (Pesce	  et	  
al.,	  2009)	  or	  Ym1	  (for	  “Myeloid	  precursor	  in	  the	  Yolk	  sac”)	  (Webb	  et	  al.,	  2001)	  are	  generally	  
considered	   as	  markers	   of	  M2	  macrophages	   (Ghassabeh	   et	   al.,	   2006;	   Gordon	   &	  Martinez,	  
2010;	  Ichinohe	  et	  al.,	  2011;	  Raes	  et	  al.,	  2002),	  no	  real	  consensus	  on	  M2	  hallmarks	  has	  never	  
been	  established.	  It	  has	  therefore	  been	  admitted	  that	  phenotypes	  and	  functions	  of	  M2	  are	  
multiple.	   In	   order	   to	   be	   more	   complete	   in	   the	   classification,	   three	   subdivisions	   of	   M2	  
macrophages	  have	  been	  proposed:	  M2a,	  M2b	  and	  M2c	  (figure	  11).	  M2a	  are	  the	  alternative	  
macrophages	   induced	   by	   Th2	   cytokines	   IL-­‐4	   and	   IL-­‐13.	   They	   participate	   in	   the	   killing	   and	  
encapsulation	  of	  parasites,	  and	  are	  also	  implicated	  in	  allergy	  phenomena.	  M2b	  are	  the	  ones	  
activated	  by	   immune	  complexes	  and	  TLR	   ligands.	  They	  exert	   immunomodulatory	   functions	  
and	   drive	   a	   Th2	   response.	   M2c	   are	   immunosuppressor	   macrophages	   activated	   by	   IL-­‐10	  
(Gueirard	  et	  al.,	  2003;	  Mantovani	  et	  al.,	  2004;	  Vega	  &	  Corbi,	  2006).	  This	  classification	  helps	  
the	  understanding	  of	  immune	  mechanisms	  but	  remains	  a	  simplification	  of	  the	  real	  situation.	  
A	  continuum	  of	  states	  probably	  exists,	  all	  dependent	  on	  multiple	  conditions.	  	  






	   	  
Figure	  12	  :	  Schematic	  view	  of	  L-­‐arginine	  metabolism.	  Arginine	  is	  a	  precursor	  involved	  in	  two	  pathways.	  
ARG1	  hydrolyses	  arginine	  to	  L-­‐ornithine	  and	  Urea.	   L-­‐Ornithine	  is	  used	  for	   the	  synthesis	  of	   L-­‐Proline	  by	  
ornithine	   aminotransferase	   (OAT)	   and	   for	   the	   production	   of	   polyamines	   by	   ornithine	   decarboxylase	  
(ODC).	   L-­‐proline	   is	   involved	   in	   collagen	   production	   and	   polyamines	   affect	   cellular	   proliferation.	   Nitric	  
oxide	  synthase	  2	  (NOS2)	  is	  responsible	  for	  the	  production	  of	  NOHA	  which	  is	  involved	  in	  the	  synthesis	  of	  
citrulline	  and	  nitric	  oxide	  (NO).	  The	  latter	  generates	  reactive	  oxygen	  species,	  responsible	  for	  damage	  and	  
death	  of	  pathogens.	  ARG1,	  Arginase	  1; NOHA,	  NG-­‐hydroxy-­‐L-­‐arginine;	  OAT,	  ornithine	  aminotransferase;	  
ODC,	  ornithine	  decarboxylase.	  (adapted	  from	  Bronte	  et	  al,	  2005)	  
 
Figure	   13:	   Reprogramming	   of	   glucose	   metabolism	   in	   polarized	   macrophages.	   LPS	   promotes	   the	  
polarization	  of	  macrophages	  toward	  a	  pro-­‐inflammatory	  M1	  lineage,	  whereas	  they	  differentiate	  toward	  
a	   suppressive	  M2	   lineage	   in	   response	   to	   IL-­‐4	   and	   IL-­‐13	   stimulation.	   M1	  macrophages	   	   produce	   pro-­‐
inflammatory	  cytokines	  	  such	  as	  TNFα,	  IL-­‐12,	  IL-­‐6	  that	  promote	  inflammatory	  T	  cell	  differentiation,	  and	  
M2	  macrophages	  produce	  a	  higher	  level	  of	  scavenger	  receptors	  and	  immunomodulatory	  cytokines	  such	  
as	   IL-­‐10	   and	   TGFβ.	   LPS	   signaling	   mediates	   NF-­‐κB-­‐mediated	   cytokine	   production	   and	   reduce	   the	  
production	   of	   Carbohydrate	   Kinase-­‐Like	   (CARKL)	   protein.	  Without	   CARKL,	  M1	  metabolism	   is	   oriented	  
through	   glycolysis	   and	   the	   oxidative	   pentose	   phosphate	   pathway	   (Ox-­‐PPP).	   It	   leads	   to	   an	   increased	  
redox	   potential	   (NADH	  :	   NAD,	   GSH	  :	   GSSG)	   and	   a	   reduced	   oxygen	   consumption	   rate	   (OCR).	   In	   M2	  
macrophages,	   CARKL	   promotes	   sedoheptulose-­‐7-­‐phosphate	   (S7P),	   reducing	   metabolism	   through	   the	  
PPP	  but	  maintaining	  	  glycoysis	  and	  OCR.	  	  
G6P,	  glucose-­‐6-­‐phosphate;	  F6P,	  fructose-­‐6-­‐phosphate;	  G3P,	  glyceraldehyde-­‐3-­‐phosphate;	  Ru5P,	  ribuose-­‐







5.2.1. M2	  macrophages,	  a	  strategic	  plan	  for	  pathogens	  
Despite	   the	   diversity	   and	   plasticity	   of	   macrophages,	   we	   can	   use	   macrophages	  
classification	   into	   M1	   and	   M2	   if	   we	   think	   about	   the	   general	   state	   of	   the	   cells.	   M2	  
macrophages	   have	   globally	   an	   opposite	   function	   of	   M1	   macrophages	  :	   M1	   are	   pro-­‐
inflammatory	   cells,	   with	   an	   important	   anti-­‐microbial	   function,	   and	   M2	   have	   little	   or	   no	  
microbicidal	   activity,	   are	   anti-­‐inflammatory	   cells,	   participate	   in	   the	   regeneration	   and	  
remodeling	  of	   the	   tissues.	   To	   ensure	   their	   functions,	  M2	  macrophages	  undergo	  metabolic	  
switches	   that	   can	   be	   profitable	   for	   some	   intracellular	   pathogens	   such	   as	   Francisella	  
tularensis	   or	   Mycobacterium	   tuberculosis;	   establish	   their	   niche	   far	   from	   the	   pro-­‐
inflammatory	  microbicidal	  conditions	  of	  M1	  macrophages	  (Gordon	  &	  Martinez,	  2010):	  	  
	  
Firstly,	  the	  expression	  of	  Arg1	  is	  promoted	  in	  M2	  macrophages	  in	  mice.	  Arginase	  1	  is	  
an	  enzyme	  of	  the	  arginine	  metabolism.	  Globally,	  arginine	  is	  an	  amino	  acid	  that	  can	  be	  used	  
for	  the	  production	  of	  nitric	  oxyde	  (NO)	  or	  for	  the	  synthesis	  of	  polyamines	  and	  proline	  (Figure	  
12).	  The	  enzyme	  arginase	  1	  orients	  the	  arginine	  metabolism	  into	  the	  production	  of	  these	  two	  
last	   components,	   which	   are	   necessary	   for	   the	   reparative	   function	   of	   M2	   macrophages	  
(cellular	  proliferation	  and	  collagen	  production,	   respectively)	   (Vega	  &	  Corbi,	  2006).	  Without	  
this	   enzyme,	   arginine	   is	   converted	   in	   NO,	   a	   strong	   microbicidal	   effector	   of	   the	   M1	  
macrophages.	   The	   inhibition	   of	   NO	   production	   in	   M2	   offers	   a	   better	   environment	   for	  
intracellular	  microbes	  (Chawla,	  2010).	  	  
	  
Secondly,	  glucose	  metabolism	  is	  differentially	  regulated	  in	  M1	  and	  M2	  macrophages	  
(figure	  13).	  M1	  have	  to	  be	  able	  to	  activate	  rapidly	  their	  microbicidal	  functions,	  and	  generally	  
to	  deal	  with	  hypoxic	  environment.	  Therefore,	  LPS	  signal	  triggers	  the	  shift	  of	  the	  metabolism	  
toward	  the	  anaerobic	  glycolysis	  and	  oxydative	  pentose	  phosphate	  pathway	  (PPP)	  whereas,	  
in	  IL-­‐4	  stimulated	  M2	  macrophages,	  aerobic	  glycolysis	  is	  maintained	  and	  PPP	  is	  reduced.	  The	  
elevated	  PPP	  flux	  in	  M1	  macrophages	  generates	  high	  concentration	  of	  NADPH,	  which	  is	  then	  
used	   for	   several	   M1	   processes	   such	   as	   the	   anti-­‐microbial	   NADPH-­‐dependent	   respiratory	  
burst	  and	  glutathione	  biosynthesis	  to	  buffer	  reactive	  oxygen	  species	  (ROS)	  (Haschemi	  et	  al.,	  
2012).	   The	   small	   quantity	   of	   available	   oxygen	   is	   mainly	   used	   as	   a	   substrate	   for	   NADPH	  
oxydase	   during	   the	   respiratory	   burst	   (Figure	   14).	   Therefore,	   glycolysis,	   using	   glucose	   as	   a	  
substrate,	   is	   anaeorbic	   in	  M1	  macrophages.	   This	  process	  produces	  16	   times	   less	  ATP	   than	  







	   	  
Figure	  14:	  Respiratory	  burst.	  NADPH	  oxydase	  uses	  O2	  	  and	  NADPH	  to	  produce	  superoxyde	  anion	  
(O2-­‐),	  a	  Reactive	  Oxygen	  Species	  (ROS)	  and	  a	  precursor	  of	  others.	  Hydrogen	  peroxyde	  (H2O2)	   is	  
produced	  by	  the	  enzyme	  superoxyde	  dismutase.	  Then	  H2O2	   is	   converted	  into	  hypochlorus	  acid	  
(HOCl)	  by	  myeloperoxydase	  or	   into	  hydroxyl	   radical	   (OH-­‐)	  (fenton	   reaction)	   in	  presence	  of	  Fe2+	  
and	  O2-­‐.	  These	  ROS	  participate	   into	   the	  microbial	  killing.	  H2O2	  can	  be	   reduced	   into	  H2O	  by	   the	  






the	  same	  amount	  of	  ATP	  than	  aerobic	  glycolysis.	  The	  consequence	  is	  that	  concentration	  of	  
glucose	   decreases	   in	   the	  M1	  macrophages	   and	   cannot	   be	   easily	   used	   by	   pathogens	   as	   a	  
nutrient	   source.	  Moreover,	   surviving	   in	  hypoxia	  and	  dealing	  with	  microbicidal	  processes	   is	  
clearly	   detrimental	   for	   most	   of	   pathogens.	   On	   the	   contrary,	   in	   M2	   macrophages,	   the	  
environment	  is	  aerobic,	  there	  is	  less	  anti-­‐microbial	  prossesses	  and	  glycolysis	  supplies	  energy	  
to	   repair	   the	   tissue	   while	   leaving	   nutrients	   available	   for	   pathogens	   in	   the	   cell	   (Biswas	   &	  
Mantovani,	   2012;	   Blagih	   &	   Jones,	   2012;	   Nagler-­‐Anderson,	   2001;	   Ricardo-­‐Gonzalez	   et	   al.,	  
2010).	  	  
	  
Thirdly,	   lipid	  metabolism,	   and	   especially	   fatty	   acids	   (FAs)	   uptake	   and	   oxydation,	   is	  
upregulated	   in	   alternative	  M2	  macrophages.	   This	   phenomenon	  was	   first	   described	   in	   the	  
context	   of	   obesity.	  Macrophages	   associated	   to	   adipose	   tissue	   are	  M2	  polarized	   in	   healthy	  
condition.	  They	  may	  have	  many	  functions	  in	  the	  tissue:	  they	  are	  anti-­‐inflammatory	  notably	  
by	  producing	  of	  IL-­‐10	  and	  inhibiting	  recruitment	  and	  polarization	  of	  M1	  macrophages,	  they	  
participate	   in	  adipose	   tissue	  expansion,	  and	  are	   involved	   in	   the	  clearance	  of	   free	  FAs.	  The	  
last	  function	  is	  associated	  with	  over-­‐	  expression	  of	  proteins	  involved	  in	  the	  uptake	  (such	  as	  
the	  scavenger	  receptor	  and	  FA	  translocase	  “CD36”)	  and	  oxidation	  (such	  as	  Long	  chain	  acyl-­‐
CoA	  dehydrogenase	  “LCAD”)	  of	  FAs	  (Shapiro	  et	  al.,	  2011).	  A	  huge	  excess	  of	  free	  FAs	  (FFAs)	  
can	   finally	   disturb	   adipocytes	   (implicated	   in	   storage	   and	   release	   of	   FAs	   depending	   on	   the	  
energy	  requirement)	  integrity	  and	  function,	  can	  lead	  to	  apoptosis,	  necrosis,	  M1	  polarization	  
of	  macrophages	  and	  inflammation	  that	  lead	  to	  insulin	  resistance.	  In	  a	  more	  general	  context,	  
the	   ability	   of	   M2	   macrophages	   to	   store	   and	   use	   fatty	   acid	   is	   an	   essential	   parameter	   to	  
produce	  enough	  energy	  to	  fulfill	  their	  functions	  	  (Vega	  &	  Corbi,	  2006).	  However,	  the	  storage	  
of	   FAs	   seems	   also	   to	   be	   a	   source	   of	   nutrients	   for	   some	   pathogens.	   For	   example,	  
Mycobacterium	   tuberculosis	   can	   derive	   both	   carbon	   and	   energy	   from	   lipids	   for	   their	   own	  
metabolism	  (Peyron	  et	  al.,	  2008).	  	  
	  
Fourthly,	   iron	   metabolism	   changes	   between	   M1	   and	   M2	   macrophages.	   Iron	   is	   an	  
essential	  growth	   factor	   for	  most	  bacteria.	   It	   is	  essential	   for	  DNA	  synthesis,	   respiration	  and	  
free	   radical	   detoxification.	   Bacteria	   display	   mechanisms,	   such	   as	   the	   secretion	   of	  
siderophores	   (high-­‐affinity	   iron-­‐binding	   organic	   molecule),	   to	   take	   it	   from	   the	   host	  
environment.	  M1	  macrophages	  counteract	   this	  bacterial	  strategy	  by	  sequestering	   iron.	  M1	  







	   	  
 
Figure	   15:	   Iron	   trafficking	   in	  macrophages.	   The	   expression	   of	   ferritin,	   which	   stores	   intracellular	  
iron,	   and	   ferroportin	   (Fpn),	   which	   exports	   iron	   from	   the	   cells,	   are	   affected	   by	   macrophage	  
polarization.	  M1	  macrophages	   display	   a	   high	   amount	   of	   ferritin	   and	   a	   reduced	  quantity	   of	   Fpn.	  
This	   promotes	   storage	  of	   iron	   and	  depletion	   from	   the	  microenvironment.	  M2	  macrophages	   are	  
characterized	   by	   a	   low	   concentration	   of	   ferritin	   and	   high	   amount	   of	   Fpn.	   M2	   have	   also	   more	  
scavenger	  receptors	  and	  HO-­‐1,	  which	  mediate	  heme	  uptake	  and	  degradation	  respectively.	  Thanks	  
to	  this	  metabolic	  profil,	  M2	  macrophages	  take	  up	  and	  degrade	  heme	  and	  recirculate	  free	  iron	  to	  






mechanisms	   starve	   extracellular	   microorganisms	   of	   iron,	   but	   if	   these	   macrophages	   are	  
infected,	   it	  could	  improve	  the	  growth	  of	   intracellular	  bacteria.	  Therefore,	  M1	  macrophages	  
can	  also	  limit	  iron	  available	  to	  intracellular	  bacteria	  thanks	  to	  a	  reduction	  of	  iron	  uptake	  by	  
an	  increased	  expression	  of	  iron	  exporter	  Fpn	  (Nairz	  et	  al.,	  2008).	  Besides,	  these	  macrophages	  
produce	  lipocalin-­‐2	  that	  prevent	  siderophore-­‐mediated	  iron	  capture	  by	  bacteria	  (Nairz	  et	  al.,	  
2007)	   and	   recruit	   natural	   resistance-­‐associated	   macrophage	   protein	   1	   (NRAMP1)	   to	   the	  
phagosomal	   membrane	   in	   order	   to	   export	   iron	   from	   the	   bacteria-­‐containing	   phagosome	  
(Cellier	   et	   al.,	   2007).	   M2	   macrophages	   upregulate	   Fpn	   and	   repress	   ferritin	   to	   favour	   the	  
release	   of	   iron.	   This	   condition	   is	   favorable	   for	   extracellular	   organisms.	   They	   also	   promote	  
intracellular	  growth	  of	  bacteria.	  Indeed,	  scavenger	  receptors,	  such	  as	  CD163	  and	  CD91,	  seem	  
to	   mediate	   heme	   scavenging.	   Internalization	   of	   heme	   prevent	   toxicity	   of	   extracellular	  
hemoglobin	   derived	   from	   hemolysis	   during	   inflammation.	   It	   also	   reduces	   the	   pro-­‐
inflammatory	   and	   oxydant	   properties	   of	   heme	   released	   from	   hemoglobin	   and	   degraded	  
hemoproteins	   (like	   catalase,	   peroxydase	   or	   cytochromes)	   derived	   from	   neutrophiles.	   The	  
increased	  concentration	  of	  heme	  participates	  to	  the	  activation	  of	  the	  heme	  oxydase	  OH-­‐1.	  
This	  molecule	   contributes	   to	   the	  degradation	  of	   heme	   in	   three	  products	   (Gozzelino	  et	   al.,	  
2010):	   biliverdin,	   which	   is	   then	   converted	   into	   the	   anti-­‐oxydant	   and	   anti-­‐inflammatory	  
bilirubin,	   free	   ferrous	   iron,	   and	   CO,	  which	   promotes	   vasodilatation	   and	   angiogenesis,	   and	  
suppresses	  the	  TLR4	  signaling	  and	  LPS-­‐mediated	  induction	  of	  pro-­‐inflammatory	  cytokines.	  All	  
of	  this	  reduces	  inflammation	  and	  promotes	  tissue	  repair,	  but	  the	  iron	  become	  also	  available	  
for	   extra-­‐	   and	   intracellular	   microorganisms,	   helping	   them	   to	   survive	   into	   this	   host	  
environment.	  (Cairo	  et	  al.,	  2011;	  Mayer	  et	  al.,	  2007;	  Recalcati	  et	  al.,	  2010)	  (Figure	  15).	  
	  
5.2.2. Examples	  of	  persistent	  pathogens	  targeting	  preferentially	  cells	  with	  an	  M2-­‐
like	  phenotype	  	  
All	   the	   bacteria	   are	   not	   able	   to	   take	   advantage	   of	   the	   plasticity	   of	   macrophages.	  
Bacteria	  must	   induce	  or	  maintain	   the	  alternative	  activation	  of	  macrophages	   to	  avoid	   their	  
destruction	  by	  bactericidal	  mechanisms	  of	  M1	  macrophages.	  
	  
5.2.2.1. Salmonella	  
Box	  6	  gives	  an	  overview	  on	  Salmonella.	  The	  phenotype	  of	  the	  reservoir	  cells	  for	  the	  








	   	  
Box	  6:	  Salmonella,	  an	  overview	  
	  
Salmonella	   enterica	   species	   is	   a	   gram-­‐negative	   facultative	   intracellular	   enteric	   bacterium	  
responsible	  for	  a	  worldwide	  zoonosis.	  The	  transmission	  of	  the	  pathogen	  is	  ensured	  by	  oral	  ingestion	  
of	  contaminated	  water,	  particularly	  frequent	  in	  countries	  where	  drinking	  water	  quality	  and	  sewage	  
treatment	   accommodation	   is	   weak.	   Symptoms	   in	   humans	   vary	   from	   gastroenteritis	   to	   systemic	  
infection	  with	  typhoid	  fever,	  depending	  on	  the	  susceptibility	  of	  the	  host	  and	  the	  infectious	  serovar1.	  
A	   few	  percentage	  of	  patients	  with	   typhoid	  or	  patients	  without	  any	   symptoms	  become	  chronically	  
infected	  and	  transmit	  the	  bacterium	  by	  their	  faeces	  and	  urine.	  These	  transmissions	  constitute	  real	  
public	   health	   concerns.	   Moreover,	   treatment	   of	   the	   disease	   becomes	   difficult	   because	   of	   the	  
increasing	  resistance	  of	  the	  bacteria	  (Coburn	  et	  al.,	  2006;	  Guillot	  et	  al.,	  2004;	  Hussell	  &	  Bell,	  2014;	  
MacLean	  et	  al.,	  1996).	  
	  
Salmonella	  gets	  into	  the	  body	  through	  the	  digestive	  tract.	  It	  resists	  to	  the	  acid	  environment	  
of	  the	  stomach	  and	  infection	  is	  established	  later	  in	  the	  small	  intestine.	  After	  a	  passage	  through	  the	  
M	   cells,	   Salmonella	   serovars	   that	   cause	   gastroenteritis	   and	   diarrhea,	   such	   as	   Salmonella	   enterica	  
Typhimurium	   in	   humans	   or	   cattle,	   infect	   preferentially	   phagocytes	   in	   the	   lamina	   propria.	   The	  
infection	  is	  self-­‐limiting	  and	  usually	  does	  not	  pass	  beyond	  the	  mesenteric	  lymph	  node.	  Host	  adapted	  
serovars	  such	  as	  Salmonella	  enterica	  Typhi	  in	  humans	  or	  cattle	  are	  responsible	  for	  systemic	  typhoid	  
fever	  and	  can	  cause	  persistent	   infection	  within	   the	  host.	  After	  a	  passage	  through	  the	  M	  cells,	   this	  
serovar	  is	  able	  to	  target	  dendritic	  cells	  and	  macrophages	  to	  reach	  mesenteric	  lymph	  nodes	  (MLNs)	  
through	   lymphatic	   and	   blood	   vessels.	   Then,	   they	   are	   able	   to	   disseminate	   systemically	   through	  
spleen,	   liver,	   gall	   bladder	   or	   bone	   marrow.	   The	   pathogen	   manipulates	   the	   host	   response	   by	  
secreting	  effector	  proteins	  into	  the	  host	  cells	  and	  persists	  in	  Salmonella	  containing	  vacuole	  (SCV)	  in	  
phagocytes	   of	   the	   MLNs,	   bone	   marrows	   and	   gall	   bladder	   for	   life.	   Sometimes,	   Salmonella	   can	  
reappear	   on	   the	   mucosal	   surfaces	   of	   the	   intestinal	   tract	   and	   shedding	   can	   release	   it	   for	   new	  
contaminations	  (Ruby	  et	  al.,	  2012;	  Stumbles	  et	  al.,	  1998;	  Young	  et	  al.,	  2002).	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persistence.	  The	  most	   common	  site	  of	   chronic	   retention	   is	   the	  MLNs	  and	  at	   least	  80	  %	  of	  
bacteria	   in	   these	   lymph	   nodes	   persist	   in	   Monocyte/Macrophage	   2	   (MOMA-­‐2)	   expressing	  
macrophage	   (Monack	   et	   al.,	   2004).	   Macrophages	   seem	   also	   to	   be	   the	   predominantly	  
infected	  cells	  in	  the	  liver	  (Richter-­‐Dahlfors	  et	  al.,	  1997),	  and	  the	  spleen	  (Salcedo	  et	  al.,	  2001).	  
CD18-­‐	   expressing	   phagocytes	   (Macrophage	   or	   DC)	   are	   targets	   of	   Salmonella	   in	   the	   blood	  
(Fang	   et	   al.,	   1999).	  More	   recently,	   the	   phenotype	   of	   the	   infected	  macrophages	   has	   been	  
investigated	  and	  the	  bacterium	   is	  preferentially	  associated	  with	  M2	  macrophages	   (positive	  
for	  M2	  markers	   CD301,	   Ym1	  and	  Arg1)	   at	   later	   stages	   of	   a	  murine	   infection	   (Eisele	  et	   al.,	  
2013).	  Researchers	  have	  demonstrated	  that	  the	  M2	  marker	  PPARδ is	  required	  for	  bacterial	  
peristence	   and	   that	   the	   pathogen	   actively	   induces	   its	   upregulation.	   This	   regulator	   is	  
necessary	   to	   increase	   intracellular	   glucose,	   a	   crucial	   carbon	   source	   essential	   for	   the	  
replication	   of	   Salmonella.	  Moreover,	   anti-­‐inflammatory	   cytokines	   are	   also	   required	   in	   the	  
environment	  of	  the	  bacteria	  to	  ensure	  its	  establishment	  and	  the	  maintenance	  of	  the	  chronic	  
infection	  (Eisele	  et	  al.,	  2013).	  It	  is	  not	  excluded	  that	  other	  cell	  types	  than	  M2	  macrophages	  
could	  play	  a	  role	  in	  the	  infection	  of	  Salmonella	  but	  M2	  macrophages	  are	  the	  dominant	  target	  
during	  persistent	  infection.	  
	  
5.2.2.1. Mycobacterium	  tuberculosis	  
General	  traits	  of	  M.	  tuberculosis	  are	  presented	  in	  Box	  7.	  Once	  inhaled	  and	  trapped	  by	  
the	  alveolar	  macrophages	  of	   the	   lungs,	   the	  bacillus	  enters	   in	  a	  proliferative	  phase	  with	  an	  
exponential	   growth.	   It	   corresponds	   to	   the	   initiation	   of	   the	   granuloma	   formation:	   infected	  
macrophages,	   dendritic	   cells	   and	   non-­‐infected	  macrophages	   aggregate	   to	   form	   a	   nascent	  
granuloma	   (Holt	   et	   al.,	   1993;	   Russell	   et	   al.,	   2009;	   Wolf	   et	   al.,	   2007).	   These	   cells	   also	  
contribute	  to	  the	  development	  of	  a	  protective	  Th1	  immunity.	  CD4+	  T	  cells	  participate	  to	  the	  
enlargement	  of	  the	  granuloma	  by	  recruitment	  of	  other	  cell	   types	  such	  as	   lymphocytes	  and	  
fibroblasts,	   and	   activate	   the	   secretion	   of	   reactive	   nitrogen	   and	   oxygen	   species	   by	  
macrophages.	  At	  this	  period,	  when	  immunity	  begins	  to	  control	  the	  infection,	  bacterial	  load	  is	  
highly	  reduced	  and	  the	  remaining	  bacteria	  enter	   in	  a	  non	  replicative	  persistence	  (Co	  et	  al.,	  
2004).	  In	  mature	  granuloma,	  secretion	  of	  TNFα	  and	  TGF-­‐β	  by	  T	  cells	  and	  macrophages	  takes	  
part	   in	   the	   integrity	   of	   the	   granuloma	   by	  mediating	   the	   formation	   of	   a	   fibrous	   capsule.	   T	  
lymphocytes	  are	  expelled	   in	  the	  periphery	  and	  blood	  vessels	  decrease	   in	  the	  center	  of	   the	  








	   	  
Box	  7:	  Mycobacterium	  Tuberculosis	  
	  
Mycobacterium	   tuberculosis	   is	   an	   aerobe	   intracellular	   bacillus	   and	   the	   causative	   agent	   of	  
tuberculosis.	  The	  disease	  is	  responsible	  for	  9	  millions	  new	  cases	  and	  2	  million	  deaths	  every	  year.	  We	  
can	  estimate	  that	  one	  third	  of	  the	  population	  is	  contaminated	  but	  only	  2	  –	  3	  %	  develop	  symptoms	  
during	  their	  life	  span	  (World	  Health	  Organization,	  2009).	  The	  aerosol	  route	  ensures	  the	  transmission	  
of	   the	   pathogen.	   Droplets	   containing	   bacteria	   expelled	   by	   infected	   host	   are	   engulfed	   by	   alveolar	  
macrophages	   of	   the	   receiver	   host’s	   lungs	   (Kaufmann,	   2001).	   It	   uses	  multiple	   strategies	   to	   survive	  
and	  replicate	  in	  its	  host.	  It	  avoids	  the	  maturation	  of	  the	  phagosome	  and	  its	  acidification	  and	  it	  resists	  
to	  the	  antimicrobial	  agents.	  It	  is	  also	  able	  to	  manipulate	  the	  immune	  response	  to	  its	  advantage;	  the	  
balance	   between	   the	   stimulation	   of	   the	   immune	   response	   and	   its	   inhibition	   is	   essential	   for	  
mycobacterium	  to	  establish	  its	  replicative	  niche	  on	  the	  long	  term	  (Ramakrishnan,	  2012).	  On	  the	  one	  
hand,	  it	  limits	  the	  onset	  and	  the	  importance	  of	  the	  pro-­‐inflammatory	  responses:	  it	  has	  been	  shown	  
for	  example	  that	  it	  interferes	  with	  the	  responses	  to	  IFNγ	  or	  that	  it	  reduces	  its	  detection	  by	  TLR2	  and	  
the	   subsequent	   activation	   of	   macrophages	   (Madan-­‐Lala	   et	   al.,	   2011).	   On	   the	   other	   hand,	   M.	  
tuberculosis	  stimulates	  the	  inflammation	  by	  inducing	  the	  recruitment	  of	  macrophages	  to	  initiate	  the	  
formation	   of	   granulomas	   that	   are	   supposed	   to	   prevent	   dissemination	   of	   bacteria	   and	   limit	   their	  
number	  in	  lungs	  but	  that	  can	  be	  beneficial	  for	  bacteria	  in	  some	  conditions	  (Davis	  &	  Ramakrishnan,	  
2009).	  
	  
Figure	  16:	  Foamy	  macrophages	  and	  the	  progression	  of	  the	  human	  tuberculosis	  






progressively	   die	   by	   apoptosis	   and	   necrosis.	   It	   leads	   to	   accumulation	   of	   debris	   named	  
caseum.	  The	  apoptosis	  of	  the	  cells	  is	  associated	  with	  killing	  of	  contained	  bacteria	  (Dheda	  et	  
al.,	  2005).	  In	  most	  infected	  people,	  granulomas	  keep	  their	  structural	  integrity,	  do	  not	  evolve	  
and	   can	  even	   resolve.	  However,	   in	   some	   cases,	   they	  become	  a	  place	   that	   favors	   bacterial	  
persistence	  and	  dissemination;	   it	  happens	  when	  Mycobacterium	  manipulates	  the	  host	  cells	  
to	  promote	  differentiation	  of	  alveolar	  macrophages	   into	   foamy	  macrophages	  that	  are	   lipid	  
rich	   and	   display	   an	  M2-­‐like	   phenotype	   (see	   box	   8	   to	   have	  more	   information	   about	   these	  
cells).	  
	  
5.1. Brucella	  persistence…	  what	  is	  going	  on?	  
Brucella	   is	   a	   non-­‐spore	   forming	   bacterium.	   Up	   to	   now,	   persister	   cells	   have	   not	   been	  
discovered	   but	   their	   presence	   is	   not	   excluded	   because	   of	   the	   chronicity	   in	   the	   host.	   As	  
explained	   in	  the	  chapter	  2,	  Brucella	  displays	  a	   large	  panel	  of	  mechanisms	  to	  survive	   in	  the	  
host:	   it	   is	   adapted	   to	   the	  harmful	   environment,	  mainly	  by	  avoiding	   the	   immune	  effectors,	  
and	   it	  modifies	   the	   environment	   by	  manipulating	   the	   intravacuolar	   trafficking	   of	   the	   host	  
cell.	   These	   strategies	   offer	   to	   Brucella	   the	   opportunity	   to	   establish	   a	   preferential	   niche	  
where	   it	   persists	   and	   replicates.	   Chronic	   Brucellosis	   is	   far	   from	   being	   understood	   but	  
persistence	   is	   a	   fact	   described	   in	   the	   literature.	   For	   example,	   calves	   infected	   by	   Brucella	  
abortus	  in	  utero	  or	  by	  ingestion	  of	  contaminated	  milk	  can	  acquire	  a	  persistent	  infection	  that	  
will	   stay	   latent	   until	   a	   reactivation	   during	   the	   pregnancy,	   generating	   abortion	   (Wilesmith,	  
1978;	   terHuurne	   et	   al.,	   1993).	   In	   humans,	   approximately	   10	   %	   of	   patients	   experience	   a	  
relapse	   after	   antibiotic	   treatment.	   The	  phenomenon	   frequently	   happens	  within	   the	   first	   6	  
months	   after	   the	   treatment	   but	   some	   cases	   of	   reactivation	   of	   the	   disease	   have	   been	  
reported	  years	   later	   (OnderOgredici	  et	  al.,	  2010).	  Symptoms	  of	   the	  chronic	  disease	  can	  be	  
multiple,	  from	  muscular	  complications	  to	  neurological	  issues,	  suggesting	  that	  Brucella	  is	  able	  
to	  survive	  in	  various	  environment.	  Studies	  of	  the	  infection	  in	  the	  mouse	  model	  confirm	  this	  
versatility:	  spleen	  is	  known	  to	  be	  chronically	  infected	  (Vitry	  et	  al.,	  2012),	  and	  bioluminescent	  
imaging	  has	  permitted	  to	  see	  Brucella	   in	  joints,	  tail,	  extremities	  and	  submandibular	  regions	  
weeks	   after	   i.p.	   infection	   (Rajashekara	   et	   al.,	   2005).	   But	   very	   little	   is	   known	   regarding	  







	  	   	  
Box	  8	  :	  Foamy	  macrophages	  
	  
The	   formation	   of	   foamy	   macrophages	   during	  Mycobacterium	   tuberculosis	   infection	   starts	   by	  
progressive	  accumulation	  of	  lipid	  bodies	  by	  alveolar	  macrophages	  (Cẚceres	  et	  al.,	  2009).	  Actually,	  at	  
the	   beginning	   of	   the	   infection,	   activation	   of	   TLRs	   by	   the	   PAMPs	   and	   the	   presence	   of	   pro-­‐
inflammatory	   signals,	   such	   as	   TNF	   and	   IFNγ,	   are	   responsible	   for	   classical	   M1	   polarization	   of	  
macrophages.	   It	   seems	   that	   some	   of	   these	   signals	   also	   trigger	   the	   internalization	   of	   lipids	  
(cholesterol,	  triacylglycerides	  and	  phospholipids)	  into	  the	  pro-­‐inflammatory	  macrophages	  that	  form	  
lipid	  droplets	   (also	   referred	   to	  as	   lipid	  bodies)	   in	   the	  endoplasmic	   reticulum	   leaflet	   (Russell	  et	  al.,	  
2009).	   These	   lipid	   bodies	   have	   a	   role	   in	   regulating	   host	   response	   to	   infection	   by	   modulating	  
inflammatory	  mediators	  (D’Avila	  et	  al.,	  2008;	  Saka	  et	  al.,	  2012).	  It	  also	  appears	  that	  the	  pathogen	  is	  
able	   to	   take	   advantage	   of	   these	   lipid	   droplets	   because	   they	   can	   constitute	   a	   nutrient	   source	   for	  
bacteria	  notably	  to	  synthesize	  their	  cell	  wall	  (Russell	  et	  al,	  2009).	  For	  example,	  an	  in	  vitro	  study	  has	  
shown	   that	  Mycobacterium	   accumulates	   lipids	  as	   intracytoplasmic	   lipid	   inclusions	   (ILI)	   thanks	   to	  a	  
fusion	  between	  lipid	  bodies	  of	  the	  host	  cell	  and	  Mycobacterium-­‐containing	  phagosome.	  At	  this	  time,	  
the	   bacterium	   undergoes	   an	   elongation	   but	   does	   not	   divide.	   Lipid	   accumulation	   is	   intimacy	  
correlated	   with	   the	   phase	   of	   latency	   and	   persistence	   of	   bacteria	   (Caire-­‐Brändli	   et	   al,	   2014).	  	  
However,	  long	  persistence	  of	  Mycobacterium	  in	  these	  lipid-­‐rich	  cells	  does	  not	  seem	  to	  be	  achieved	  
in	   a	   pro-­‐inflammatory	   environment.	   Indeed,	   it	   has	   been	   shown	   that	   the	   lipid-­‐rich	   macrophages	  
progressively	   lose	  their	  ability	  to	  phagocytose	  and	  to	  activate	  bactericidal	   functions	  (Peyron	  et	  al.,	  
2008).	   Reduction	   of	   pro-­‐inflammatory	   activity	   of	   these	   macrophages	   combined	   with	   a	   lipid-­‐rich	  
environment	  could	  form	  a	  secure	  reservoir	  for	  the	  pathogen.	  	  
The	   reduction	   of	   pro-­‐inflammatory	   activity	   of	   macrophages	   is	   often	   associated	   with	   the	   M2	  
phenotype.	  Some	  clues	  lead	  us	  to	  think	  that	  foamy	  macrophages	  are	  indeed	  M2	  cells.	  For	  example,	  
a	  study	   in	  mice	  has	  shown	  that	  production	  of	   iNOS	  by	  alveolar	  macrophages	  decreases	  during	  the	  
chronic	  phase	  of	  the	  infection	  while	  expression	  of	  Arg1	  increases.	  Moreover,	  there	  is	  production	  of	  
IL-­‐4	   in	  broncho-­‐alveolar	   fluid	  of	  chronically	   infected	  mice	  by	  Mycobacterium	  tuberculosis	   (Redente	  
et	  al.,	   2010).	  However,	   foamy	  macrophages	  also	  express	  markers	   characteristic	  of	  other	   cell	   type,	  
such	   as	   DEC205	   and	   CD11c	   that	   are	   typical	   of	   dendritic	   cells	   (Ordway	   et	   al.,	   2005).	   Foamy	  
macrophages	   are	   anti-­‐inflammatory,	   lipid-­‐rich	   and	   Arg1-­‐expressing	   cells	   like	   alternative	   activated	  
macrophages	  (M2)	  but	  seem	  to	  have	  their	  own	  characteristics	  that	  make	  them	  a	  cell	  type	  aside.	  	  
Besides	   their	   role	   in	   persistence	   of	   the	   pathogen,	   foamy	   macrophages	   could	   be	   used	   by	   the	  
pathogen	   for	   later	   dissemination;	   it	   seems	   that	   granulomas	   containing	   these	   cells	   can	   have	   a	  
compromised	   fibrous	   capsule	   and	   can	   eventually	   release	   caseus	   material	   discharging	   infectious	  
bacteria	  into	  surrounding	  blood	  vessels	  and	  airways	  to	  allow	  the	  reinfection	  of	  macrophages	  and	  a	  
rapid	  expansion	  of	  the	  colonization	  (Co	  et	  al.,	  2004;	  Dheda	  et	  al.,	  2005;	  Russel	  et	  al.,	  2009;	  Stumbles	  
et	   al.,	   1998).	   Figure	   15	   shows	   a	   schematic	   evolution	   of	   these	   structures	   during	   a	  Mycobacterium	  






Our	  team	  has	  investigated	  infected	  cells	  in	  the	  spleen	  at	  12	  days	  in	  an	  i.p.	  model	  and	  
has	  shown	  that	  bacteria	  are	  located	  in	  the	  white	  pulp	  with	  two	  main	  infected	  populations:	  in	  
close	   proximity	   of	   the	  marginal	   zone,	  we	   have	   found	   infected	   cells	   expressing	  MOMA1,	   a	  
specific	  marker	  of	  metallophilic	  marginal	  zone	  macrophages,	  and	  deeply	   in	  the	  white	  pulp,	  
infected	   cells	   are	   CD11c+	   and	  Dec205+,	   both	   specific	  markers	   for	  DCs	   (Copin	  et	   al.,	   2012).	  
Other	  studies	  have	  shown	  that	  DCs	  can	  be	  a	  target	  during	  an	  infection	  by	  Brucella	  (Billard	  et	  
al.,	   2005).	   In	   vitro	   and	   in	   vivo	   studies	   have	   shown	   that	   Brucella	   is	   able	   to	   survive	   and	  
replicate	   in	   other	   cell	   types	   such	   as	   endothelial	   cells	   (Baldi	   &	   Giambartolomei,	   2013),	  
fibroblasts	   	   (Detilleux	   et	   al.,	   1990),	   hepatocytes	   (Delpino	   et	   al.,	   2010),	   Hela	   cells	   (Pizarro-­‐
Cerdá	  et	  al.,	  1998),	  and	  our	  team	  has	  recently	  demonstrated	  that	  erythrocytes	  can	  also	  be	  	  
infected	  by	  the	  bacterium	  ((Vitry	  et	  al.,	  2014),	  see	  appendix	  3).	  Thus,	  it	  is	  not	  excluded	  that	  
Brucella	  could	  infect	  other	  cell	  types	  during	  the	  chronic	  phase	  of	  the	  infection.	  
	  
Recently,	   the	  research	  team	  of	  Tsolis	  has	   investigated	   for	   the	   first	   time	  the	  relative	  
importance	  of	  alternative	  activated	  macrophages	  as	  a	  potential	  chronical	  niche	  for	  Brucella.	  
They	  have	  shown	  that	  M2	  macrophages	  are	  more	  abundant	  during	  a	  chronic	  infection	  than	  
during	  an	  acute	  one.	  In	  vitro,	  bone	  marrow-­‐derived	  macrophages	  (BMDM),	  treated	  with	  IL-­‐4	  
to	   become	   alternative	   activated	   macrophages	   (AAM),	   support	   a	   higher	   level	   of	   bacterial	  
replication	   than	   non-­‐treated	   BMDM.	   BMDM	   treated	   with	   IFNγ	   to	   become	   M1-­‐like	  
macrophages,	  eliminate	  the	  bacterium.	  Finally,	  they	  have	  shown	  that	  the	  M2	  marker	  PPARγ	  
has	   to	   be	   expressed	   in	   macrophages	   to	   allow	   Brucella	   to	   acquire	   glucose	   and	   promote	  
intracellular	   replication	   in	  AAM	   in	   vitro	   and	  persistence	   in	   vivo	   (Xavier	  et	  al.,	   2013).	  These	  
investigations	  are	  good	  clues	  to	  postulate	  that	  M2	  macrophages	  could	  be	  the	  reservoir	  cells	  
during	  a	  chronic	  in	  vivo	  infection,	  but	  it	  has	  not	  been	  demonstrated	  yet.	  














Brucella	  melitensis	  is	  a	  bacterium	  having	  a	  particularly	  efficient	  mode	  of	  infection;	  by	  
hiding	   and	  manipulating	   its	   host,	   it	   is	   able	   to	   partially	   evade	   the	   immune	   surveillance	   to	  
promote	  its	  survival	  and	  its	  replication.	  Thanks	  to	  a	  balance	  between	  its	  strategies	  and	  the	  
host	   immune	  defenses,	  Brucella	   is	  able	   to	   survive	  on	   the	   long	   term	   in	   its	  host.	  These	  past	  
decades,	   research	   has	   improved	   our	   understanding	   of	   the	   infectious	   mechanisms	   of	   the	  
pathogen	   and	   the	   associated	   protective	   immune	   response	   but	   there	   remains	   much	   to	  
elucidate.	   Most	   experiments	   have	   used	   an	   intraperitoneal	   model	   of	   infection	   in	   mice.	  
However,	  the	  natural	  routes	  of	  infection	  are	  mainly	  the	  ingestion	  of	  contaminated	  products	  
and	  the	  inhalation	  of	  Brucella	  contaminated	  aerosol.	  By	  taking	  the	  mucosal	  route,	  Brucella	  is	  
potentially	   able	   to	   infect	   other	   cellular	   populations	   and	   to	   activate	   other	   immune	  
mechanisms.	   Therefore,	   we	   decided	   to	   develop	   an	   intranasal	   model	   of	   infection	   to	  
characterize	  the	  immune	  response	  of	  mice	  against	  Brucella	  melitensis.	  
	  
The	  work	  has	  been	  divided	  into	  two	  main	  parts:	  
	  
-­‐	  in	  the	  first	  part	  of	  the	  thesis,	  we	  studied	  the	  nature	  and	  the	  contribution	  of	  cellular	  
populations	   into	   the	   control	   of	  Brucella	  melitensis	   infection.	   To	   achieve	   this	   objective,	  we	  
compared	   wt	   and	   genetically	   deficient	   C57BL/6	   mice	   for	   key	   elements	   of	   the	   immune	  
system;	   immune	   actors	   known	   to	   control	   intraperitoneal	   Brucella	   infection,	   but	   also	  
elements	  of	  the	  mucosal	  environment	  have	  been	  investigated.	  
	  
-­‐	   in	   the	   second	   part	   of	   the	   work,	   we	   analysed	   by	   immunohistofluorescence	   the	  
phenotype	   of	   infected	   cells	   in	   spleen	   of	   susceptible	   BALB/c	   IL12p40-­‐deficient	  mice	   during	  
the	  persistent	  phase	  of	  Brucella	  melitensis	  infection.	  We	  evaluated	  a	  recent	  hypothesis	  that	  
Th2-­‐induced	   M2	   macrophages	   could	   be	   the	   main	   reservoir	   cells	   for	   Brucella.	   For	   this	  
purpose,	  we	  have	  investigated	  the	  impact	  of	  STAT6-­‐deficiency	  on	  the	  bacterial	  load	  and	  the	  























































If we knew what it it was we were doing,  
it would not be called research, would it? 
















1.	   Both	   Th1	   and	   Th17	   cellular	   immunity	   constitute	   the	   core	   of	  
protective	   lung	   immune	   response	   following	   intranasal	   Brucella	  
melitensis	  infection	  in	  mice.	  
Delphine	  Hanot	  Mambres,	  Arnaud	  Machelart,	  	  Carl	  De	  Trez,	  Marjorie	  Vermeersch,	  David	  
Pérez-­‐Morga,	  	  Bernhard	  Ryffel,	  Jean-­‐Jacques	  Letesson,	  Eric	  Muraille	  
	  
In	  preparation	  for	  publication.	  
	  
Over	   past	   decades,	   numerous	   studies	   using	   the	   intraperitoneal	   (i.p.)	   model	   of	  
infection	   in	  mice	   have	   improved	  our	   knowledge	   about	   the	   host	   immune	   response	   against	  
Brucella	   melitensis.	   It	   has	   been	   learned	   that	   MHCII-­‐dependent	   antigen	   presentation	   to	   T	  
lymphocytes	  elicits	  an	  essential	  Th1	   immune	  response	  against	  Brucella	  and	   IFNγ-­‐producing	  
CD4+	  T	  cells	  are	  the	  crucial	  cell	  population	  that	  controls	  the	  infection.	  It	  has	  also	  been	  found	  
that	   B	   lymphocytes,	   TAP1-­‐dependent	   antigen	   presentation,	   and	   Th2	   and	   Th17	   immune	  
responses	  do	  not	  play	  major	  roles	  in	  controlling	  growth	  of	  the	  brucellae	  in	  the	  host	  (Vitry	  et	  
al.,	   2012).	   However,	   this	   widely	   used	   model	   is	   not	   representative	   of	   natural	   routes	   of	  
infection.	   Specifically,	   i.p.	   infection	   bypasses	   the	  mucosal	   environment	  with	   its	   associated	  
cell	   populations	   and	   effectors	   that	   could	   participate	   in	   the	   defenses	   against	   ingested	   or	  
aerosolized	  Brucella.	  
	  
When	  we	  began	  our	   intrasal	  (i.n.)	  study	  in	  2010,	  few	  investigators	  had	  used	  the	  i.n.	  
model	  of	   infection	  to	  study	  protective	   immunity	  against	  Brucella	   infections.	  The	  kinetics	  of	  
dissemination	   of	   the	   brucellae	   to	   the	   lungs,	   spleen	   and	   liver	   had	   been	   reported,	   the	  
presence	   of	   granulomas	   in	   the	   spleens	   and	   liver	   of	   	   	   infected	   mice	   had	   been	   observed	  
(Mense	   et	   a.l,	   2001),	   and	   the	   roles	   of	   TLR2,	   TLR4	   and	  MyD88	   (Pei	   et	   al.,	   2012)	   and	   the	  
function	  of	  adaptive	  immunity	  (Izadjoo	  et	  al.,	  2000)	  in	  the	  host	  immure	  response	  had	  been	  
described.	   But	   the	   role	   of	   	   specific	   immune	   cell	   populations	   and	   cytokines	   in	   protective	  







Using	   a	   panel	   of	   genetically	   deficient	  mice,	   we	   have	   confirmed	   the	   importance	   of	  
MHCII-­‐dependent	   antigen	  presentation,	   Th1	   immune	   response	   and	   IFNγ-­‐producing	   CD4+	   T	  
cells	   in	  the	  control	  of	  the	  infection	  in	  spleen,	   liver	  and	  lungs.	  We	  have	  also	  highlighted	  the	  
collaboration	  of	  γδ	  T	  lymphocytes	  and	  production	  of	  IL-­‐17A	  in	  the	  early	  control	  of	  bacteria	  in	  
the	  lungs.	  The	  absence	  of	  B	  lymphocytes	  or	  TAP-­‐1-­‐dependent	  antigen	  presentation	  does	  not	  
influence	  the	  efficiency	  of	  the	   immune	  defenses.	  We	  also	  showed	  that	  early	   localization	   in	  
the	  spleen	  was	  different	  from	  what	  had	  been	  described	  after	  the	  i.p.	  infection.	  Finally,	  study	  
of	  the	  humoral	  immune	  response	  during	  a	  second	  i.n.	  infection	  allowed	  us	  to	  conclude	  that	  
in	   contrast	  with	   the	   i.p.	  model	  of	   infection,	   antibodies	  do	  not	  participate	   in	   the	   sterilizing	  
immune	   response	   against	   the	   challenge	   strain.	   The	   mode	   of	   dissemination	   could	   be	   the	  
reason	   for	   this	  main	  difference	  with	   i.p.	  model.	   Taken	   together	   these	   results	  highlight	   the	  
importance	  of	  the	  route	  of	   infection	  for	   identifying	  the	  immune	  effectors	   implicated	  in	  the	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Brucella spp. are intracellular bacteria that cause brucellosis, one of the most common 
zoonoses in the world. Brucella infection has mainly been studied following intraperitoneal 
(i.p.) injection in mice. This protocol leads to an immediate bacterial dissemination to the 
spleen and bypasses all mucosal immune barriers. Since natural infection often occurs by the 
oral or respiratory route, mucosal vaccination may offer a way to confer local immune 
protection. Here, we characterize the cells and signaling pathways implicated in the 
development of a protective immune response following intranasal (i.n.) infection by B. 
melitensis 16M. The persistence of bacteria was analyzed in the lungs, spleen, liver and blood. 
Using a panel of genetically-deficient mice, we observed that CD4+ T cells play a central role 
in the late control of Brucella growth in all of the analyzed tissues. Both Th1 and Th17 
responses appear equally able to eliminate Brucella in lungs and liver, but only Th1 seems 
able to control the level of Brucella persistence in the spleen. Deficiency of CD8+ T cells does 
not significantly impact the course of Brucella infection but absence of γδ T cells strongly 
affects the early infection control in the lungs. In contrast to the i.p. infection model where 
antibodies play a crucial role in protection against a secondary infection, we showed that B 
cells are dispensable in both primary and secondary i.n. infections. Taken together, our results 
demonstrated that both Th1 and Th17 cellular immunity constitute the core of the protective 
immune response against i.n. infection by B. melitensis.  Identification of Th1 and Th17 
cellular response as immune protective markers could help to define a rational strategy for 









Brucella are facultative intracellular Gram-negative coccobacilli that infect humans as 
well as domestic and wild mammals. Human brucellosis is a zoonotic infection acquired 
through contact with infected animals or their products via ingestion, inhalation, or contact 
with conjunctiva or skin lesions (1). Although it is rarely fatal, it is a severe and debilitating 
chronic disease without prolonged antibiotic treatment (2). Despite significant progress, the 
incidence of human brucellosis remains very high in endemic areas (3) and is considered to be 
largely underestimated (4). In addition, Brucella species have been “weaponized” by several 
governments and are presently classed as category B threat agents (5). As the complete 
eradication of Brucella would be unpractical due to its presence in a large range of wild 
mammals (6, 7) and because antibiotic treatment is costly and patients frequently suffer from 
relapses following treatment (8), vaccination remains the more rational strategy to confer 
protection to populations living in endemic countries and to professionals frequently exposed 
to Brucella. Unfortunately, there is currently no vaccine against human brucellosis. All of   
the commercially available animal vaccines cause disease in humans (9, 10). 
Live vaccines are widely accepted to be superior to inactivated vaccines for protection 
against brucellosis (11–13), suggesting that the intracellular persistence of Brucella antigens 
generates key signals allowing the development of protective immunity. In addition, several 
studies from the Brucella experimental model (14, 15) but also from other infectious models 
reviewed in (16) have demonstrated that the infection route can influence the localization, the 
duration and the nature of protective immune responses. However, to date, the large majority 
of experimental studies with live Brucella strains have predominantly focused on 
intraperitoneal (i.p.) delivery in mouse models, frequently limiting their analysis to present 
bacteriologic counts in organs such as the spleen and liver after challenge. Thus, in spite of 
the importance of aerosol exposure as a natural route of infection (17) and the potential risk of 






focused on the respiratory route of infection. A limited number of brucellae seem sufficient to 
infect humans by aerosol (24). In agreement, aerosol or intranasal (i.n.) exposure of mice (23) 
or macaques (25) with low (102–103) doses of virulent B. melitensis 16M caused pulmonary 
infection followed by systemic infection of the spleen and liver. Interestingly, immune 
effector mechanisms controlling Brucella growth in the lungs, liver and spleen appear to 
differ depending upon the route of  infection used in the mouse model (18), suggesting that 
caution is warranted in interpretation of the significance of host immune effectors components 
previously identified using the i.p. route of  infection and spleen colonization as the measure 
of  Brucella virulence.  
To increase our understanding of the nature of protective mechanisms induced by i.n. 
administration of live Brucella vaccines, we analyzed the protection levels and the immune 
responses elicited in several host compartments (e.g. the lungs, spleen, liver and blood) and at 
different times after primary and secondary i.n. infection with virulent B. melitensis 16M. In 
this model, using a large panel of genetically deficient C57BL/6 mice, we compared the 
importance Th1, Th17 and CD4+T, CD8+T, γδ+T and B cells in the early and late control of 
Brucella growth. On the whole, these results identify both Th1- and Th17-based cellular 
immunity as potential markers of protective immune response against i.n. infection by B. 
melitensis, and could thus help to develop a rational strategy to identify protective live 






MATERIALS AND METHODS 
	  
Ethics Statement 
Procedures of this study and mice handling is conform with current European 
legislation (directive 86/609/EEC) and the corresponding Belgian law “Arrêté royal relatif à 
la protection des animaux d'expérience du 6 avril 2010 publié le 14 mai 2010". The Animal 
Welfare Committee of the Université de Namur (UNamur, Belgium) has reviewed and 
approved the complete protocol (Permit Number: 05-558). 
 
Mice and reagents 
Wild-type C57BL/6 mice were acquired from Harlan (Bicester, UK). IFNγR-/- 
C57BL/6 mice (26), IL-12p35-/- C57BL/6 mice (27), IL12p40-/- C57BL/6 mice (28)from Dr. 
B. Ryffel (University of Orleans, France). IL17RA-/- C57BL/6 mice (29), IL23p19-/- C57BL/6 
mice (30) from Dr. K. Huygen (Belgian Scientific Institute for Public Health, Bruxelles, 
Belgium). TAP1-/- C57BL/6 mice (31), MHCII-/- C57BL/6 mice (32) from Jörg Reimann 
(University of Ulm, Ulm, Germany). RAG1-/- C57BL/6 mice (33) from Dr. S. Goriely 
(Université Libre de Bruxelles, Belgium). AID-/- C57BL/6 mice (34) from Dr. H Jacobs (The 
Netherlands Cancer Institute, The Netherlands).). CD3ε-/- C57BL/6 mice (35), IL-1R-/- (36), 
CCR2-/- (37) and MuMT-/- (38) C57BL/6 mice were purchased from The Jackson Laboratory 
(Bar Harbor, ME). All wild-type and deficient mice used in this study were bred in the animal 
facility of the Gosselies campus of the Université Libre de Bruxelles (ULB, Belgium). 
We used a strain of Brucella melitensis 16M stably expressing a rapidly maturing 
variant of the red fluorescent protein DsRed (39): the mCherry protein (mCherry-Br), under 
the control of the strong Brucella spp. promoter, PsojA. Construction of the mCherry-Br 
strain has been described previously in detail (40). It grows in biosafety level III laboratory 






broth with double quantity of yeast extract) and were washed twice in RPMI 1640 (Gibco 
Laboratories) (3500xg, 10 min.) before the inoculation in mice. 
 
Mice infection and challenge 
Mice were anaesthetized with a cocktail of Xylasin (9mg/kg) and Ketamin (36 mg/kg) 
in PBS before being inoculated intra-nasally (i.n.) with 2x104 CFU of wild type or mCherry-
expressing B. melitensis in 30 µL of RPMI. Control animals were inoculated with the same 
volume of RPMI. Plating serial dilutions of inoculums validated the infectious doses. At 
selected time after infection, mice were sacrificed by cervical dislocation. Immediately after 
sacrifice, spleen, liver and lung cells were collected for bacterial count, flow cytometry and/or 
microscopic analyses. The intra-peritoneal infection made as a comparison with our i.n. model 
was previously described (40).  
 
Bacterial count 
Spleens, livers and lungs were crushed and transferred in PBS/0.1% X-100 triton 
(Sigma). For bacterial counts in the blood, 75 µl of blood was collected from the tail with 
heparinated capillaries at selected time points and diluted in PBS/0.1% X-100 triton (Sigma). 
We performed successive serial dilutions of the triton lysate in RPMI to get the most accurate 
bacterial count and plated them onto 2YT medium. The CFU were counted after 5 days of 
culture at 37°C. The CFU were counted after 5 days of culture at 37°C.  
 
Cytofluorometric analysis 
As previously described (41), spleens were harvested, reduced in small pieces and 
incubated for 30 minutes at 37°C with a mix of DNAse I fraction IX (Sigma-Aldrich Chimie 
SARL, Lyon, France) (100 µg/ml) and 1.6 mg/ml of collagenase (400 Mandl U/ml). Spleen 
cells were washed and filtered before being incubated in saturating doses of purified 2.4G2 






during 20 minutes at 4 °C to prevent antibody binding to Fc receptor. Various fluorescent 
mAb combinations in FACS buffer were used to stain 3-5x106 cells. We acquired the 
following mAbs from BD Biosciences: Fluorescein (FITC)-coupled 145-2C11 (anti-CD3ε), 
Phycoerythrin (PE)-coupled RM4-5 (anti-CD4), Phycoerythrin (PE)-coupled 53-6.7 (anti-
CD8α), Biotin-conjugated RB6-8C5 (anti-Gr1), streptavidin Phycoerythrin (PE), Fluorescein 
(FITC)-coupled M1/70 (anti-CD11b), Fluorescein (FITC)-coupled 1A8 (anti-Ly6G), 
allophycocyanin (APC)-coupled 1-A/1-E (anti-MHCII), allophycocyanin (APC)-coupled 
BM8 (anti-F4/80). The cells were analyzed on a FACScalibur cytofluorometer. Dead cells 
and debris were eliminated from the analysis according to size and scatter. 
 
Intracellular cytokine staining 
To guarantee an intracellular staining, after DNase-collagenase treatment, spleen cells 
were incubated for 4 h in RPMI 10% FCS with 1 µl/ml Golgi Stop (BD Pharmingen) at 37°C, 
5% CO2. After washing with FACS buffer and staining for cell surface markers, cells were 
fixed in PBS/1% PFA for 15-20 min at 4 °C. They were then permeabilized for 30 min using 
a saponin-based buffer (10X Perm/Wash, BD Pharmingen in FACS buffer) and stained with 
allophycocyanin (APC)-coupled XMG1.2 (anti-IFN-γ; BD Biosciences) or allophycocyanin 
APC-coupled eBio17B7 (anti-IL17a; BD Biosciences). After final fixation in PBS/1% PFA, 




Spleens and livers were fixed for 4 hours at room temperature in 2% 
paraformaldehyde (pH 7.4), washed in PBS, and incubated overnight at 4°C in a 20% PBS-
sucrose solution. Lungs were submitted to the same treatments at room temperature and under 
vacuum. Tissues were then embedded in the Tissue-Tek OCT compound (Sakura), frozen in 






rehydrated in PBS and incubated in a PBS solution containing 1% blocking reagent 
(Boeringer) (PBS-BR 1%) for 20 minutes before being incubated overnight in a PBS-BR 1% 
containing any of the following mAbs or reagents: DAPI nucleic acid, Alexa Fluor 350 or 488 
phalloidin (Molecular Probes), Alexa Fluor 647-coupled BM8 (anti-F4/80, Abcam), Alexa 
Fluor 647-coupled M1/70 (anti-CD11b), Alexa Fluor 647-coupled HL3 (anti-CD11c), Biotin-
coupled (anti-Gr1) or IgG M-19 (anti-NOS2) to stain the cells of interest. Biotin-coupled anti-
Gr1 mAb and anti-NOS2 polyclonal antibodies were detected using Alexa 350-coupled 
streptavidin  Alexa Fluor 488-coupled goat anti-rabbit IgG (Molecular Probes) in PBS-BR 
1%, respectively. Slides were mounted in Fluoro-Gel medium (Electron Microscopy Sciences, 
Hatfield, PA). Labelled tissue sections were visualized with an Axiovert M200 inverted 
microscope (Zeiss, Iena, Germany) equipped with a high-resolution monochrome camera 
(AxioCam HR, Zeiss). Images (1384x1036 pixels, 0.16µm/pixel) were acquired sequentially 
for each fluorochrome with A-Plan 10x/0.25 N.A. and LD-Plan-NeoFluar 63x/0.75 N.A. dry 
objectives and recorded as eight-bit grey-level *.zvi files. At least 3 slides per organ were 
analyzed from 3 different animals and the results are representatives of 2 independent 
experiments.   
 
Lung electronic microscopy 
The lung samples were fixed with glutaraldehyde 2.5 % for few hours at 4°C, rinsed in 
cacodylate buffer 0.1 M, pH 7.0 and cut with a LEICA  vibratome VT1200S to 300 µm-thick 
sections. After serial dehydration in increasing concentrations of ethanol and finally acetone, 
samples were dried at CO2 critical point and mounted on SEM stubs. Observations were 
perfomed with ESEM Quanta F200 (FEI) microscope. Images were analyzed and processed 










Specific murine IgM, IgA, IgG1, IgG2a and IgG3 isotypes were determined by 
enzyme-linked immunosorbent assay (ELISA). Polystyrene plates (Nunc 269620) were 
coated with heat-killed B. melitensis (107 CFU/ml). After incubation overnight at 4°C, plates 
were blocked for 2 hours at room temperature (RT) with 200 µl of PBS-3.65% casein. Then 
plates were incubated overnight at 4 °C with 50 µl of serial dilutions of the serum in PBS-
3.5% casein. The sera from unimmunized mice were used as the negative control. After 4 
washes with PBS, isotype-specific goat anti-mouse horseradish peroxidase conjugates were 
added (50 µl/well) at appropriate dilutions (anti-IgM from Sigma; anti-IgA from Invitrogen; 
LO-MG1-13 HRPO, LO-MG2a-9 HRPO, LO-MG3-13 HRPO from LO-IMEX). Plates were 
incubated for 2 hours at room temperature and washed 4 times in PBS before the addition of 
100 µl of substrate solution (BD OptEiA) to each well. After 10 minutes of incubation at 
room temperature in the dark, the enzyme reaction was stopped by adding 25 µl/well of 2N 
H2SO4, and absorbance was measured at 450 nm. 
 
Statistical analysis 
We used a (Wilcoxon-) Mann-Whitney test provided by GraphPad Prism software to 
statistically analyze our results. Each group of deficient mice was compared to wild-type 
mice. We also compared each group with each other and displayed the results when required. 
Values of p < 0.05 were considered to represent a significant difference. *, **, *** denote 















Intranasal inoculation leads to dissemination of Brucella in mice 
 In the present study, we used B. melitensis 16M strain to infect C57BL/6 mice by the 
i.n. route to investigate the nature of the protective immune responses in the lungs, spleen, 
liver and blood. This model has been previously used by several research groups (18, 20, 21). 
However, as infectious dose, origin of mice and animal facility conditions could influence the 
course of infection, we began by establishing the kinetics of i.n. infection under our laboratory 
conditions. 
 Following i.n. inoculation with 2x104 CFU of B. melitensis, mice were sacrificed at 1, 
3, 6, 12, 20, 28, and 50 days post infection (p.i.) (Figure 1.A). We observed that the brucellae  
persist at the same level in the lungs for the first 12 days p.i. before being progressively 
eliminated. At 28 days p.i., only rare mice displayed detectable CFU in the lungs. The 
dissemination of Brucella from the lungs to the spleen and liver took approximately 3 days. 
From 6 days p.i. the spleen and liver of the majority of mice displayed detectable CFU counts 
that reached a maximum at 12 days p.i.. Infection persisted in the spleen until the end of the 
experiment (50 days p.i.) but decreased from 12 days p.i. to below the limit of detection in the 
livers of  the majority of mice. When compared to i.p. infection with the same dose of bacteria 
((42) and Figure 1.B), a striking characteristic of i.n. infection was the slow dissemination 
from the primary site of infection to the spleens and livers and the absence of detectable 
brucellae in the blood (detection threshold = 10 CFU / ml). 
 It has been reported that B abortus infects mainly CD11c+ F4/80+ MHCII- alveolar 
macrophages in the lungs (43). Using a high dose (2x107 CFU) of mCherry-expressing B. 
melitensis 16M, we confirmed this observation at 1d p.i. (Supplementary Figure 1.A). After 
i.n. administration of 2x104 CFU, flow cytometry analysis of infected lungs did not show a 
significant modification of the frequency of neutrophils, alveolar and interstitial macrophages 
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Figure 1Figure 1. Course of B. melitensis infection in organs of C57BL/6 wild-type (wt) mice. Mice were 
intranasally (i.n.) injected with 2x104 CFU of B. melitensis and sacrificed at the indicated times. A, The data 
represent the number of CFU per gram of lungs (up), spleen (middle) and liver (down). Grey bars represent 
the medians. B, The data represent the number of CFU per ml of blood. These results are representative of at 
























































Figure 2: Course of B. melitensis mcherry in organs of C57BL/6 wild type, CCR2- and IL-1R- 
deficient mice. Mice were i.n. infected with a dose of 2x104 CFU of B. melitensis and sacrificed at the 
indicated times. The data represent the number of CFU per gram of lungs (up), spleen (middle) and liver 
(down). Bars represent the medians. n denotes the number of mice used for each lineage at each time. These 








Figure 3: CD11b+ granulomas in the spleen and liver of C57BL/6 wt mice. Mice were infected i.n. with 
a dose of 2x104 CFU of B. melitensis and sacrified at the indicated times. The panels represent the 
localization by immunofluorescence of CD11b+ and iNOS expressing cells in spleen (A) and liver (B) from 
naïve (control) and infected mice since 12, 20, 28 and 50 days. Right panels of (A) and (B) are higher 
magnification views of the left panels (A) and (B), respectively. Panels are color-coded with the text for Dapi 
or the antigen examined. Scale bar=100 µm and 20 µm, as indicated. r.p.: red pulp; w.p.: white pulp. Data are 







not observe granuloma formation in the lungs at any phase of infection (Supplementary 
Figure 1.C). These results suggest that the control of Brucella infection in mucosal lung tissue 
does not induce or require an inflammatory reaction. In order to test this hypothesis, we 
compared the course of Brucella infection in wild type, IL-1R-/- (deficient for 
proinflammatory cytokine IL-1 signaling) and CCR2-/- (deficient for monocyte recruitment) 
C57BL/6 mice (Figure 2). As expected, deficient mice displayed similar CFU counts in the 
lungs to wild-type mice during the first 12 days of infection, confirming that inflammation 
and monocyte recruitment are not required to control Brucella infection in the lungs. 
 In drastic contrast to what was observed in the lungs, colonization of the spleen 
(Figure 3.A) and liver (Figure 3.B) is accompanied by granuloma formation in i.n. infected 
mice which was detected by CD11b and iNOS/NOS2 staining. As expected, these granulomas 
were stained by rabbit anti-Brucella LPS (supplementary Figure 2). Interestingly, the location 
of the granulomas in the spleens and livers after i.n. infection was clearly different from their 
location after i.p. infection. As previously reported (40), following i.p. infection, granulomas 
were located predominately in the red pulp during the first days of infection and were found 
in the white pulp only after 12d. After i.n infection, granulomas appeared directly and only 
inside the white pulp, suggesting that the red pulp location of granulomas could be an artifact 
of  the i.p. route of  infection allowing a rapid and abrupt infection of  the spleen. 
  
Both Th1 and Th17 response contribute to the control of intranasal infection 
 The central role of the IFN-γ-mediated Th1 immune response in controlling spleen 
colonization by Brucella strains following i.p. infection has been well established (40, 44, 45). 
A weak compensatory role of Th17 in absence of Th1 in the spleen has been also reported by 
comparing IL-12p35-/- and IL-12p40-/- C57BL/6 mice (45). Using a battery of mice 
genetically deficient for key factors promoting Th1 (IL-12) and Th17 (IL-23) (Figure 4), we 
investigated the importance of both responses in controlling the persistence of  the brucellae 







































































Figure 4: Course of B. melitensis mcherry in organs of C57BL/6 wt, p40-, p35- and p19-deficient 
mice. Mice were i.n. infected with a dose of 2x104 CFU of B. melitensis and sacrificed at the indicated times. 
The data represent the number of CFU per gram of lungs (up), spleen (middle) and liver (down). Bars 
represent the medians. n denotes the number of mice used for each lineage at each time. These results are 








Figure 5: Course of B. melitensis mcherry in organs of C57BL/6 wt, IFNγR- and IL-17AR-deficient 
mice. Mice were i.n. infected with a dose of 2x104 CFU of B. melitensis and sacrificed at the indicated times. 
The data represent the number of CFU per gram of lungs (up), spleen (middle) and liver (down). Bars 
represent the medians. n denotes the number of mice used for each lineage at each time. These results are 






















































































Figure 6: Comparison between the B.melitensis infection of C57BL/6 wt, IL12p35-, CD3-and IFNγR-
deficient mice. Mice were i.n. injected with 2x104 CFU of B. melitensis; A, Survival curve of the four 
lineages of infected mice. B, mice were sacrificed at 35 days post-infection. The data represent the number of 
CFU per gram of lung (up), spleen (middle) and liver (down). Grey bars represent the medians. n denotes the 
number of mice used for each lineage. These results are representative of at minimum two independant 







spleen after i.p. infection. IL-23p19-/- mice (Th17-) displayed CFUs count in the spleen similar 
to wild type mice at any time tested p.i.. In contrast, IL-12p35-/- (Th1-) present higher CFU 
counts during the entire course of infection. IL-12p40-/- mice, deficient for IL-12 and IL-23 
(Th1- and Th17-), displayed higher CFU counts at later time p.i.. 
 In drastic contrast to what was obseved in the spleen, IL-12p35 deficiency had only a 
transient impact on the capacity of  the brucellae to colonize the lungs and liver. At 50d p.i., 
these mice eliminate Brucella like wild-type mice. Only IL-12p40 deficiency, affecting both 
Th1 and Th17 response, leads to high persistence in the lungs and liver. IL-23p19 deficiency 
did not affect the course of infection. These results showed that the immune requirements to 
control Brucella infection are tissue-specific, and that both Th1 and Th17 responses are 
equally able to control Brucella in the lungs and liver. 
 As IFN-γ and IL-17 are the signature effector cytokines of the Th1 and Th17 immune 
responses, respectively, we compared the impact of IFN-γR and IL-17RA deficiencies on the 
course of i.n. Brucella infection. As previously reported by others (46–48), absence of 
functional IFN-γ signaling led to high CFU counts in all of  the tested organs (Figure 5) and 
mortality after 35d p.i. (Figure 6.A). In comparison, the impact of IL-17 signaling deficiency 
appears to be limited to higher CFU counts in the lungs early in the infection (Figure 5) 
without any associated mortality (data not shown). Interestingly, the impact of IL-17R 
deficiency is already marked at 5d p.i.. At this time, IFN-γ signaling deficiency has no impact 
in the lungs, suggesting that the Th17 response starts before the Th1 response in the lungs,  
and constitutes the first line of defense against Brucella in this organ.  
 
High mortality in IFN-γ  signaling deficient mice in response to Brucella infection is 
associated to dramatic neutrophilia  
 The fatal course of Brucella infection in all mice displaying a deficiency in IFN-γ 











Figure 7: Electronic and fluorescent microscopic analysis of lungs of C57BL/6 wt and IFNγR-
deficient mice. Mice were i.n. injected with 2x104 CFU of B. melitensis and killed 35 days post-infection; A, 
Electronic microscopic analysis of lung in infected wt (left) and IFNγR-deficient mice (right). White arrows 
indicate a large zone devoid of alveoles, The two lower panels are higher magnification view. B, 
Immunohistofluorescence of lung in wt (left) and IFNγR-deficient mice (right). Panels are color-coded with 
the text for phalloidin or the antigen examined (Gr1). Scale bar=500, 250 and 100 µm, as indicated. Data are 







in mediating a protective immune response. However, the complete absence of mortality in 
RAG1-/- (45), MyD88-/- (44) and IL-12p35-/- (45) mice is on the surface parodoxical as T cells 
are described as being the main producer of IFN-γ during chronic Brucella infections (44, 45) 
and both MyD88 (44) and IL-12p35 (45) have been implicated in IFN-γ induction. When 
comparing the CFU counts in organs of IL-12p35-/-, CD3ε-/- and IFN-γR-/- mice 35d after i.n. 
infection (Figure 6.B), we observed that the numbers of  brucellae in these organs are similar 
in CD3ε-/- and IFN-γR-/- mice, but that only the IFN-γR-/- mice died (Figure 6.A). This result 
suggests that lack of control of bacterial growth is not the only reason underlying the IFN-γ 
deficiency induced mortality in response to Brucella infection. 
 In order to address this enigma, we analyzed in situ by electron and fluorescent 
microscopy the tissues of wild type, IL-12p35-/-, CD3ε-/- and IFN-γR-/- 35d after i.n. infection. 
We observed that only IFN-γR-/- infected mice displayed major alteration in lung (Figure 
7.A), spleen and liver structure (data not shown) at 35d p.i.. These alterations seem mainly 
due to a dramatic recruitment of Gr1+ cells (Figure 7.B for lung and supplementary Figure 
supplementary S3 for lung, spleen and liver). Flow cytometry analysis identified Gr1+ cells in 
the spleen as neutrophils as demonstrated by their typical cell surface phenotype: Ly-6G+ 
F4/80- MHC-II- CD11b+ (supplementary Figure S4). This dramatic neutrophilia is not 
correlated with a higher frequency of IL-17+ cells in IFN-γR-/- infected mice (supplementary 
Figure S5), suggesting that a compensatory Th17 response developing in the absence of a Th1 
response is not implicated in mortality. Interestingly, neutrophilia strongly affects the cellular 
composition of the granuloma in the liver (Figure 8.A) and spleen (data not shown). We have 
previously shown (40) that granulomas induced by Brucella infection in immunocompent 
mice are mainly composed of iNOS+ monocytes (CD11b+ CD11c- F4/80low) and inflammatory 
dendritic cells (CD11b+ CD11c+ F4/80high) with few neutrophils (GR1+). We observed a 
similar cellular composition of granulomas in the liver after i.n. infection in wild type and IL-








































Figure 8: Comparison between wt, IL12p35- CD3- and IFNγR-deficient mice 35 days post infection. 
Mice were infected i.n. with 2x104 CFU of B. melitensis and sacrificed 35 days later. A, Phenotypic analysis 
of granuloma in the liver of infected wt, ILp35- and IFNγR-deficient mice. Panels are color-coded with the 
text for Dapi or the antigen examined. scale bar=100 µm as indicated. B, The data represent the number of 
CFU per mL of blood in wt, ILp35-, CD3- and IFNγR-deficient mice. Grey bars represent the medians. n 







































































Figure 9: Course of B. melitensis mcherry in organs of C57BL/6 wt and deficient mice for different T 
cell populations. Mice were i.n. infected with a dose of 2x104 CFU of B. melitensis and sacrificed at the 
indicated times. A, Comparison between wt and Ƴδ T cell-deficient mice. B, Comparison between wt, TAP-
1- and MHCII-deficient mice. The data represent the number of CFU per gram of lungs (up), spleen (middle) 
and liver (down). Grey bars represent the medians. n denotes the number of mice used for each lineage at 
each time. These results are representative of at minimum two independant experiments. *, P<0,05; **, 






















































5 12 20 28 500
5 12 20 28 500
Time post-infection (days)
5 12 20 28 500
























































Figure 10: IFNγ production in the spleen of C57BL/6 wt mice after a B. melitensis mcherry infection. 
Mice were i.n. or i.p. infected with a dose of 2x104 CFU of B. melitensis and sacrificed at the indicated times. 
Spleen cells were collected and analyzed by flow cytometry. Cells were gated according to the size and 
scatter to exclude dead cells and debris for analysis. A, Spleen cells were analyzed for total IFNγ production. 
B, Spleen cells were analyzed for CD4 marker versus IFNγ production. C, Spleen cells were analyzed for 
CD8  marker versus IFNγ production. D, Spleen cells were analyzed for γδ marker versus IFNγ production. 
E, Spleen cells were analyzed for NK.1.1 and TCRβ markers versus IFNγ production. The data represent the 
mean ± SEM of the number of IFNγ producing cells (A), CD4+ IFNγ+ cells (B), CD8+ IFNγ+ cells (C), γδ+ 
IFNγ+ cells (D) or NK1.1+ TCRβ- IFNγ+ cells (E) per 105 spleen cells acquired at different times after the 
infection. Square and intermittent line indicate the level of IFNγ production by each cell type in naïve mice. 







IFN-γR-/- infected mice display large granulomas dominated by iNOS- CD11b+ Gr1+ CD11c- 
F4/80- cells (Figure 8.A). These neutrophil-rich granulomas do not seem able to contain 
Brucella infection as they are correlated with large numbers of  brucellae in the blood (Figure 
8.B). Taken together, these results suggest that IFN-γ signaling deficiency is characterized by 
a dramatic neutrophilia leading to multiple organ failure and a major alteration of granuloma 
formation associated with persistence of  brucellae in the blood. 
 
γδ  T cells and CD4+ T cells are the main effector T cell populations controlling Brucella 
growth after primary intranasal infection 
 In order to determine which lymphocyte populations are implicated in the control of 
i.n. Brucella infection, we compared the course of infection in various strains of C57BL/6 
mice genetically deficient for key genes affecting specific lymphocyte subsets. 
 Absence of γδ T lymphocytes led to a strong defect in early Brucella control in the 
lungs before 12 days p.i (Figure 9.A). γδ T cell deficiency has only a transient impact on 
colonization of  the spleen and liver. In contrast, MHC-II deficiency affecting CD4+ T 
lymphocytes abrogates Brucella control in all organs at 12 days p.i. until 50 days p.i., 
confirming their crucial role in the protective immune response against chronic Brucella 
infections (Figure 9.B). TAP-1 deficiency affecting CD8+ T lymphocytes had only minor 
consequences on the course of infection (Figure 9.B). Thus, while γδ T cells play a role as a 
first line of defense in mucosal lung tissue, CD4+ T cells are involved in the later control of 
infection. 
 Comparison of the cell surface phenotypes of IFN-γ producing cells in the spleen 
following i.p. and i.n. Brucella infection showed that CD4+ T lymphocytes are the dominant 
IFN-γ-producing cells at all times during infection (Figure 10). In contrast to i.p. infection, we 











































































































Figure 11Figure 11: Analysis of the importance of immunoglobulins in the control of B. melitensis infection of 
C57BL/6 mice. A, primary infection. Course of B. melitensis mCherry in organs of C7BL/6 wt, Rag1-, AID- 
and MuMT-deficient mice. They were i.n. infected with a dose of 2x104 CFU of B. melitensis and sacrified at 
the indicated times. The data represent the number of CFU per gram of lungs (up), spleen (middle) and liver 
(down). Grey bars represent the medians. n represents the number of mice used for each lineage at each time. 
B, secondary infection. B, CFU counting of the B. melitensis challenge strain in the spleen of C57BL/6 wt 
and muMT mice. C57BL/6 wt and muMT mice were first intranasally (up) or intraperitoneally (down) 
infected with a dose of 2x104 CFU of B. melitensis (immunization). 50 days later, they were challenged 
intranasally (up) or intraperitoneally (down) with the same dose of B. melitensis mcherry strain (challenge). 
Immunized mice with B. melitensis mcherry strain were used as the control (primo wt). Mice were finally 
sacrificed 28 days post-challenge. The data represent the number of CFU per gram of spleen. Grey bars 
represent the medians. n denotes the number of mice used in each group. Two asterisks (**) denote the 
percentage of mice free of bacteria in the spleen, three asterisks (***) denote significant differences with 








lymphocytes during i.n. infection suggesting that early activation of these cells during i.p. 
infection is an artifact due to the rapid dissemination of Brucella to the spleen.  
 
Humoral immune response plays only a minor role in the control of secondary 
intranasal Brucella infection in mice 
 Previous studies employing the i.p. Brucella infection model from our group (41, 45) 
and others (49) have shown that B cell deficiency has positive effect on the control of primary 
infection, but impaired the elimination of Brucella from the spleen following a secondary 
infection. 
 i.n. Brucella infection induced a detectable humoral immune response in the blood 
(Supplementary Figure S6.A), but we failed to detect a significant Brucella-specific antibody 
response in a bronchoalveolar lavage (data not shown).  
 The course of Brucella infection appears similar in the lungs, spleen and liver of i.n. 
infected wild type, AID-/- (deficient for activation-induced deaminase-mediated isotype 
switch) and MuMT-/- (deficient for B lymphocytes) C57BL/6 mice at all times tested (Figure 
11.A). 
 In order to estimate the importance of the humoral immune response in the control of 
secondary i.n. infection, wild type and MuMT-/- mice that had been infected for 50d with B. 
melitensis 16M were challenged with an mCherry-expressing derivative of  this strain. i.p. 
challenge was used as an internal control in this experiment. Figure 11.B displays the number 
of  brucellae detected in the spleens at 28d post challenge with the mCherry-expressing 
Brucella strain. We observed that, as previously published (41), the control of i.p. challenge 
required B lymphocytes as none of  the MuMT-/- mice appeared to be able to eliminate the 
brucellae from the spleen. In striking contrast, 75% of the MuMT-/- mice cleared Brucella 
from this organ after the i.n. challenge. The minor role of B lymphocytes in the control of i.n. 
challenge is not a consequence of the inability of i.n. infection-induced specific antibodies to 






equally able to control the bacterial level in the blood after i.p. challenge with 5x107 brucellae 










The major entry point for many human pathogens occurs at gastrointestinal, 
respiratory, or genital mucosal surfaces (reviewed in (16)). Protective immunity against 
mucosal pathogens will require novel vaccine strategies to induce mucosal immune responses 
tailored to the anatomic location and the threat of the invading pathogen. However, the 
requirement for mucosal immunization to generate protective “frontline immunity” against 
pathogens remains largely undefined. Immune responses required for mucosal protection can 
differ vastly depending on the individual pathogen. In addition, the route of vaccination 
appears important for selected and programmed protective immune responses. Despite recent 
progress in the understanding of Brucella infection very few studies (18–23) have 
investigated the dynamics of infection in several compartments following mucosal lung 
infection. Here, we compared the location of B. melitensis in tissues and the nature of 
protective immune responses following i.n. infection in mice to our previous results obtained 
using the classical i.p. infection model (40–42, 45). 
In contrast to i.p. infection, i.n. infection does not lead to a rapid dissemination of 
Brucella to the spleen and liver nor to persistence of these bacteria in the blood. This could 
explain why Brucella-induced granulomas in the spleen appeared immediately localized in the 
white pulp and not in the red pulp as previously described following i.p. infection (40). We 
hypothesize that i.p. infection saturates the marginal zone filter of the spleen containing 
marginal zone macrophages, allowing the infection of red pulp F4/80+ macrophages. Thus, we 
demonstrated in our model that the route of infection can alter the tissue localization of the 
brucellae and the type of  host cells these bacteria infect. 
The role of humoral immunity in the control of primary and secondary infection by 
Brucella strains appears complex. Our work (45) and that of  others (49) has shown that the 






deficiency can even favor Brucella clearance as B cells can be infected by Brucella (50) and 
thus contribute to chronic bacterial infections by providing an intracellular niche that may 
exert an immunoregulatory role by the production of IL-10 and TGF-β (49). As expected, our 
results showed that absence of B cells does not affect the course of Brucella infection 
following intranasal infection. However, we have also observed that circulating antibodies 
play a crucial role in the control of secondary i.p. infection by Brucella (41). In the absence of 
B cells, the Th1 cellular immune response is unable to clear Brucella from the spleen after a 
challenge infection. Following i.p. inoculation, Brucella are found associated with 
erythrocytes in the blood (42). After a brief extracellular phase, Brucella is able to invade 
erythrocytes and to persist for several weeks in the bloodstream. Circulating specific 
antibodies are able to neutralize Brucella before erythrocyte invasion and thus reduce 
Brucella dissemination to organs. In striking contrast to the i.p. infection model, we observed 
that i.n. challenge is weakly affected by B cell deficiency. We hypothesize that Brucella 
disseminate from the lungs to the spleen and liver inside myeloid phagocytic cells and thus 
avoid neutralizing antibodies. A result in accordance with this observation is that Brucella is 
rapidly found in dendritic cells and alveolar macrophages in lung draining lymph nodes (43). 
These results suggest that humoral immunity is dispensable for controlling natural mucosal 
infection by Brucella and that cellular immunity is the key marker of protective immunity. 
Studies performed with the i.p. infectious model have clearly established the crucial 
role of IFN-γ-secreting CD4+ Th1 cells in the control of Brucella infections (40, 45–48). 
Here, we demonstrated that the mortality associated with IFN-γ deficiency is not primarily 
linked to uncontrolled Brucella growth in tissues, but mainly to the strong neutrophilia 
causing multiple organ failure. Unfortunately, we failed to reduce Brucella-induced mortality 
in IFN-γR-/- mice by repeated administration of neutrophile-depleting antibodies, such as 1A8 
or GR1 (data not shown). This could be because the chronic nature of Brucella infections 






compensatory Th17 response as we did not detect a higher frequency of IL-17 producing cells 
in the spleens of  infected IFN-γR-/- mice when compared to infected wild type mice. In 
agreement, cutaneous and musculoskeletal inflammation observed following i.p. Brucella 
infection in IFN-γ-/- mice is independent of the Th17 response (51). In the Ehrlichia muris 
infection model, it has been shown (52) that IFN-γ acts to control infection by directly 
promoting the differentiation of myeloid cells toward monocytes. In the absence of IFN-γ 
signaling, infection promotes exclusively the expansion of neutrophils. These latter cells do 
not play a protective role during Brucella infection (53) and are generally associated with  
massive tissue damage, particularly in the lungs (reviewed in (54)). In agreement, in our 
model, absence of IFN-γ signaling is associated with drastic alteration of the granuloma 
composition that appeared mainly composed of neutrophils and lack of tissue confinement of 
Brucella as demonstrated by the high level of bacteria observed in the blood of IFN-γR-/- mice 
during chronic but not the early phase of infection. In conclusion, our results strongly suggest 
that the protective role of IFN-γ against Brucella infection has been over interpreted based on 
the exceptional mortality in mice associated with IFN- γ deficiency (46, 48). IFN-γ is clearly 
indispensable for Brucella control but is not sufficient as we have observed (45) that a similar 
frequency of IFN-γ-producing CD8+ T cells does not replace IFN-γ-producing CD4+ T cells to 
control Brucella growth in the spleen. 
The Th17 response has been mainly associated with host defense against several 
extracellular pathogens (reviewed in (55)). However, a growing number of studies have also 
associated Th17 with the control of intracellular microorganisms, such as Listeria 
monocytogenes, Salmonella enterica, and Mycobacterium tuberculosis (reviewed in (56)). Up 
to now, studies of the function of Th17 responses in immunity against Brucella infections 
have been scarce. In the classical i.p. infection model, we have reported that IL-23p19 
deficiency does not impact the control of Brucella in the  spleen, confirming that Th1 and not 






observed similar results in the spleen after i.n. infection. Both IL-17RA and Il-23p19 
deficiency have only a minor or no effect on CFU counts in the spleen and liver at all times 
post infection. In striking contrast, IL-17RA-/- mice display a limited capacity to control 
Brucella infections in the lungs. This defect is limited to the early stages of infection, e.g. 
prior to 12 days p.i.. Interestingly, during this period, IL-23p19 and IFN-γR deficiency have 
no, or minor, effect on the CFU counts of Brucella in the lungs. These results suggest that the 
Th17 response constitutes the first line of defense against Brucella infections in the lungs. The 
Th1 response develops later, and in the absence of IL-12p35, the Th1 response can be 
replaced in the lungs by a Th17 response, as demonstrated by the fact that wild type and IL-
12p35-/- mice display similar levels of control at later times during the infection. A similar 
compensatory phenomenon is also observed in the liver, suggesting that the key role of IL-12-
induced Th1 in the spleen may be the exception and not the general rule. The Th17 response 
is generally considered to be strictly dependent on IL-23, but reduced IL-17 production can be 
detected even in IL-23-/- mice (30). Unfortunately, we failed to identify the source of IL-17 in 
the lungs (data not shown). However, we observed that γδ T cell deficiency, but not CD4+ T 
cell deficiency, also impacts early Brucella control in the lungs, suggesting that γδ T cells 
could be a potential source of IL-17 in our model.  
In summary, our work highlights the importance of identifying protective immune 
responses in more realistic experimental models. We showed that bacterial localization in 
organs and effector immune mechanisms required to control infection are strongly dependent 
on the route of infection. In the intranasal infectious model, we identified CD4+ T cell-
mediated Th1 and Th17 cellular immune responses as the core protective immune responses 
against Brucella and exclude a major role for B cells and CD8+ T cells. These findings could 
improve our ability to develop protective vaccines or therapeutic treatments against 
brucellosis. As CD4+ T cell dependent cellular immunity only developed following the 






active, seem to remain the easiest and most potent tools for the production of candidate 
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S1: analysis of lungs in C57BL/6 wt mice. Mice were infected i.n. with a dose of 2x104 CFU of B. melitensis 
and sacrified at the indicated times. Naïve mice were used as a control (cont). A, lungs were collected and 
examined by immunohistofluorescence. The panels represent the phenotype of infected cells in lungs 1 day post-
infection. Panels are color-coded with the text for Dapi, phalloidin, mCherry-Bru or the antigen examined. 
Yellow arrowheads indicate the presence of bacteria. B, lungs cells were collected and analyzed by flow 
cytometry. Cells were gated according to the size and scatter to exclude dead cells and debris for analysis. lung 
cells were analyzed for F4/80, CD11b, Ly6G and CD11c markers. The panels shows representative dot plots from 
an individual lung. The left figure shows total lung cells analyzed for the F4/80 marker versus CD11b marker per 
105 cells acquired, the middle figure shows lung cells gated on CD11c positive cells (R1) and the right figure 
shows lung cells gated on Ly6G positive cells (R3).  The graph indicates the mean ± SEM of the percentage of 
cells in gate R1 (alveolar macrophages as indicated), R2 (interstitial macrophages as indicated) and R3 
(neutrophiles as indicated) per 105 cells acquired in naïve mice, 1 day (d) and 5 days infected mice. n denotes the 
number of mice used. C, lungs were collected and examined by immunohistofluorescence. The panels represent a 
section of a naive lung (left) and a lung 5 day post-infection (right). Panels are color-coded with the text for 
phalloidin and the antigen examined (CD11b). . Scale bar= 10 and 200 µm. These results are representative of at 
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S2: localization of Brucella in the spleen of C57BL/6 wt mice. Mice were infected i.n. with a dose of 
2x104 CFU of B. melitensis and sacrified at 20 days post infection. The left figure shows the localization by 
immunofluorescence of CD11b-expressing cells and cells stained with anti-Brucella Ab in spleen. The right 
figure is higher magnification view of the left one. Panel is color-coded with the text for Dapi, anti-Brucella 
or the antigen examined (CD11b). Scale bar=200 µm and 50 µm, as indicated. r.p.: red pulp; w.p.: white 
pulp. Data are representative of at least two independent experiments.  
S3: Study of Gr1-expressing cells in lungs, spleen and liver of C57BL/6 wt, IL12p35-, CD3- and 
IFNγR- deficient mice. Mice were infected i.n. with a dose of 2x104 CFU of B. melitensis and sacrified 35 
days post infection. Organs were collected and examined by immunohistofluorescence. The panels show 
Gr1-expressing cells in lungs (A), spleen (B) and liver (C) of wt, IL12p35-, CD3- and IFNγR- deficient mice 
from the left to the right. Panels are color-coded with the text for phalloidin and the antigen examined (Gr1). 
Scale bar= 100 µm. as indicated. r.p.: red pulp; w.p.: white pulp. These results are representative of at 
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Supplementary Figure 4
IFNγR
S4: Phenotyping of Gr1high cells into the spleen of C57BL/6 WT, IL12p35 and IFNγR-deficient mice. 
Mice were i.n. injected with 2x104 CFU of B. melitensis and killed at indicated times. Spleen cells were 
collected and analysed by flow cytometry. Cells were gated according to the size and scatter to exclude dead 
cells and debris for analysis. A, Spleen cells were analysed for Forward Size Scatter (FSC) versus Gr1 
production. The figure shows representative dot plots from individual spleen in each group. One asterisk (*) 
denotes the number of cells in gate R1 out of 105 cells acquired. B, Gr1 high spleen cells (R1) were selected for 
wt and IFNγR-deficient mice and analyzed for the expression of a panel of markers: Ly6G, F4/80, MHCII 









































Supplementary Figure 5S5: Cytokine IL-17A production in the spleen of C57BL/6 wt, IL12p35 and IFNγR-deficient mice. 
Mice were i.n. injected with 2x104 CFU of B. melitensis and killed 35 days post-infection. Naïve wt mice 
were used as a control (cont). Spleen cells were collected and analyzed by flow cytometry. Cells were gated 
according to the size and scatter to exclude dead cells and debris for analysis. Spleen cells were analyzed for 
Forward Size Scatter (FSC) and IL17A production. The data represent the mean ± SEM of the number of 
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Supplementary Figure 6S6: Comparison of B. melitensis specific Immunoglobulins and CFU in the blood of i.p. versus i.n. 
infected C57BL/6 wt and muMT-deficient mice. A, wt mice were i.p. or i.n. infected with a dose of 2x104 
CFU of B. melitensis and sera were collected 50 days later. The data represent the mean ± SEM of the optical 
density that increases with the presence of immunoglobulins in the serum. 6 dilutions have been analyzed. B, 
wt and muMT mice were immunized with a dose of 2x104 CFU of B. melitensis. One group of wt mice was 
i.p. immunized and one group of wt and muMT mice was i.n. immunized. 50 days later, all mice were i.p. 
infected a second time (challenge) with B. melitensis mcherry strain. I.p. immunized mice with B. melitensis 
mcherry strain were used as a control. Blood was drawn 3 hours post infection. The data represent the 
number of CFU per mL of blood 3 hours post-infection. Grey bars represent the medians. n denotes the 
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2. The	   phenotype	   of	   Brucella	   melitensis	   infected	   cells	   in	   vivo	   is	  
independent	  of	  STAT6	  
Delphine	  Hanot	  Mambres,	  	  Carl	  De	  Trez,	  	  Jean-­‐Jacques	  Letesson,,	  Eric	  Muraille	  
	  
This	   is	  a	  preliminary	  manuscript	  describing	  the	  results	  obtained	  during	  the	  second	  part	  of	   research	  
described	  in	  this	  thesis.	   It	  does	  not	  correspond	  to	  the	  final	  version	  of	  a	  published	  paper.	  We	  would	  
like	  to	  associate	  these	  results	  with	  the	  ones	  obtained	  by	  Arnaud	  Machelard	  and	  Georges	  Potemberg	  
working	  on	  the	  combination	  of	  asthma	  and	  Brucella	   infection	  in	  mice.	  Their	  work	  will	  complete	  our	  
study	   by	   showing	   the	   impact	   of	   an	   induced	   Th2	   immune	   response	   in	   wild-­‐type	   mice	   on	   Brucella	  
infection	  and	  reservoir	  cells.	  
	  
It	  has	  been	  demonstrated	  that	  alveolar	  macrophages	  are	  the	  first	  cells	  to	  be	  infected	  	  
when	   aerosolized	  Brucella	   colonize	   the	   lungs	   of	  mice	   (Archambaud	  et	   al.,	   2010).	   It	   is	   also	  
known	   that	   trophoblasts	   are	   a	   preferential	   location	   during	   pregnancy	   in	   natural	   hosts	  
(Andreson	  et	   al.,	   1986),	   and	   that	   Brucella	   is	   able	   to	   infect	   a	   large	  panel	   of	   cells,	   including	  
professional	  phagocytes	  (Billard	  et	  al.,	  2005;	  Copin	  et	  al.,	  2012).	  However,	  the	  range	  of	  host	  
cells	   colonized	   during	   the	   chronic	   phase	   of	   the	   disease	   is	   unknown.	   Research	   in	  mice	   has	  
shown	   that	   that	   the	   extremities,	   joints	   in	   the	   tail	   and	   the	   spleen	   are	   anatomic	   locations	  
where	   persistent	   Brucella	   infections	   can	   be	   found	   (Rajashekara	   et	   al.,	   2005;	   Vitry	   et	   al.,	  
2012).	  	  
	  
The	  objective	  of	  this	  part	  of	  	  the	  work	  was	  to	  analyze	  infected	  cells	  in	  the	  spleens	  of	  
mice	  during	   the	  “chronic”	  phase	  of	   infection.	  Unfortunately,	   studying	   reservoir	  cells	   in	   the	  
spleens	   of	   wild-­‐type	   mice	   is	   particularly	   complicated	   because	   of	   the	   limited	   number	   of	  
infected	   cells	   during	   this	   phase	   of	   the	   infection.	   Thus,	   we	   decided	   to	   use	   susceptible	  
IL12p40-­‐deficient	  BALB/c	  mice	  that	  show	  higher	  CFU	  counts	   in	  the	  spleen	  at	  28	  days	  post-­‐
infection.	  This	  mouse	  lineage	  does	  not	  develop	  an	  effective	  Th1	  immune	  response	  but	  has	  a	  
pro-­‐Th2	  bias.	  A	  recent	  study	  has	  suggested	  that	  M2	  macrophages,	  developed	  during	  a	  Th2	  
immune	   response,	   could	   be	   the	   preferential	   niche	   for	   Brucella	   during	   chronic	   infection	  
(Xavier	  et	  al.,	  2013).	  We	  decided	  to	  test	  this	  hypothesis	  by	  depletion	  of	  the	  STAT6	  gene	   in	  
IL12p40-­‐deficient	  mice.	  These	  double	  knockout	  mice	  do	  not	  develop	  an	  effective	  Th1/Th17	  







Interestingly,	   bacterial	   numbers	   and	   the	   phenotypes	   of	   reservoir	   cells	   were	   not	  
influenced	   by	   STAT6	   pathway.	   This	   suggests	   that	   infected	   cells	   are	   not	   Th2-­‐induced	   M2	  
macrophages,	   even	   if	   they	   are	   positive	   for	   the	   M2	   marker	   Arg1.	   The	   staining	   profiles	   of	  
infected	  cells	  (CD11c+,	  DEC205+,	  Arg1+	  and	  high	  lipid	  content)	  reveals	  characteristics	  shared	  
by	   foamy	   macrophages	   encountered	   during	  Mycobacterium	   tuberculosis	   infection.	   Thus,	  
Brucella	  may	  manipulate	  the	  host	  environment	  to	  produce	  a	  favorable	  niche	  full	  of	  nutrients	  
for	  its	  replication	  and	  persistence	  like	  Mycobacterium	  tuberculosis.	  






The	  phenotype	  of	  Brucella	  melitensis	   infected	  cells	   in	  vivo	   is	  
independent	  of	  the	  STAT6	  dependent	  signaling	  pathway.	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Brucella	   are	   zoonotic	   bacterial	   pathogens	   that	   establish	   long-­‐term	   intracellular	  
infections	   in	   their	   host.	   Recent	   studies	   suggest	   that	   chronic	   phase	   of	  Brucella	   infection	   is	  
associated	  with	  induction	  of	  alternatively	  activated	  (M2)	  macrophages.	  In	  several	  infectious	  
models,	   it	  has	  been	  shown	  that	  M2	  macrophages	  are	  induced	  by	  IL-­‐4/IL-­‐13	  (Th2)	  cytokines	  
and	   can	   constitute	   a	   favorable	  niche	   for	   long-­‐term	  bacterial	   persistence.	   In	   this	   study,	  we	  
analyzed	  in	  situ	  the	  phenotype	  of	  Brucella	  melitensis	  infected	  cells	  in	  the	  spleen	  from	  highly	  
susceptible	   IL-­‐12p40-­‐/-­‐	  BALB/c	  mice	  and	  the	   impact	  of	  STAT6	  deficiency	  on	  this	  phenotype.	  
Surprisingly,	   we	   observed	   that	   the	   absence	   of	   IL-­‐4/IL-­‐13	   signaling	   pathways	   in	   IL-­‐12p40-­‐/-­‐	  
STAT6-­‐/-­‐	   mice	   does	   not	   affect	   the	   bacterial	   number	   in	   the	   spleen	   nor	   the	   phenotype	   of	  
reservoir	  cells	  when	  compared	  to	  IL-­‐12p40-­‐/-­‐	  mice.	  In	  both	  mouse	  strains,	  the	  phenotype	  of	  
infected	   spleen	   cells	   appears	   heterogeneous	   and	   mainly	   comprised	   of	   dendritic	   cells	  
(CD11c+)	   or	   marginal	   zone	   macrophages	   (MOMA1+	   and	   ERTR9+)	   expressing	   low	   levels	   of	  
MHC-­‐II	   and	   located	   in	   the	   T	   cell	   area	   of	   the	   white	   pulp.	   These	   cells	   frequently	   express	  
Arginase1	  but	  are	  negative	  for	  Fizz1	  or	  CD301	  M2	  markers.	  They	  also	  contain	  high	   level	  of	  
lipid	   droplets	   detected	   by	   bodipy	   staining	   suggesting	   the	   presence	   of	   high-­‐energy	   carbon	  
sources	  in	  these	  cells.	  Taken	  together,	  we	  formally	  demonstrated	  that	  formation	  of	  reservoir	  
cells	   in	   susceptible	   mice	   is	   independent	   of	   the	   STAT6	   signaling	   pathway	   and	   as	   a	  
consequence	   that	   the	   phenotype	   of	   Brucella-­‐infected	   cells	   is	   not	   dependent	   on	   Th2	  
cytokines.	   This	   characterization	  of	  Brucella	   reservoir	   cells	   could	  help	   to	   better	   understand	  







A	   growing	   number	   of	   clinically	   relevant	   infectious	   diseases	   are	   characterized	   by	  
pathogen	  persistence	  in	  the	  host.	  Chronic	  and	  recurrent	   infections	  require	  long-­‐lasting	  and	  
costly	  therapy	  and	  are	  the	  cause	  of	  much	  morbidity	  in	  the	  world	  [1].	  Brucellosis,	  considered	  
one	  of	  the	  most	  common	  global	  zoonoses,	  affects	  a	  large	  range	  of	  mammals	  and	  is	  caused	  
by	   facultative	   intracellular	   Gram-­‐negative	   bacteria	   of	   the	   genus	   Brucella	   [2,3].	   Human	  
brucellosis	   is	   a	   severe	   and	   debilitating	   disease	   that	   may	   lead	   to	   permanent	   damage	   and	  
requires	  prolonged	  and	  combined	  antibiotic	  therapy	  [4].	  Direct	  cutaneous	  contact,	  ingestion	  
of	  animal	  products	  and	  inhalation	  of	  airborne	  agents	  are	  the	  main	  routes	  of	  transmission	  in	  
humans	  [5].	  No	  safe	  or	  effective	  vaccine	  is	  available	  to	  prevent	  human	  brucellosis	  [6].	  
Very	  little	  is	  known	  about	  the	  phenotype	  and	  the	  physiological	  state	  of	  the	  host	  cells	  
that	   harbor	   Brucella	   strains	   during	   chronic	   infections.	   Following	   intraperitoneal	   [7]	   or	  
intranasal	  infection	  [8],	  the	  spleen	  is	  chronically	  colonized	  by	  Brucella.	  Using	  a	  B.	  melitensis	  
16M	   strain	   expressing	   the	   mCherry	   fluorescent	   protein	   (mCherry-­‐Br),	   we	   previously	  
observed	   [9]	   	   in	   wild	   type	   C57BL/6	   mice	   the	   formation	   of	   iNOS+	   granuloma	   structures	  
surrounding	  infected	  spleen	  cells.	  Inflammatory	  dendritic	  cells	  (iNOS+	  CD11b+	  CD11c+	  F4/80+	  
MHC-­‐II+)	   and	   activated	  monocytes	   (iNOS+	   CD11b+	   CD11c-­‐	   F4/80+	  MHC-­‐II+)	   appeared	   as	   the	  
major	  infected	  cell	  types	  in	  the	  granulomatous	  lesions.	  Alteration	  of	  the	  MyD88/IL-­‐12/IFN-­‐γ	  
axis	  dramatically	  affects	  the	  cellular	  composition	  of	  these	  granulomas,	  reducing	  their	  ability	  
to	  control	  bacterial	  dissemination	  and	  leading	  to	  replication	  and	  persistence	  of	  the	  Brucella	  
in	  distinct	  cellular	  niches.	   In	  the	  spleen	  of	  highly	  susceptible	   IL-­‐12p40-­‐/-­‐	  BALB/c	  mice,	  these	  
cells	  are	  located	  in	  the	  T	  cell	  area	  of	  the	  white	  pulp,	  express	  CD11c,	  MOMA-­‐1	  and	  DEC-­‐205	  
C-­‐type	   lectin	   (CD205)	   markers	   and	   are	   negative	   for	   iNOS,	   CD11b	   and	   F4/80	   markers	  






The	   Th2	   cytokines	   IL-­‐4	   and	   IL-­‐13	   induce,	   through	   STAT6	   dependent	   signaling,	   the	  
polarization	  of	  macrophages	  toward	  an	  alternatively	  activated	  (also	  termed	  M2)	  phenotype.	  
These	   later	   cells	   are	   characterized	   by	   the	   selective	   expression	   of	   M2	   markers	   such	   as	  
Arginase1	   (Arg1),	   Fizz1	   (Found	   in	   Inflammatory	   Zone	   1)	   [10]	   and	   MGCL1	   (Macrophage	  
Galactose-­‐C-­‐type	   lectin,	   CD301)	   [11],	   and	   display	   low	   microbicidal	   activity	   and	   a	   lipid	  
oxidative	  metabolism	  (reviewed	  in	  [12–14]).	  In	  various	  infectious	  models,	  it	  has	  been	  shown	  
that	  M2	  macrophages	  can	  constitute	  a	  favorable	  niche	  for	  long	  term	  persistence	  of	  bacteria	  
[15,16]	   and	   protozoa	   [17,18].	   A	   recent	   report	   [19]	   suggests	   that	   the	   chronic	   phase	   of	  
Brucella	   infection	   is	  associated	  with	  the	   induction	  of	  M2	  macrophages	  and	  that	  these	  cells	  
could	   constitute	   a	   favorable	   intracellular	   niche	   for	   Brucella	   persistence.	   In	   this	   study,	   we	  
analyzed	  in	  situ	  the	  phenotype	  of	  Brucella	  melitensis	  infected	  cells	  in	  the	  spleens	  from	  highly	  
susceptible	   IL-­‐12p40-­‐/-­‐	  BALB/c	  mice	  and	  the	   impact	  of	  STAT6	  deficiency	  on	  this	  phenotype.	  
Surprisingly,	   we	   observed	   that	   the	   absence	   of	   IL-­‐4/IL-­‐13	   signaling	   pathways	   in	   IL-­‐12p40-­‐/-­‐	  
STAT6-­‐/-­‐	  mice	  does	  not	  affect	  the	  phenotype	  of	  Brucella-­‐infected	  cells	  when	  compared	  to	  IL-­‐
12p40-­‐/-­‐	  mice.	  This	  demonstrates	  that	  the	  formation	  of	  reservoir	  cells	  in	  susceptible	  mice	  is	  
independent	   of	   STAT6	   signaling	   pathways,	   and	   consequently	   that	   these	   cells	   are	   not	   Th2-­‐






MATERIALS	  AND	  METHODS	  
	  
Ethics	  Statement	  
Procedures	   of	   this	   study	   and	   mice	   handling	   is	   conform	   with	   current	   European	  
legislation	  (directive	  86/609/EEC)	  and	  the	  corresponding	  Belgian	  law	  “Arrêté	  royal	  relatif	  à	  la	  
protection	   des	   animaux	   d'expérience	   du	   6	   avril	   2010	   publié	   le	   14	  mai	   2010".	   The	   Animal	  
Welfare	   Committee	   of	   the	   Université	   de	   Namur	   (UNamur,	   Belgium)	   has	   reviewed	   and	  
approved	  the	  complete	  protocol	  (Permit	  Number:	  05-­‐558).	  
	  
Mice	  and	  reagents	  
Wild-­‐type	   BALB/c	   mice	   were	   acquired	   from	   Harlan	   (Bicester,	   UK).	   	   We	   used	   also	  
STAT6-­‐/-­‐	   BALB/c	   mice	   (strain	   C.129S2-­‐STAT6tm1Gru/J),	   IL12p40-­‐/-­‐	   BALB/c	   mice	   (C.129S1-­‐
IL12btm1Jm/J),	   both	   purchased	   from	   Jackson	   Laboratory,	   and	   the	   double	   knockout	  
STAT6/IL12p40	   BALB/c	   mice,	   obtained	   by	   cross	   between	   the	   two	   simple	   knockout	   cited	  
above.	  All	  wild-­‐type	  and	  deficient	  mice	  used	  in	  this	  study	  were	  bred	  in	  the	  animal	  facility	  of	  
the	  Gosselies	  campus	  of	  the	  Université	  Libre	  de	  Bruxelles	  (ULB,	  Belgium).	  
	  
We	   used	   a	   strain	   of	   Brucella	   melitensis	   16M	   stably	   expressing	   a	   rapidly	   maturing	  
variant	   of	   the	   red	   fluorescent	   protein	   DsRed	   (Shaner	   et	   al.	   2004):	   the	   mCherry	   protein	  
(mCherry-­‐Br),	  under	  the	  control	  of	  the	  strong	  Brucella	  spp.	  promoter,	  PsojA.	  Construction	  of	  
the	  mCherry-­‐Br	  strain	  has	  been	  described	  previously	  in	  detail	  (Copin	  et	  al.	  2012).	  It	  grows	  in	  
biosafety	   level	   III	   laboratory	  facilities.	  Cultures	  grew	  overnight	  with	  shaking	  at	  37	  °C	   in	  2YT	  
media	  (Luria-­‐Bertani	  broth	  with	  double	  quantity	  of	  yeast	  extract)	  and	  were	  washed	  twice	  in	  
RPMI	  1640	  (Gibco	  Laboratories)	  (3500xg,	  10	  min.)	  before	  the	  inoculation	  in	  mice.	  
	  
Mice	  infection	  
Mice	  were	  anaesthetized	  with	  a	  cocktail	  of	  Xylasin	  (9mg/kg)	  and	  Ketamin	  (36	  mg/kg)	  
in	  PBS	  before	  being	   inoculated	   intra-­‐nasally	   (i.n.)	  with	  2x104	  CFU	  of	  wild	   type	  or	  mCherry-­‐
expressing	  B.	  melitensis	   in	  30	  μL	  of	  RPMI.	  Control	   animals	  were	   inoculated	  with	   the	   same	  
volume	  of	  RPMI.	  Plating	  serial	  dilutions	  of	   inoculums	  validated	  the	   infectious	  doses.	  At	  the	  
selected	  time	  after	  infection,	  mice	  were	  sacrificed	  by	  cervical	  dislocation.	  Immediately	  after	  
sacrifice,	   spleen,	   liver	   and	   lung	   cells	   were	   collected	   for	   bacterial	   count,	   flow	   cytometry	  








Spleens,	   livers	   and	   lungs	   were	   crushed	   and	   transferred	   in	   PBS/0.1%	   X-­‐100	   triton	  
(Sigma).	  We	  performed	  successive	  serial	  dilutions	  in	  RPMI	  to	  get	  the	  most	  accurate	  bacterial	  




Spleens	  were	   fixed	   for	   4	   hours	   at	   room	   temperature	   in	   2%	   paraformaldehyde	   (pH	  
7.4),	  washed	   in	  PBS,	   and	   incubated	  overnight	   at	   4°C	   in	   a	  20%	  PBS-­‐sucrose	   solution.	   Lungs	  
were	   submitted	   to	   the	   same	   treatments	   but	   in	   a	   vacuum	   chamber	   at	   room	   temperature.	  
Tissues	   were	   then	   embedded	   in	   the	   Tissue-­‐Tek	   OCT	   compound	   (Sakura),	   frozen	   in	   liquid	  
nitrogen,	  and	  cryostat	  sections	  (5	  nm)	  were	  prepared.	  For	  the	  staining,	  tissue	  sections	  were	  
rehydrated	   in	   PBS	   and	   incubated	   in	   a	   PBS	   solution	   containing	   1%	   blocking	   reagent	  
(Boeringer)	   (PBS-­‐BR	   1%)	   for	   20	  minutes	   before	   being	   incubated	   overnight	   in	   a	   PBS-­‐BR	   1%	  
containing	   mAbs	   or	   reagents:	   DAPI	   nucleic	   acid	   stain	   Alexa	   Fluor	   350	   or	   488	   phalloidin	  
(Molecular	   Probes)	   to	   visualize	   the	   structure	   of	   the	   organ,	   and	   Allophycocyanin	   (APC)-­‐
coupled	   BM8	   (anti-­‐F4/80,	   Abcam),	   Alexa	   Fluor	   647-­‐coupled	   M1/70	   (anti-­‐CD11b,	   BD	  
Biosciences),	   Alexa	   Fluor	   647-­‐coupled	   HL3	   (anti-­‐CD11c,	   BD	   biosciences),	   Alexa	   Fluor	   647-­‐
coupled	  53-­‐6.7	  (anti-­‐CD8α,	  Santa	  Cruz	  technology),	  Alexa	  Fluor	  647-­‐coupled	  	  RB6-­‐8C5	  (anti-­‐
Gr1,	  ebioscience),	  	  APC-­‐coupled	  M5/114.15.2	  (anti-­‐MHCII,	  	  I-­‐A/I-­‐E),	  Alexa	  Fluor	  647-­‐coupled	  
NLDC-­‐145	   (anti-­‐Dec205/CD205,	  Biolegend),	  Alexa	  Fluor	  647-­‐coupled	  ER-­‐MP23	   (anti-­‐CD301,	  
AbD	   Serotec),	   Bodipy	   493/503	   (Molecular	   Probes),	   Biotin-­‐coupled	   HL3	   (anti-­‐CD11c,	   BD	  
Biosciences)	   Biotin-­‐coupled	   RB6-­‐8C5	   (anti-­‐Gr1,	   ebioscience),	   Biotin-­‐coupled	  MOMA1	   (anti-­‐
Marginal	  Zone	  Macrophages,	  BMA	  Biomedicals),	  Biotin-­‐coupled	  ERTR9	  (anti-­‐SIGN-­‐R1,	  	  BMA	  
Biomedicals),	   Biotin-­‐coupled	   HL3	   (anti-­‐CD11c	   BD	   Biosciences),	   IgG	   H-­‐52	   (anti-­‐Arg1,	   Santa	  
Cruz	  technology),	  and	  IgG	  Fizz	  (anti-­‐RELMα,	  Abcam)	  to	  stain	  the	  cells	  of	  interest.	  Incubation	  
with	  a	  streptavidin	  coupled	  fluorochrome	  for	  2	  hours	  was	  necessary	  for	  the	  biotin-­‐coupled	  
Ab:	  Alexa	   Fluor	   350	  or	  Alexa	   Fluor	   647	   streptavidin	   (Molecular	   Probes).	   Incubation	  with	   a	  
secondary	   antibody	   Alexa	   Fluor	   647-­‐coupled	   goat	   anti-­‐rabbit	   IgG	   (Molecular	   Probes)	   was	  
necessary	   for	   the	  anti-­‐Arg1	  and	  anti-­‐Fizz	  mAb.	  Slides	  were	  mounted	   in	  Fluoro-­‐Gel	  medium	  
(Electron	  Microscopy	  Sciences,	  Hatfield,	  PA).	  Labelled	  tissue	  sections	  were	  visualized	  with	  an	  






monochrome	   camera	   (AxioCam	  HR,	   Zeiss).	   Images	   (1384x1036	   pixels,	   0.16μm/pixel)	   were	  
acquired	   sequentially	   for	   each	   fluorochrome	   with	   A-­‐Plan	   10x/0.25	   N.A.	   and	   LD-­‐Plan-­‐
NeoFluar	  63x/0.75	  N.A.	  dry	  objectives	  and	  recorded	  as	  eight-­‐bit	  grey-­‐level	  *.zvi	  files.	  At	  least	  
3	  slides	  per	  organ	  were	  analyzed	  from	  3	  different	  animals	  and	  the	  results	  are	  representatives	  
of	  2	  independent	  experiments.	  	  	  
	  
Statistical	  analysis	  
We	  used	  a	  (Wilcoxon-­‐)	  Mann-­‐Whitney	  test	  provided	  by	  GraphPad	  Prism	  software	  to	  
statistically	   analyze	   our	   results.	   Each	   group	   of	   deficient	   mice	   was	   compared	   to	   wild-­‐type	  
mice.	   We	   also	   compared	   each	   group	   with	   each	   other	   and	   displayed	   the	   results	   when	  
required.	  Values	  of	  p	  <	  0.05	  were	  considered	  to	  represent	  a	  significant	  difference	  and	  were	  
noted	  by	  	  *.	  	  
	  
DNA	  extraction,	  Polymerase	  Chain	  Reaction	   (PCR)	  and	  electrophoresis	  gel	   to	  define	  mice	  
lineages	  	  
DNA	   extraction	   from	   tail	   of	   mice	   was	   carried	   out	   with	   high	   pure	   PCR	   template	  
preparation	   kit	   (ROCHE):	   0,2	   cm	   of	   tails	   were	   incubated	   overnight	   at	   55°C	   with	   40	  µL	   of	  
Proteinase	   K	   in	   200	   µL	   of	   Tissue	   lysis	   buffer.	   Samples	   were	   sheared	   few	   seconds	   with	   a	  
vortex	  before	  adding	  200	  µL	  of	  binding	  buffer	  and	  100	  µL	  of	  isopropanol.	  They	  were	  mixed	  
and	  centrifuged	  during	  5	  minutes	  at	  13,000x	  g.	   	   Liquid	   sample	  was	  pipeted	   in	  a	  high	   filter	  
tube	  inserted	  in	  a	  collection	  tube	  and	  centrifuged	  1	  minute	  at	  8,000x	  g.	  The	  filter	  tube	  was	  
removed	  from	  the	  collection	  tube	  and	  combined	  with	  a	  new	  one.	  500	  µL	  of	  inhibitor	  removal	  
buffer	  were	  added	  to	  the	  upper	  reservoir	  of	  the	  filter	  tube	  and	  all	  of	   it	  was	  centrifuged	  at	  
8,000x	   g	   during	   1	   minute.	   The	   collection	   tube	   was	   discarded	   and	   the	   filter	   tube	   was	  
combined	   with	   a	   new	   one	   before	   the	   addition	   of	   500	   µL	   of	   wash	   buffer	   to	   the	   upper	  
reservoir	  of	   the	   filter	   tube	  and	   centrifugation	  was	  made	  during	  1	  minute	  at	  8,000x	  g.	   The	  
washing	   step	   was	   made	   a	   second	   time.	   Then,	   the	   filter	   tube	   was	   inserted	   into	   a	   clean	  
microcentrifuge	  tube.	  200	  µL	  of	  prewarmed	  (70°C)	  elution	  buffer	  to	  the	  upper	  reservoir	  of	  
the	  filter	  tube.	  We	  centrifuged	  all	  of	  it	  1	  minute	  at	  8,000x	  g.	  By	  this	  step,	  the	  eluted	  DNA	  was	  
released	  in	  the	  microcentrifuge	  tube.	  	  
	  
1	   µL	   of	   Extracted	   DNA	   was	   mixed	   with	   5	   µL	   of	   Green	   buffer	   5x,	   2	   µL	   of	  






polymerase	   (2.5mM	   each)	   and	   0,2	   µL	   of	   each	   primer	   (see	   table	   1	   below	   for	   primer	  
sequences).	  PCR	  cycling	  parameters	  are	  as	  follow:	  denature	  at	  94°C	  for	  3	  minutes,	  anneal	  at	  
66°C	   for	   1	   min	   and	   extend	   at	   72°C	   for	   1min.	   35	   cycles	   were	   programmed.	   Finally,	   PCR	  
products	  were	  pipeted	  on	  1%	  agarose	  gel	  in	  1x	  TAE	  buffer	  for	  migration	  to	  check	  their	  size.	  	  
	  
Primers	  used	  to	  amplify	  STAT6	  gene	  
primers	   Sequence	  (5’-­‐3’)	  
oIMR7416	  wt	  	   AGTGGGTCCCCTTCACTCT	  
oIMR1822	  common	   CTCCGGAAAGCCTCATCTT	  
oIMR0092	  Neo	  	   ATCCATCTTGTTCAATGGCCGATC	  
	  
	  
	   	  
Primers	  used	  to	  amplify	  IL12p40	  gene	  
primers	   Sequence	  (5’-­‐3’)	  
oIMR0457	  wt	  	   AGTGAACCTCACCTGTGACACG	  
oIMR0458	  common	   TCTTTGCACCAGCCATGAGC	  







STAT6	  deficiency	  does	  not	  affect	  the	  control	  of	  Brucella	  infection	  in	  IL-­‐12p40-­‐/-­‐	  mice	  
Based	  on	  indirect	  observations,	  it	  has	  been	  recently	  proposed	  that	  the	  reservoir	  cells	  
for	  Brucella	  in	  the	  spleens	  of	  experimentally	  infected	  mice	  could	  be	  M2	  macrophages	  (19).	  In	  
order	  to	  test	  this	  hypothesis,	  we	  developed	  a	  model	  by	  which	  Brucella-­‐infected	  cells	  can	  be	  
visualized	  in	  situ	  and	  where	  the	  differentiation	  of	  M2	  macrophages	  is	  favored	  by	  the	  absence	  
of	   Th1.	   In	   a	   previous	   study	   (7),	   we	   have	   shown	   that	   IL-­‐12p40-­‐/-­‐	   BALB/c	   mice	   are	   highly	  
susceptible	   to	  Brucella	   infection	  and	  display	  higher	  bacterial	  numbers	   in	   the	  spleen	  during	  
the	  chronic	  phase	  of	   infection	  allowing	   the	  direct	  observation	  of	   infected	  cells	   in	   situ	  with	  
mCherry-­‐expressing	  Brucella	  melitensis	  (mCherry-­‐Br).	  In	  these	  mice,	  both	  protective	  Th1	  and	  
Th17	   responses	   were	   severely	   impaired	   by	   the	   absence	   of	   functional	   IL-­‐12	   and	   IL-­‐23	  
complexes.	  We	   compared	   these	  mice	  with	   IL-­‐12p40-­‐/-­‐	   STAT6-­‐/-­‐	   BALB/c	  mice	   in	   a	  model	   of	  
intranasal	   infection	   using	   inoculums	   of	   	   2x104	   CFU	   (low	   dose)	   or	   2x107CFU	   (high	   dose)	   of	  
mCherry-­‐Br.	   STAT6	   deficiency	   neutralizes	   the	   signaling	   pathways	   of	   IL-­‐4R	   and	   impairs	   the	  
formation	  of	  M2	  macrophages	  [20][21].	   	  Wild	  type	  and	  STAT6-­‐/-­‐	  BALB/c	  mice	  were	  used	  as	  
internal	  controls.	  The	  CFU	  counts	  in	  the	  lungs,	  spleens	  and	  livers	  were	  analyzed	  at	  12,	  28	  and	  
50	   days	   post	   infection	   (Figure	   1).	   The	   absence	   of	   STAT6	   and	   IL-­‐12p40	   functional	   genes	   in	  
each	   group	   of	   deficient	  mice	   has	   been	   confirmed	   by	   PCR	   (supplementary	   Figure	   1).	  Wild-­‐
type	  mice	  and	  STAT6-­‐/-­‐	  mice	  display	  similar	  CFU	  counts	   following	   inoculation	  with	  a	   low	  or	  
high	   infectious	   dose,	   in	   all	   organs	   and	   at	   all	   time	   tested,	   confirming	   previous	   results	   [7]	  
showing	   that	   absence	   of	   a	   Th2	   response	   does	   not	   favor	   a	   Th1	   protective	   response.	  
Surprisingly,	   we	   observed	   that	   absence	   of	   a	   functional	   STAT6	   signaling	   pathway	   does	   not	  
affect	  the	  control	  of	  infection	  even	  in	  absence	  of	  a	  Th1	  response	  in	  IL-­‐12p40-­‐/-­‐	  mice.	  Only	  a	  
weak	  and	  brief	  difference	   is	  observed	  at	  28	  days	  post	   infection	   in	   the	   lungs	   following	   low	  






	   	  
Figure	   1:	   Course	   of	   B.	   melitensis	   infection	   in	   organs	   of	   BALB/c	   wild-­‐type	   (wt),	   STAT6-­‐,	   IL12p40-­‐	   and	  
STAT6/IL12p40-­‐deficient	  mice.	  A,	  Mice	  were	   intranasally	   (i.n.)	   injected	  with	   2.104	   CFU	  of	  B.	  melitensis	  and	  
sacrificed	  at	  the	  indicated	  times.	  B,	  Mice	  were	  i.n.	  injected	  with	  2.107	  CFU	  of	  B.	  melitensis	  and	  sacrificed	  at	  the	  
indicated	   times.	   The	   data	   represent	   the	   number	   of	   CFU	   per	   gram	   of	   lung,	   spleen	   and	   liver.	   Grey	   bars	  
represent	  the	  medians.	  “n”	  is	  the	  number	  of	  mice	  used.	  These	  results	  are	  representative	  of	  at	  minimum	  two	  







does	   not	   support	   the	   hypothesis	   that	   M2	   macrophages	   constitute	   a	   reservoir	   for	   the	  
persistence	  of	  	  Brucella	  in	  vivo.	  
	  
STAT6	  deficiency	   does	   not	  modify	   the	   phenotype	   of	  Brucella	   infected	   cells	   in	   IL-­‐12p40-­‐/-­‐	  
mice	  
Direct	  observation	  of	  mCherry-­‐Br	  in	  situ	  requires	  a	  minimum	  of	  5x106	  CFU/g	  in	  organs	  
(9).	  Unfortunately,	  this	  limiting	  condition	  is	  only	  achieved	  in	  the	  spleens	  of	  	  IL-­‐12p40-­‐/-­‐	  mice	  
(Figure	   1).	   In	   order	   to	   determine	   the	   impact	   of	   STAT6	   deficiency	   on	   the	   phenotype	   of	  
infected	  spleen	  cells,	  we	  compared	   in	  situ	  using	  fluorescence	  microscopy	  the	  expression	  of	  
various	  cell	  surface	  markers	  on	  infected	  cells	   in	  the	  spleens	  from	  IL-­‐12p40-­‐/-­‐	  and	  IL-­‐12p40-­‐/-­‐	  
STAT6-­‐/-­‐	   mice.	   	  We	   analyzed	   the	   expression	   of	   GR1,	   F4/80,	   CD11b,	   CD11c,	   CD8a,	  MHC-­‐II,	  
MOMA-­‐1,	  ER-­‐TR9	  on	  a	  minimum	  of	  200	  infected	  cells	  from	  3	  animals	  per	  group	  and	  in	  two	  
different	  experiments.	  Signal	   intensity	  of	  expression	  associated	  with	  mCherry	  Brucella	  was	  
classified	   as	   high,	   low	   and	   negative.	  High	   corresponds	   to	   the	   highest	   staining	   observed	   in	  
tissue.	  The	  frequency	  of	  each	  level	  on	  infected	  cells	  from	  both	  mouse	  strains	  is	  presented	  in	  
Figure	   2.	   The	   general	   distribution	   for	   each	   staining	   and	   an	   example	  of	   each	   signal	   level	   is	  
presented	   Figure	   3.	   No	   significant	   difference	   between	   STAT6+/+	   and	   STAT6-­‐/-­‐	   mice	   was	  
observed	   regardless	   of	   the	  markers	   tested.	   Accordingly,	  we	   present	   only	   staining	   from	   IL-­‐
12p40-­‐/-­‐	  mice	  to	  illustrate	  each	  staining.	  
As	  previously	  reported	  [9],	  during	  the	  chronic	  phase	  of	  spleen	  infection	  infected	  cells	  
locate	  mainly	  in	  the	  white	  pulp	  of	  the	  spleen	  and	  preferentially	   in	  the	  T	  cell	  area	  (data	  not	  
shown).	  
A	   recruitment	   of	   GR1+	   cells	   (presumably	   neutrophils,	   based	   on	   the	   characteristic	  
nucleus	  visualized	  by	  DAPI	  staining)	   in	  the	  red	  and	  white	  pulp	   is	  observed	   in	   infected	  mice	  







	   	  
Figure	   2:	   Comparison	   of	   the	   phenotype	   of	   infected	   cells	   in	   spleen	   of	   BALB/c	   IL12p40-­‐	   and	  
IL12p40/STAT6-­‐	  deficient	  mice.	  IL12p40-­‐	  and	  IL12p40/STAT6-­‐deficient	  BALB/c	  mice	  were	  injected	  i.n.	  
with	   2.107	   CFU	   of	   mCherry-­‐Br.	   Mice	   were	   sacrificed	   at	   28	   days	   post-­‐infection	   and	   spleens	   were	  
collected	  and	   examined	  by	   immunohistofluorescence.	  Data	   represent	  a	  comparative	  analysis	  of	   the	  
percentage	  of	  mcherry-­‐Br	   that	   colocalize	   or	  not	  with	  GR1-­‐,	   F4/80-­‐,	   CD11b-­‐,	   CD11c-­‐,	   CD8a-­‐,	  MHCII-­‐,	  
ER-­‐TR9-­‐	  and	  MOMA-­‐1-­‐	  	  expressing	  cells	  (high	  and	  low	  expression)	  in	  the	  two	  lineages	  of	  mice.	  These	  
results	   are	   representative	   of	   at	   minimum	   three	   independent	   experiments.	   *,	   Percentage	   of	  
colocalization	   between	   mCherry-­‐Br	   and	   positive	   cells	   for	   the	   antigen	   (addition	   of	   high	   and	   low	  







colocalize	  with	  GR1	   staining.	  Most	   of	   them	  express	   low	  GR1	   staining	   and	   are	   observed	   in	  
dense	  aggregates	  of	  cells	  rending	  the	  precise	  identification	  of	  infected	  cells	  uncertain.	  
Following	  intraperitoneal	  infection	  of	  wild-­‐type	  mice,	  the	  majority	  of	  infected	  cells	  in	  
granulomas	   exhibit	   CD11b,	   CD11c	   and	   F4/80	   staining	   [9],	   a	   phenotype	   corresponding	   to	  
iNOS-­‐producing	   inflammatory	   dendritic	   cells	   (DC)	   [22].	   In	   our	   intranasal	   model,	   only	   the	  
CD11c	  marker	  appears	  predominantly	  expressed	  on	  infected	  cells.	  92%	  of	  these	  latter	  cells	  
express	   high	  or	   low	   levels	   of	   CD11c	   for	   33	   and	  23%	  of	   CD11b	   and	   F4/80,	   respectively.	   As	  
expected,	  CD11b	  staining	  strongly	  colocalized	  with	  GR1	  staining,	  suggesting	  that	  a	  majority	  
of	  infected	  CD11b+	  cellsare	  also	  GR1+	  (data	  not	  shown)	  and	  are	  neutrophils.	  The	  frequency	  of	  
infected	  cells	  expressing	  high	  levels	  of	  F4/80	  is	  particularly	  low.	  
In	  the	  spleens	  of	  	  naive	  mice,	  CD8a	  is	  mainly	  expressed	  on	  T	  cells	  and	  a	  subset	  of	  DC	  
and	   were	   located	   mainly	   in	   the	   T	   cell	   area	   of	   the	   white	   pulp.	   Very	   rare	   infected	   cells	  
colocalize	   with	   CD8a	   staining	   (6%)	   and	   the	   majority	   express	   low	   levels,	   suggesting	   that	  
CD11c+	   infected	  cells	   are	   rarely	  CD8a	  positive.	   Interestingly,	  MHCII,	   generally	  expressed	  at	  
high	   levels	   on	   splenic	   DC,	   is	   mainly	   expressed	   at	   low	   levels	   on	   infected	   cells.	   Numerous	  
CD11c+	  infected	  cells	  express	  low	  or	  undetectable	  level	  of	  MHCII	  (supplementary	  Figure	  2),	  
suggesting	  that	  Brucella	  infection	  could	  reduce	  the	  expression	  of	  MHC-­‐II	  on	  DC	  in	  vivo.	  
A	  strong	  association	  between	  ER-­‐TR9	  (SIGN-­‐R1),	  MOMA-­‐1	  markers	  and	  infected	  cells	  
is	  also	  observed.	  In	  naive	  mice,	  these	  markers	  are	  mainly	  present	  in	  the	  marginal	  zone	  and	  
identify	  marginal	   zone	  macrophages	   (MZM)	   and	  metallophilic	  marginal	   zone	  macrophages	  
(MMM),	  respectively.	  	  Surprisingly,	  colocalization	  between	  CD11c	  and	  low	  levels	  of	  MOMA-­‐1	  
(supplementary	   Figure	   3)	   and	   ER-­‐TR9	   (data	   not	   shown)	   on	   infected	   cells	   is	   observed.	   This	  






	   	  
Figure	  3:	  Characterization	  of	  infected	  cells	  in	  the	  spleen	  of	  BALB/c	  IL12p40-­‐deficient	  mice.	  IL12p40-­‐deficient	  BALB/c	  mice	  
were	  injected	  i.n.	  with	  2.107	  CFU	  of	  mCherry-­‐Br.	  Mice	  were	  sacrificed	  at	  28	  days	  post-­‐infection	  and	  spleens	  were	  collected	  
and	  examined	  by	   immunohistofluorescence.	  The	   left	  panels	   show	  global	  distribution	  of	   the	  Gr1-­‐,	   F4/80-­‐,	  CD11b-­‐,	  CD11c-­‐,	  
CD8a-­‐,	   ERTR9	   and	   MOMA-­‐1-­‐expressing	   cells	   in	   the	   spleen.	   The	   panels	   to	   the	   right	   of	   the	   first	   ones	   show	   mCherry-­‐Br	  
colocalization	  with	   negative	   cells	   for	  Gr1,	   F4/80,	  CD11b,	  CD11c,	   CD8a,	   ER-­‐TR9	   and	  MOMA-­‐1.	  The	   panels	   to	   the	   right	   are	  
immunofluorescence	  analysis	  of	  mCherry-­‐Br	  colocalization	  with	  weakly	  positive	  cells	   for	  Gr1,	  F4/80,	  CD11b,	  CD11c,	  CD8a,	  
ER-­‐TR9	  and	  MOMA-­‐1.	  The	  right	  panels	  show	  mCherry-­‐Br	  colocalization	  with	  highly	  positive	  cells	  Gr1,	  F4/80,	  CD11b,	  CD11c,	  
CD8a,	  ERTR9	  and	  MOMA-­‐1.	  Panels	  are	  color-­‐coded	  with	  the	  text	  for	  phalloidin,	  the	  antigen	  examined	  or	  mCherry-­‐Br.	  Scale	  
bar=	  200	  and	  20	  µm,	  as	   indicated.	  r.p.:	   red	  pulp:;	  w.p.:	  white	  pulp.	   Yellow	  arrowheads	   indicate	   the	  presence	  of	  bacteria.	  






Brucella	  infected	  cells	  do	  not	  express	  typical	  M2	  markers	  such	  as	  Fizz1	  and	  CD301	  
In	   order	   to	   better	   characterize	   the	   phenotype	   of	   infected	   cells,	   we	   analyzed	   the	  
expression	   of	   the	   DC	   marker	   DEC-­‐205	   (CD205)	   and	   of	   several	   well	   established	   M2	  
differentiation	  markers	  such	  as	  Arginase1	  (Arg1),	  Fizz1	  and	  CD301	  expression	  (Figure	  4.A).	  A	  
strong	  association	  of	  CD205	  and	  Arg1	  staining	  was	  observed	  with	  infected	  cells.	  The	  majority	  
of	  highly	   infected	  cells	   (displaying	   large	  aggregates	  of	  mCherry-­‐Br)	  expressed	  high	   levels	  of	  
both	  markers	   (Figure	  4.B).	   In	  contrast,	  Fizz1	  and	  CD301	  displayed	  weak	  colocalization	  with	  
mCherry-­‐Br	  signal	  staining	  (Figure	  4.A)	  and	  was	  mainly	  located	  in	  the	  red	  pulp	  and	  marginal	  
zone	   (Figure	   4.B).	   As	   previously	   observed	   for	   other	   markers,	   no	   significant	   differences	  
between	  STAT6+/+	  and	  STAT6-­‐/-­‐	  mice	  were	  observed	  for	  all	  markers	  tested.	  
As	  expected,	  a	  strong	  colocalization	  of	  CD11c	  and	  CD205	  on	  infected	  cells	  is	  observed	  
(Figure	  5.A).	   	  Similarly,	   the	  staining	   for	  MOMA-­‐1	  (Figure	  5.B)	  and	  ER-­‐TR9	  (data	  not	  shown)	  
colocalize	   with	   the	   CD205	   staining	   on	   infected	   cells.	   It	   is	   interesting	   to	   see	   that	   CD205	  
expression	   on	  MOMA-­‐1	   cells	   is	  mainly	   found	   on	   infected	   cells	   but	   not	   on	  MOMA-­‐1+	   cells	  
located	  in	  the	  marginal	  zone	  (Figure	  5.B).	  Similar	  results	  were	  observed	  for	  ER-­‐TR9	  (data	  not	  
shown).	  	  
	  
Brucella	  infected	  cells	  are	  lipid	  rich	  cells	  
Finally,	  in	  order	  to	  investigate	  the	  metabolism	  of	  Brucella	  infected	  cells,	  we	  analyzed	  
the	   level	   of	   lipid	   present	   in	   infected	   cells	   using	   Bodipy	   staining	   (Figure	   6).	   A	   very	   strong	  
colocalization	  between	  mCherry-­‐Br	  and	  bodipy	  staining	   is	  observed	   in	  both	  strains	  of	  mice	  
(Figure	   6.A).	   This	   colocalization	   is	   observed	   on	   both	   isolated	   and	   cells	   within	   aggregates	  
(Figure	  6.B).	  	  As	  expected,	  Bodipy	  staining	  also	  colocalizes	  with	  CD11c	  (Figure	  6.C)	  and	  Arg1	  








	   	  
Figure	  4:	  Characterization	  of	  infected	  cells	  with	  CD205	  expression	  and	  M2	  markers	  in	  the	  spleen	  of	  BALB/c	  IL12p40-­‐	  and	  
STAT6/IL12p40-­‐deficient	  mice.	   IL12p40-­‐deficient	  BALB/c	  mice	  were	   injected	   i.n.	  with	  2.107	  CFU	  of	  mCherry-­‐Br.	  Mice	  were	  
sacrificed	  at	  28	  days	  post-­‐infection	  and	  spleens	  were	  collected	  and	  examined	  by	  immunohistofluorescence.	  A,	  Comparative	  
analysis	   of	   the	   percentage	   of	  mcherry-­‐Br	   that	   colocalize	   or	   not	  with	  Dec205-­‐,	   Arg1-­‐,	   Fizz1-­‐	   and	   CD301-­‐expressing	   cells	   in	  
spleen	   of	   BALB/c	   IL12p40-­‐	  and	   IL12p40/STAT6-­‐	  deficient	  mice.	   The	  percentage	   of	   colocalization	   between	  mCherry-­‐Br	   and	  
positive	  cells	   for	  the	  antigen	   in	   IL12p40-­‐deficient	  mice	  is	   indicated.	  B,	   Immunohistofluorescence	  analysis	  of	  CD205	  and	  M2	  
markers	   in	   spleen	   of	   infected	   IL12p40-­‐deficient	   mice	   and	   colocalization	   with	   mCherry-­‐Br.	   The	   left	   panels	   show	   global	  
distribution	   of	   the	   Dec205-­‐,	   Arg1-­‐,	   Fizz1-­‐	   and	   CD301-­‐expressing	   cells	   in	   the	   spleen.	   The	  middle	   panels	   show	  mCherry-­‐Br	  
colocalization	  with	  negative	   cells	   for	  Dec205,	  Arg1,	   Fizz1	  and	  CD301.	  The	   right	  panels	  are	   immunofluorescence	  analysis	  of	  
mCherry-­‐Br	   colocalization	  with	  positive	   cells	   for	   Dec205,	   Arg1,	   Fizz1	   and	   CD301.	   Panels	   are	   color-­‐coded	  with	   the	   text	   for	  
DAPI,	  phalloidin,	   the	  antigen	  examined	  or	  mCherry-­‐Br.	  Scale	  bar=	  200	  and	  20	  µm,	  as	   indicated.	  r.p.:	  red	  pulp:;	  w.p.:	  white	  








	   	  
Figure	   5:	   Characterization	   of	   infected	   cells	   expressing	   CD11c,	   CD205	   and	   MOMA-­‐1	   in	   the	   spleen	   of	   BALB/c	  
IL12p40-­‐deficient	  mice.	   IL12p40-­‐deficient	  BALB/c	  mice	  were	   injected	   i.n.	  with	  2.107	  CFU	  of	  mCherry-­‐Br.	  Mice	  were	  
sacrificed	  at	  28	  days	  post-­‐infection	  and	  spleens	  were	  collected	  and	  examined	  by	  immunohistofluorescence.	  	  A,	  The	  
left	   panels	   show	   mCherry-­‐Br	   colocalization	   with	   cells	   expressing	   CD11c.	   The	   middle	   panels	   show	   mCherry-­‐Br	  
colocalization	  with	  cells	  expressing	  CD205	  and	  the	  right	  panels	  show	  colocalization	  of	  CD11c-­‐	  and	  CD205-­‐expressing	  
cells.	  B,	   The	  upper	  panels	   show	  distribution	  of	  MOMA-­‐1-­‐expressing	   cells	   and	   colocalization	  with	  mCherry-­‐Br	   (left),	  
distribution	  of	  DEC205-­‐expressing	  cells	  and	  colocalization	  with	  mCherry-­‐Br	  (middle),	  and	  colocalization	  of	  MOMA-­‐1-­‐	  
and	  CD205-­‐expressing	  cells	  (right).	  The	  	  panels	  below	  are	  higher	  magnification	  views	  of	  the	  same	  stainings.	  Panels	  are	  
color-­‐coded	  with	  the	  text	  for	  phalloidin,	  the	  antigen	  examined	  or	  mCherry-­‐Br.	  Scale	  bar=	  50	  and	  20	  µm,	  as	  indicated.	  
r.p.	   :	  red	  pulp.	  w.p.:	  white	  pulp.	  Yellow	  arrowheads	  indicate	  the	  presence	  of	  bacteria.	  Data	  are	  representative	  of	  at	  







	   	  
Figure	   6:	   Characterization	   of	   the	   lipid	  metabolism	   of	   infected	   cells	   and	   Arg1	   expression	   in	   the	   spleen	   of	  BALB/c	  
IL12p40-­‐deficient	   mice.	   IL12p40-­‐deficient	   BALB/c	   mice	  were	   injected	   i.n.	   with	   2.107	   CFU	   of	   mCherry-­‐Br.	   Mice	   were	  
sacrificed	   at	   28	   days	   post-­‐infection	   and	   spleens	   were	   collected	   and	   examined	   by	   immunohistofluorescence.	   A,	   Data	  
represent	  a	  comparative	  analysis	  of	  the	  percentage	  of	  mcherry-­‐Br	  that	  colocalize	  or	  not	  with	  cells	  stained	  with	  Bodipy.	  
The	   percentage	   of	   colocalization	   between	   mCherry-­‐Br	   and	   cells	   stained	   with	   Bodipy	   in	   IL12p40-­‐deficient	   mice	   is	  
indicated.	  B,	  Colocalization	  of	  mCherry-­‐Br	  and	  cells	  stained	  with	  Bodipy.	  C,	  The	  upper	  panels	  show	  distribution	  of	  CD11c-­‐
expressing	   cells	   and	   colocalization	   with	   mCherry-­‐Br	   (left),	   and	   distribution	   and	   colocalization	   of	   Bodipy	   staining	   and	  
CD11c-­‐expressing	  cells	  (right).	  The	  panels	  below	  are	  higher	  magnification	  views	  of	  the	  same	  stainings.	  D,	  The	  left	  picture	  
shows	   colocalization	   between	   Arg1-­‐expressing	   cells	   and	   mCherry-­‐Br,	   the	   right	   picture	   shows	   colocalization	   between	  
Arg1-­‐expressing	  cells	  and	  Bodipy	  staining.	  Panels	  are	  color-­‐coded	  with	  the	  text	  for	  DAPI,	  the	  antigen	  examined,	  Bodipy	  or	  
mCherry-­‐Br.	  Scale	  bar=	  200,	  50	  and	  20	  µm,	  as	  indicated.	  r.p.	  :	  red	  pulp.	  w.p.:	  white	  pulp.	  Yellow	  arrowheads	  indicate	  the	  









Recently	  acquired	  	  evidence	  suggests	  that	  persisting	  pathogens	  are	  able	  to	  reprogram	  
host	  cellular	  microenvironments	  to	  their	  advantage.	  They	  frequently	  polarize	  the	  phenotype	  
of	  host	  cells	  to	  produce	  an	  anti-­‐inflammatory	  and	  nutriment	  rich	  environment	  assuring	  their	  
long	  term	  persistence	  in	  the	  host	  (reviewed	  in	  [12–15]).	  According	  to	  this	  new	  paradigm,	  it	  
appears	  crucial	  to	  identify	  the	  main	  reservoir	  cells	  of	  bacteria	  during	  chronic	  infection	  and	  to	  
define	  the	  signaling	  pathways	  implicated	  in	  their	  polarization	  during	  infectious	  processes.	  
Taken	   together,	   our	   analysis	   of	   the	   phenotypes	   of	   Brucella-­‐infected	   cells	   in	   highly	  
susceptible	   IL-­‐12p40-­‐/-­‐	   BALB/c	   mice	   confirms	   previous	   observations	   obtained	   using	   the	  
intraperitoneal	   infection	   model	   [9]	   which	   showed	   that	   these	   cells	   express	   mainly	   CD11c	  
(92%)	  and	  CD205	  (69%)	  receptors,	  two	  well	  defined	  markers	  of	  DCs.	  The	  absence	  of	  CD11b	  
and	   F4/80	   staining	   demonstrates	   that	   these	   cells	   are	   distinct	   from	   CD11b+	   CD11c+	   F4/80+	  
infected	   inflammatory	  DCs	  observed	  during	   the	  acute	  phase	  of	   infection	   in	  wild-­‐type	  mice	  
[9].	   The	   absence	   of	   CD8a	   expression	   showed	   that	   they	   are	   also	   distinct	   from	   the	   CD11b-­‐	  
CD11c+	   CD8a+	   DEC205+	   classical	   DC	   subset	   located	   in	   the	   T	   cell	   area	   of	   naive	   mice	   [23].	  
Coexpression	  of	  MOMA-­‐1	  and	  SIGN-­‐R1/ER-­‐TR9	  on	  a	  fraction	  of	  CD11c	  infected	  cells	  suggests	  
that	  some	  of	  	  these	  cells	  could	  be	  from	  the	  marginal	  zone.	  Like	  DCs,	  both	  MOMA-­‐1+	  MMM	  
and	  ER-­‐TR9+	  MZM	  migrate	  from	  the	  marginal	  zone	  to	  the	  T	  cell	  area	  in	  response	  to	  Listeria	  
monocytogenes	  infection	  [24].	  Initially	  exclusively	  considered	  to	  be	  macrophages,	  MZM	  have	  
recently	   been	   divided	   into	  MHC-­‐II-­‐	   and	  MHCII+	   cells.	   The	   latter	   display	   a	   high	   capacity	   to	  
ingest	  and	  present	  antigens	  to	  T	  cells	  [25]	  during	  L.	  monocytogenes	  infection.	  In	  our	  Brucella	  
model,	  the	  low	  level	  of	  MHC-­‐II	  observed	  on	  infected	  cells	  suggests	  that	  ER-­‐TR9+	  infected	  cells	  
are	  "real"	  MZMs	  infected	  the	  in	  marginal	  zone	  that	  have	  migrated	  to	  the	  T	  cell	  area.	  To	  our	  
knowledge,	  co-­‐expression	  of	  MOMA-­‐1	  and	  ER-­‐TR9	  with	  CD11c	  has	  not	  been	  described	  and	  






Recent	  work	   [19]	   has	   shown	   that	  M2	  macrophages	   (identified	   by	   CD301	   and	   Fizz1	  
expression	  in	  situ)	  are	  induced	  during	  the	  chronic	  phase	  of	  Brucella	  abortus	  infection	  in	  wild	  
type	  C57BL/6	  mice.	  	  Based	  on	  the	  observation	  that	  M2	  macrophages	  are	  strongly	  infected	  in	  
vitro	  and	  that	  PPAR	  agonists,	  known	  to	  induce	  M2	  macrophages	  polarization	  [26],	  	  can	  affect	  
the	  course	  of	   infection,	  the	  authors	  concluded	  that	  M2	  macrophages	  can	  be	  a	  preferential	  
niche	   for	   Brucella	   in	   vivo.	   In	   the	   majority	   of	   infectious	   and	   non-­‐infectious	   experimental	  
models	   [20,21],	   M2	   macrophages	   are	   dependent	   on	   the	   STAT6	   signaling	   axis	   for	   their	  
induction.	  In	  our	  model,	  we	  found	  that	  intranasal	  B.	  melitensis	  infection	  of	  IL-­‐12p40-­‐/-­‐	  BALB/c	  
mice	   induces	   a	   recruitment	   of	  M2	  macrophages	   to	   the	   spleen,	   	   but	   that	  Brucella-­‐infected	  
cells	   do	   not	   express	   typical	  M2	  markers	   such	   as	   Fizz1	   and	   CD301,	   and	   that	   the	   course	   of	  
infection	   or	   the	   phenotype	   of	   infected	   cells	   is	   not	   affected	   by	   STAT6	   deficiency.	   Taken	  
together,	  these	  results	  strongly	  suggest	  that,	  even	  if	  infected	  cells	  express	  high	  level	  of	  Arg1,	  
they	   should	  not	  be	  considered	  as	   "classical"	  M2	  macrophages,	  which	  are	  dependent	  upon	  
the	   Th2	   response	   and	   the	   STAT6	   signaling	   pathway.	   These	   results,	   together	   with	   our	  
previous	   report	   [7]	   showing	   that	   the	   absence	   of	   a	   Th2	   response	   does	   not	   favor	   Brucella	  
elimination	  from	  BALB/c	  mice,	  suggest	  that	  the	  Th2	  response	  plays	  only	  a	  minor	  role	  in	  the	  
persistence	  of	  Brucella	  in	  the	  host.	  
During	  the	  chronic	  phase	  of	   infection,	  the	  phenotype	  of	  the	  major	  type	  of	  Brucella-­‐
infected	  spleen	  cell	  (CD11c+	  CD205+	  bodipy+	  Arg1+)	  is	  strongly	  reminiscent	  of	  the	  phenotype	  
displayed	   by	   the	   ‘foamy	   cells’	   observed	   in	   the	   lungs	   during	  Mycobacterium	   tuberculosis	  
infection.	  These	  cells	  also	  express	  both	  CD11c	  and	  CD205	  markers,	  low	  levels	  of	  MHC-­‐II	  [27],	  
and	   high	   levels	   of	   lipid	   and	   Arg1	   [28,29].	   High	   levels	   of	   	   lipid	   droplets	   in	   infected	   cells	   is	  
induced	   by	   several	   intracellular	   pathogens	   such	   as	  M.	   tuberculosis,	  M.	   leprae,	   Chlamydia	  
[31],	   and	   Toxoplasma	   (reviewed	   in	   [32])	   suggesting	   that	   these	   pathogens	   induce	   the	  






investigators	   to	   consider	   foamy	  macrophages	   as	   nutrient	   rich	   reservoir	   cells	   that	   facilitate	  
bacterial	   persistence	   in	   vivo	   [30].	   Interestingly,	   it	   has	   recently	   been	   shown	   in	   the	   M.	  
tuberculosis	  model	   that	   lipid	   accumulation	   in	  macrophages	   favors	   bacterial	   latency	  by	   the	  
reversible	  blockage	  of	  bacterial	  division	  (33).	  The	  preferential	  persistence	  of	  Brucella	  in	  lipid	  
rich	   cells	   suggests	   that	   it	   could	   be	   informative	   to	   more	   deeply	   analyze	   the	   relationship	  
between	  the	  Brucella	  cell	  cycle	  and	  the	  availability	  of	  	  lipid	  nutrients.	  	  
In	  summary,	  our	  results	  allow	  us	  to	  better	  define	  the	  phenotype	  of	  the	  main	  host	  cell	  
type	  favoring	  the	  persistence	  of	  B.	  melitensis	   in	  the	  spleen	  of	  susceptible	  mice.	  These	  data	  
could	  help	  to	  develop	  new	  strategies	  to	  control	  Brucella	  infections.	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Figure	   S1:	   Confirmation	   of	   the	   deficiency	   of	   IL12p40	   and	   STAT6	   in	   BALB/c	   mice	   used	   for	   the	  
experiments.	  Data	  are	  the	  PCR	  products	  of	  mice	  DNA	  on	  agarose	  gel.	  A,	  PCR	  amplification	  of	  STAT6	  gene	  
with	  the	  lanes	  from	  the	  left	  to	  the	  right	  being:	  Ladder,	  DNA	  of	  wt,	  STAT6-­‐deficient	  mice,	  IL12p40-­‐deficient	  
mice,	   STAT6/IL12p40-­‐deficient	  mice,	   ladder.	   The	   amplification	   in	  Wt	   and	   IL12p40-­‐deficient	  mice	   is	   275	  
base	  pairs	  (bps)	  long	  and	  the	  amplification	  in	  STAT6	  and	  STAT6/IL12p40-­‐deficient	  mice	  is	  380	  bps	  long.	  B,	  
PCR	  amplification	  of	  IL12p40	  gene	  with	  the	  lanes	  from	  the	  left	  to	  the	  right	  being:	  Ladder,	  DNA	  of	  wt	  mice,	  
STAT6-­‐deficient	  mice,	   IL12p40-­‐deficient	  mice,	  STAT6/IL12p40-­‐deficient	  mice,	   ladder.	   The	  amplification	   in	  
Wt	   and	   STAT6-­‐deficient	   mice	   is	   687	   base	   pairs	   (bps)	   long	   and	   the	   amplification	   in	   IL12p40	   and	  








Figure	  S2:	   Characterization	   of	  MHCII	   and	   CD11c	   infected	   cells	   in	   the	   spleen	   of	  BALB/c	   IL12p40-­‐deficient	  mice.	  
IL12p40-­‐deficient	  BALB/c	  mice	  were	  injected	  i.n.	  with	  2.107	  CFU	  of	  mCherry-­‐Br.	  Mice	  were	  sacrificed	  at	  28	  days	  post-­‐
infection	   and	   spleens	   were	   collected	   and	   examined	   by	   immunohistofluorescence..The	   upper	   panels	   show	   global	  
distribution	   of	  MHCII-­‐expressing	   cells	   in	   the	   spleen	   (left),	   mCherry-­‐Br	   colocalization	   with	   negative	   cells	   for	  MHCII	  
(middle)	  and	  mCherry-­‐Br	  colocalization	  with	  cells	  weakly	  expressing	  MHCII	  (right).	  The	  panels	  below	  show	  mCherry-­‐Br	  
colocalization	   with	   negative	   cells	   for	   MHCII	   (left)	   and	   colocalization	   of	   mCherry-­‐Br	   and	   CD11c-­‐expressing	   cells	  
negative	  for	  MHCII	  (right).	  Panels	  are	  color-­‐coded	  with	  the	  text	  for	  phalloidin,	  the	  antigen	  examined	  or	  mCherry-­‐Br.	  
Scale	  bar=200	  and	  20	  µm,	  as	  indicated.	  r.p.	  :	  red	  pulp.	  w.p.:	  white	  pulp.	  Yellow	  arrowheads	  indicate	  the	  presence	  of	  








Figure	  S3:	  Colocalization	  between	  MOMA-­‐1-­‐expressing	  cells,	  CD11c-­‐expression	  cells	  and	  mCherry-­‐Br	  staining	   in	  
the	   spleen	   of	   BALB/c	   IL12p40-­‐deficient	  mice.	   IL12p40-­‐deficient	   BALB/c	  mice	  were	   injected	   i.n.	  with	   2.107	   CFU	   of	  
mCherry-­‐Br.	   Mice	   were	   sacrificed	   at	   28	   days	   post-­‐infection	   and	   spleens	   were	   collected	   and	   examined	   by	  
immunohistofluorescence.	  The	  left	  panels	  show	  mCherry-­‐Br	  colocalizarion	  wirh	  MOMA-­‐1-­‐expressing	  cells,	  the	  middle	  
panels	   show	   mCherry-­‐Br	   colocalization	   with	   CD11c-­‐expressing	   cells	   and	   the	   right	   panel	   shows	   colocalization	   of	  
MOMA-­‐1-­‐	  and	  CD11c-­‐expressing	  cells.	  Panels	  are	  color-­‐coded	  with	  the	  text	  for	  phalloidin,	  the	  antigen	  examined	  or	  
mCherry-­‐Br.	  Scale	  bar=	  20	  µm,	  as	  indicated.	  w.p.:	  white	  pulp.	  Yellow	  arrowheads	   indicate	  the	  presence	  of	  bacteria.	  













DISCUSSION	  AND	  CONCLUSIONS	  
	  
1. Context	  
Brucella	   is	   responsible	   for	   a	   particularly	   pernicious	   disease	   in	   livestock	   all	   over	   the	  
world.	  Abortion	  in	  females	  occurs	  only	  once	  after	  a	  long	  latency	  of	  bacteria	  during	  which	  
animals	   generally	   do	  not	   show	  any	   visible	   symptoms.	   In	  males,	   the	   pathogen	   can	   also	  
cause	  epididymitis	  and	  orchitis	  resulting	  in	  sterility.	  These	  symptoms	  are	  not	  specific	  and	  
farmers	  are	  not	  always	  conscious	  that	  Brucella	  is	  the	  cause,	  but	  economic	  losses	  can	  be	  
huge.	  As	  soon	  as	  the	  diagnosis	  is	  made,	  the	  only	  way	  to	  stop	  the	  disease	  in	  a	  herd	  is	  to	  
kill	   all	   the	   animals	   that	   have	   been	   in	   contact	   with	   the	   infected	   ones.	  Moreover,	   wild	  
animals	   constitute	   a	   reservoir	   and	   can	   transmit	   the	   bacterium	   to	   domestic	   animals.	  
Vaccination	  can	  reduce	  the	  risk.	  Current	  vaccines	  are	  able	  to	  prevent	  transmission	  of	  the	  
pathogen	   in	   the	  herd	  but	  are	  not	  optimal	  since	  they	  can	  trigger	  abortion	  and	   interfere	  
with	  the	  diagnosis.	  Moreover,	  these	  vaccines	  are	  not	  safe	  enough	  to	  be	  used	  in	  humans.	  
Throughout	  the	  last	  years,	  scientists	  have	  improved	  their	  knowledge	  of	  Brucella	  including	  
its	  establishment	   in	   the	  host	  cells	  and	   the	  mechanisms	  used	   to	  hide	   from	  the	   immune	  
system	   and	   to	   manipulate	   the	   host.	   However,	   interactions	   of	   the	   pathogen	   with	   the	  
immune	   system	   are	   not	   yet	   fully	   understood	   and	   mechanisms	   used	   by	   Brucella	   to	  
establish	  a	  long	  lasting	  infection	  are	  far	  from	  being	  elucidated.	  We	  performed	  this	  work	  
to	   contribute	   to	   the	   knowledge	   of	   this	   exciting	   pathogen	   and	   the	   associated	   host	  
immune	   response,	   hoping	   also	   to	   improve	   the	   understanding	   of	   other	   intracellular	  
pathogens	  that	  could	  have	  similar	  infectious	  mechanisms.	  
	  
2. Immune	   response	   against	   Brucella	   melitensis	   following	  
intranasal	  infection	  	  
Much	   of	   	   the	   information	   acquired	   concerning	   Brucella	   infections	   and	   the	   associated	  
host	   immune	   response	   has	   been	   obtained	   using	   the	   intraperitoneal	  model	   of	   infection	   in	  
mice.	  Our	  work	  uses	  an	   intranasal	   (i.n.)	  model	  and	  shows	   that	   the	   route	  of	   infection	   is	  an	  
important	   parameter	   that	   will	   influence	   the	   outcome	   of	   experimental	   murine	   infections.	  
Dissemination	  and	   localization	  can	  be	  different.	  Cell	  populations	  can	  change	  depending	  on	  






	   	  
Figure	  I:	  Migration	  pathways	  of	  Mycobacterium	  tuberculosis	  from	  the	  primary	  site	  of	  







2.1. Influence	  of	  the	  model	  of	  infection	  on	  dissemination	  and	  localization	  of	  bacteria	  
Ten	  minutes	  after	  an	  i.p.	  infection	  in	  mice,	  the	  blood,	  spleen	  and	  liver	  are	  colonized.	  This	  
systemic	  dissemination	  is	  drastically	  reduced	  in	  i.n.	  infection,	  where	  the	  respiratory	  tract	  and	  
mesenteric	   lymph	   nodes	   are	   directly	   colonized	   (Archambaud	   et	   al,	   2010),	   but	   5	   days	   are	  
necessary	  before	  bacteria	  are	  detected	  in	  the	  spleens	  and	  livers	  of	  	  all	  of	  	  the	  infected	  mice.	  
Bacteria	  are	  not	  detected	  in	  the	  blood	  of	  wild-­‐type	  mice	  infected	  by	  the	  i.n.	  route.	  However,	  
detection	  of	  bacteria	  in	  the	  blood	  of	  IL-­‐12p35	  and	  IFNγ	  knockout	  mice	  allows	  us	  to	  speculate	  
that	  Brucella	   disseminate	   progressively	   from	   the	   lungs	   to	   other	   organs	   via	   the	   blood.	   The	  
exact	   pathway	   used	   by	   the	   pathogen	   to	   exit	   the	   respiratory	   tract	   is	   not	   known,	   but	   it	   is	  
known	   that	   the	  brucellae	   are	  phagocytosed	  by	  alveolar	  macrophages	   (Archambaud,	   2010)	  
and	   these	   cells	   as	   well	   as	   DCs	   can	   transport	   the	   bacteria	   to	   draining	   lymph	   nodes	  
(Archambaud,	   2010).	   Figure	   I	   shows	   pathways	   potentially	   used	   by	   Mycobacterium	  
tuberculosis	   to	   disseminate	   in	   the	   host	   (Figure	   1).	   Free	   or	   intracellular	   bacteria	   can	   be	  
released	  from	  the	  lungs	  directly	  into	  the	  bloodstream	  by	  migration	  across	  alveolar	  epithelial	  
barriers.	   Alternatively,	   they	  may	  migrate	   through	   the	   lymph	   to	   the	   draining	   lymph	   nodes	  
thanks	   to	   dendritic	   cells	   and	   macrophages.	   Dissemination	   routes	   could	   be	   similar	   for	  
Brucella.	  
	  
Differences	  observed	  in	  Brucella	  dissemination	  to	  the	  deep	  organs	  between	  the	  i.p.	  and	  
i.n.	   routes	   of	   infection	   could	   explain	   why	   bacteria	   appear	   everywhere	   in	   the	   spleen,	  
including	   the	   red	   pulp,	   during	   the	   first	   days	   after	   an	   i.p.	   infection,	   and	   not	   after	   an	   i.n.	  
infection	   where	   Brucella	   appear	   mainly	   in	   the	   white	   pulp.	   When	   foreign	   substances	   or	  
pathogens	  reach	  the	  spleen,	  they	  are	  usually	  stopped	  and	  phagocytozed	  by	  macrophages	  in	  
the	  marginal	  zone.	  The	  large	  amount	  of	  Brucella	  reaching	  the	  spleen	  after	  an	  i.p.	  inoculation	  
could	  be	  too	  large	  to	  be	  contained	  in	  the	  marginal	  zone	  and	  the	  excess	  could	  spread	  to	  the	  
red	  pulp.	  	  






2.2. Influence	  of	  the	  model	  of	  infection	  on	  the	  immune	  effectors	  
In	   previous	   i.p.	   studies	   in	   our	   lab,	   it	   has	   been	   confirmed	   that	   production	   of	   IL-­‐12	   and	  
presentation	   of	   Brucella	   antigens	   with	   the	   MHCII	   complex	   are	   important	   for	   triggering	   a	  
protective	   Th1	   immune	   response.	   IFNγ-­‐producing	   CD4+T	   lymphocytes	   are	   the	   crucial	  
population	  to	  control	  B.	  melitensis	  during	  the	  primary	  infection.	  In	  the	  same	  model,	  Th2	  and	  
IFNγ-­‐producing	  CD8+T	  lymphocytes	  do	  not	  play	  major	  roles	  in	  effective	  defense	  against	  the	  
pathogen	   (Vitry	   et	   al,	   2012).	   With	   the	   i.n.	   model,	   we	   obtained	   similar	   results	   for	   these	  
cellular	  immune	  responses	  and	  we	  showed	  that	  the	  Th1	  pathway	  is	  also	  the	  crucial	  response	  
for	  controlling	  the	  infection.	  	  
	  
However,	  analysis	  of	  the	  lungs,	  spleen	  and	  liver	  following	  intranasal	  infection	  allowed	  us	  
to	  improve	  our	  knowledge	  on	  the	  role	  of	  IL-­‐23,	  a	  cytokine	  generally	  associated	  with	  the	  Th17	  
immune	   response.	   IL12p19	   (IL-­‐23)-­‐deficient	   mice	   are	   not	   susceptible	   as	   long	   as	   the	   Th1	  
immune	  response	  is	  functional,	  but	  the	  cytokine	  becomes	  important	   in	  the	  absence	  of	  this	  
response.	  It	  is	  true	  for	  the	  i.p.	  model	  as	  well	  as	  for	  i.n.	  model:	  IL-­‐12p35	  (IL-­‐12)-­‐deficient	  mice	  
have	  a	  higher	  bacterial	  load	  than	  wt	  mice	  in	  the	  spleen,	  but	  less	  than	  IL-­‐12p40	  (IL-­‐12	  and	  IL-­‐
23)-­‐deficient	   mice.	   However,	   the	   importance	   of	   IL-­‐23	   is	   accentuated	   in	   the	   i.n.	   model	  
because	  we	  were	   able	   to	   observe	   that	   IL-­‐12p35-­‐deficient	  mice,	   but	   not	   IL-­‐12p40-­‐deficient	  
mice,	   eliminate	   the	  bacterium	   from	   the	   liver	   and	   lungs	   in	   the	   long	   term.	   This	   observation	  
also	  showed	  that	  elimination	  of	  bacteria	  depends	  on	  the	  organ	  involved.	  
	  
Differences	  in	  effectors	  have	  been	  highlighted	  between	  the	  i.n.	  model	  and	  the	  i.p.	  model.	  
Intraperitoneally	  infected	  IL-­‐17Ra	  knockout	  mice	  are	  not	  more	  susceptible	  than	  infected	  wt	  
mice.	  On	  the	  contrary,	  IL-­‐17Ra	  is	  important	  for	  controlling	  the	  bacterial	  load	  in	  the	  lungs	  of	  
intranasally	  infected	  mice	  during	  the	  first	  month	  p.i..	  IL-­‐23	  is	  usually	  necessary	  to	  induce	  IL-­‐
17	   production,	   but	   in	   our	   study,	   IL-­‐17a	   production	   does	   not	   seem	   to	   be	   linked	   to	   the	  
presence	  of	  IL-­‐23	  because,	  as	  explained	  above,	  IL-­‐23-­‐deficient	  mice	  are	  not	  more	  susceptible	  
than	  wt	  mice.	  IL-­‐23-­‐independent	  induction	  of	  IL-­‐17	  has	  already	  been	  reported	  (Hasegawa	  et	  
al,	  2013).	  These	  authors	  showed	  that	  IL-­‐1β	  could	  act	  as	  a	  substitute	  for	  IL-­‐23	  to	  induce	  the	  
cytokine.	  In	  our	  model,	  IL-­‐1β-­‐deficient	  mice	  are	  not	  susceptible,	  but	  the	  two	  cytokines	  could	  







γδ	  T	  lymphocytes	  are	  particularly	  abundant	  cells	  at	  mucosal	  surfaces	  (Martin	  et	  al,	  2009),	  
they	  are	  potential	  early	  producers	  of	  IL-­‐17	  and	  IFNγ	  (Roark	  et	  al,	  2008),	  and	  they	  can	  play	  a	  
protective	   role	   against	   intracellular	   pathogens	   invading	   the	  mucosal	   environment,	   such	   as	  
Listeria	  monocytogenes	   or	  Mycobacterium	  bovis	   (Sheridan	  et	   al,	   2013;	  McGill	   et	   al,	   2014).	  
This	   is	  why	  we	  tested	  deficient	  mice	  for	  this	  cell	  population.	   It	   turns	  out	  that	  they	  actually	  
play	  a	  role	  in	  the	  control	  of	  the	  bacterial	  load	  during	  the	  first	  12	  days	  of	  infection.	  The	  reason	  
for	  their	  positive	  role	  in	  protection	  has	  not	  been	  determined:	  in	  contrast	  to	  CD4+T	  cells,	  γδ	  T	  
lymphocytes	  do	  not	  seem	  to	  produce	  IFNγ	  during	  the	  infection,	  and	  we	  do	  not	  detect	  IL-­‐17a	  
production	   by	   flow	   cytometry	   during	   the	   infection.	   The	   level	   of	   this	   last	   cytokine	   stays	  
perhaps	   too	   low	   to	  observe	  a	   signal	  or	   its	  production	  could	   increase	  at	  other	   time	  points.	  
Other	  cell	  types	  can	  also	  produce	  IL-­‐17	  (Veldhoen	  et	  al,	  2006;	  Cua	  et	  al,	  2010)	  and	  thus	  could	  
be	  contributing	  to	  	  resistance	  to	  Brucella	  infection	  in	  the	  i.n.	  model.	  	  
	  
With	  the	  i.p.	  model,	  primary	  infection	  is	  not	  controlled	  by	  B	  lymphocytes	  but	  in	  case	  of	  a	  
secondary	   infection,	  specific	  antibodies	  generated	   in	  response	  to	  the	  first	  contact	  with	  the	  
pathogen	   become	   essential	   effectors	   to	   control	   the	   challenge	   strain	   in	   the	   blood	   and,	  
subsequently,	   to	   limit	   dissemination	   to	   the	   spleen.	   Primary	   i.n.	   infection	   is	   also	   not	  
controlled	   by	   B	   lymphocytes,	   but	   the	   infection	   triggers	   production	   of	   specific	   antibodies.	  
However,	  in	  this	  case	  they	  do	  not	  play	  a	  major	  role	  in	  controlling	  the	  secondary	  i.n.	  infection	  
because	   most	   mice	   completely	   eliminate	   the	   challenge	   strain	   from	   the	   spleen	   even	   in	  
absence	  of	  B	  cells	   (MuMT-­‐deficient	  mice).	  After	   i.p.	   infection	  of	  mice,	  we	  have	  shown	  that	  
bacteria	   reach	   deep	   organs	   extracellularly	   through	   blood	   during	   the	   first	   day	   of	   infection	  
(Vitry	  et	  al,2014).	  This	  may	  explain	  the	  importance	  of	  antibodies	  in	  eliminating	  the	  invaders.	  
We	   speculate	   that	   after	   an	   i.n.	   infection,	   bacteria	   are	   phagocytozed	   by	   host	   cells	   and	  
progressively	   leave	   the	   lungs	  and/or	   lymph	  nodes	  mainly	   inside	   cells;	   this	   is	  probably	  why	  
antibodies	   are	   not	   playing	   a	  major	   role	   in	   the	   elimination	   of	   the	   bacteria.	   However,	   it	   is	  
important	   to	  note	   that	   the	  group	  of	  Zinkernagel	  has	  shown	  that	  muMT-­‐deficient	  mice	  can	  
still	   produce	   immunoglobulin	   A	   (Macpherson	   et	   al.,	   2001).	   Consequently,	   we	   looked	   for	  
specific	   IgA	   in	   serum	   and	   broncho-­‐alveolar	   lavage	   by	   ELISA	   but	   we	   could	   not	   detect	   this	  
immunoglobulin	  in	  these	  mice	  (data	  not	  shown).	  






2.3. Role	  of	  IFNγ 	  in	  the	  survival	  of	  infected	  mice	  
Whatever	   the	  model	   of	   infection,	   the	   presence	   of	   IFNγ	   is	   essential	   for	   the	   survival	   of	  
infected	  mice.	  If	  IFNγ	  is	  produced	  by	  CD4+	  T	  cells,	  the	  control	  of	  the	  bacterial	  load	  is	  better	  
than	   if	   it	   is	   produced	   by	   other	   cell	   types,	   but	   as	   long	   as	   it	   is	   present,	   mice	   survive	   the	  
infection.	   IFNγ	   is	   usually	   considered	   as	   a	   cytokine	   that	   triggers	   the	   production	   of	   effector	  
mechanisms	   essential	   for	   bacterial	   control,	   and	   its	   absence	   would	   prevent	   control	   of	  
bacteria	   leading	   to	   death	   of	  mice.	  However,	   the	   explanation	   for	   its	   role	   in	   the	   survival	   of	  
mice	  during	  experimental	  Brucella	  infections	  seems	  to	  be	  more	  complex.	  It	  is	  true	  that	  IFNγ-­‐
deficient	  mice	  have	  a	  higher	  bacterial	  load	  than	  wt	  mice,	  but	  CD3-­‐deficient	  mice	  do	  not	  die	  
and	   they	   have	   as	   many	   bacteria	   in	   their	   organs	   as	   IFNγ-­‐deficient	   mice.	   This	   means	   that	  
failure	  to	  control	  replication	  of	  	  the	  brucellae	  does	  not	  seem	  to	  be	  sufficient	  to	  induce	  death	  
in	  mice.	  But,	   IFNγ-­‐deficient	  mice	  have	  a	  higher	   level	  of	   recruitment	  of	  neutrophils	   to	   their	  
spleens,	   livers	  and	   lungs	   in	  response	  to	  Brucella	   infection	  than	  do	  CD3-­‐deficient	  mice.	  This	  
can	   lead	   to	   large	   zones	   of	   obstruction	   in	   the	   alveoli.	   Indeed,	   IFNγ	   seems	   to	   play	   a	   role	   in	  
hematopoiesis	   during	   inflammation,	   by	   increasing	   monopoiesis	   and	   inhibiting	   neutrophil	  
development	  (de	  Bruin	  et	  al,	  2012).	  And	  it	  has	  been	  demonstrated	  that	  the	  absence	  of	  	  this	  
cytokine	   leads	   to	   a	  massive	   granulocytosis	   in	   the	   spleen	   and	   blood	   of	  mice	   infected	  with	  
Mycobacterium	   bovis	   (Murray	   et	   al,	   1998).	   It	   is	   also	   known	   that	   neutrophils	   can	   be	  
responsible	   for	   tissue	  destruction	  during	   inflammation	  through	  secretion	  of	  mediators	  and	  
the	   release	   of	   soluble	   microbicidals	   into	   the	   external	   environment	   to	   kill	   pathogens	   and	  
infected	  cells	  (Smith	  et	  al,	  1994;	  Wright	  et	  al,	  2010).	  Accordingly,	  systemic	  inflammation	  and	  
the	  activity	  of	  	  granulocytes	  could	  be	  the	  main	  cause	  of	  	  death	  in	  IFNγ-­‐deficient	  mice	  infected	  
with	  Brucella.	  
	  






3. Reservoir	   cells	   for	   B.	   melitensis	   during	   the	   chronic	   phase	   of	  
infection	  in	  a	  susceptible	  mouse	  
Brucella	   melitensis	   must	   be	   able	   to	   reach	   an	   intracellular	   niche	   favorable	   for	   its	  
persistence	   in	   the	  host,	   but	   the	  phenotype	  of	   	   the	  host	   cells	   that	   facilitate	   its	   persistence	  
after	  the	  acute	  phase	  of	  infection	  has	  not	  been	  elucidated.	  Unfortunately,	  study	  of	  infected	  
cells	  by	   immunohistofluorescence	   in	  C57BL/6	  wt	  mice	  after	  5	  days	   is	  very	  difficult	  because	  
the	   bacterial	   load	   is	   below	   the	   limit	   of	   detection	   of	   106	   CFU	   per	   spleen.	   In	   our	   lab,	   we	  
decided	  to	  use	  IL12p40-­‐deficient	  BALB/c	  mice	  that	  are	  more	  susceptible	  to	  the	  infection	  and	  
have	  a	  higher	  bacterial	   load	  in	  the	  spleen.	  Previous	  work	  with	  the	  i.p.	  model	  allowed	  us	  to	  
postulate	   that	   Brucella	   infects	   MOMA-­‐1	   macrophages	   close	   to	   the	   marginal	   zone	   and	  
CD11c/DEC205	   dendritic	   cells	   in	   the	   center	   of	   the	  white	   pulp	   of	   the	   spleen	   12	   days	   post-­‐
infection	  (Copin	  et	  al,	  2012).	   In	  the	  current	  work	  using	  the	   i.n.	  model,	  we	  wanted	  to	  study	  
the	   niche	   of	   Brucella	   in	   the	   spleen	   during	   the	   chronic	   phase.	   In	   wt	   mice,	   Brucella	   are	  
eliminated	   from	   the	   lungs	   and	   liver	   after	   20	   days	   but	   persist	   in	   the	   spleens.	   Thus,	   we	  
considered	   28	   days	   post-­‐infection	   as	   being	   representative	   of	   the	   chronic	   phase.	   BALB/c	  
IL12p40-­‐deficient	  mice	  do	  not	   develop	   Th1/Th17	   immune	   responses.	   Instead,	   they	  have	   a	  
pro-­‐Th2	   bias.	   This	   means	   that	   M1	   polarization	   of	   macrophages	   is	   inhibited	   and	   that	  
differentiation	   into	   alternatively	   activated	   macrophages	   (M2)	   is	   facilitated	   (Bastos	   et	   al.,	  
2002).	   These	   macrophages	   are	   known	   to	   constitute	   a	   favorable	   niche	   for	   intracellular	  
bacteria	  (see	  introduction).	  Moreover,	  the	  paper	  of	  the	  research	  team	  of	  Tsolis	  (Xavier	  et	  al,	  
2013)	   shows	   that	   M2	   macrophages	   (Fizz+	   and	   CD301+	   cells)	   are	   induced	   during	   chronic	  
infection	   by	   Brucella	   and	   that	   the	   bacteria	   survive	   and	   replicate	   particularly	   well	   in	   M2	  
macrophages	   in	   vitro.	   Based	   on	   these	   findings,	   it	   has	   been	   hypothesized	   that	   M2	  
macrophages	  could	  be	  the	  major	  reservoir	  in	  the	  spleens	  of	  these	  mice.	  Considering	  the	  fact	  
that	   experimental	   models	   show	   that	   M2	   macrophages	   can	   be	   dependent	   on	   the	   STAT6	  
signaling	  pathway	  (Stein	  et	  al,	  1992;	  Mandal	  et	  al,	  2010),	  we	  crossed	  IL12p40	  knockout	  mice	  
with	  STAT6-­‐deficient	  mice	  to	  obtain	  a	  lineage	  that	  would	  be	  susceptible	  to	  the	  infection,	  but	  
that	   would	   not	   have	   Th2	   cytokine	   dependent	  M2	   polarization.	  We	   speculated	   that	   these	  
double	  knockout	  mice	  would	  control	  better	  the	  chronic	  infection	  due	  to	  the	  absence	  of	  the	  







Surprisingly,	  enumeration	  of	  	  brucellae	  in	  the	  lungs,	  spleens	  and	  livers	  after	  low	  and	  high	  
dose	   infection	   revealed	   that	   double	   knockout	   mice	   are	   as	   susceptible	   as	   IL12p40	   mice.	  
Moreover,	   analysis	   of	   the	   phenotypes	   of	   infected	   cells	   at	   28	   days	   post-­‐infection	   in	   the	  
spleens	  of	  both	  lineages	  showed	  that	  reservoir	  cells	  for	  Brucella	  are	  similar.	  This	  means	  that	  
reservoir	   cells	   are	  not	   influenced	  by	   the	   IL-­‐4/IL-­‐13/STAT6	   signaling	  pathway.	   In	   fact,	  many	  
cell	   types	   seem	   to	   be	   infected	   in	   these	   conditions	   but	   they	   mainly	   express	   CD11c	   and	  
DEC205,	   two	  markers	   specific	   for	   DCs.	   A	   fraction	   of	   infected	   cells	   are	   also	  MOMA-­‐1	   and	  
ERTR9	  positive.	  This	  suggests	  that	  these	  cells	  come	  from	  the	  marginal	  zone,	  and	  migrate	  to	  
the	  white	  pulp	  in	  response	  to	  the	  infection,	  just	  as	  MOMA-­‐1+	  MMM	  and	  ERTR9+	  MZM	  do	  in	  
response	   to	   Listeria	  monocytogenes	   infection	   (Jablonska	   et	   al.,	   2007).	   To	   our	   knowledge,	  
colocalization	  between	  defined	  markers	   of	   distinct	   cell	   populations,	   such	   as	  MOMA-­‐1	   and	  
CD11c	  markers	   or	   ERTR9	   and	   CD11c	  markers,	   has	   not	   been	   described	   in	   the	   spleen.	   This	  
could	  be	  due	  to	  acquisition	  and	  simultaneous	  loss	  of	  markers	  during	  cell	  migration	  from	  the	  
marginal	   zone	   to	   the	  white	  pulp	  after	   the	   infection.	  An	  alternative	  explanation	  could	  be	  a	  
technical	   artifact,	   due	   to	   the	   superimposition	   of	   two	   distinct	   cells.	   Negative	   or	   low	  
expression	   of	  MHCII	   on	   cells	   infected	   by	  Brucella	   is	   in	   agreement	  with	   a	   previous	   in	   vitro	  	  
study	  with	  B.	  abortus,	  which	   shows	   that	   the	  bacterium	   is	  able	   to	   inhibit	   the	  expression	  of	  
this	  complex	  to	  prevent	  recognition	  by	  T	  cells,	  evade	  host	  immune	  responses	  and	  establish	  
chronic	  infection	  (Forestier	  et	  al.,	  2000).	  Infected	  cells	  also	  neither	  express	  CD11b	  nor	  F4/80.	  
This	   demonstrates	   that	   they	   are	   different	   from	   the	   CD11b+	   CD11c+	   F4/80+	   infected	  
inflammatory	  DCs	  observed	  during	  the	  acute	  infection	  in	  wild	  type	  mice	  (Copin	  et	  al,	  2012).	  
We	  also	  showed	  colocalization	  of	  mCherry	  and	  cells	  positive	  for	  Arg1,	  but	  not	  with	  Fizz1	  and	  
CD301.	  The	  absence	  of	  these	  last	  M2	  markers	  on	  infected	  cells	  and	  the	  independence	  of	  the	  
phenotype	  of	   infected	  cells	   from	  the	  Stat6	  pathway	   let	  us	  speculate	  that	   infected	  cells	  are	  
not	  classical	  M2	  macrophages.	  	  
	  
Most	  of	   the	  Brucella	   infected	  cells	  have	  high	   lipid	  content	   (Bodipy	  staining),	  which	   is	  a	  
characteristic	   usually	   encountered	   in	   ‘foamy’	  macrophages	   such	   as	   those	   observed	   during	  
Mycobacterium	   tuberculosis	   infection	   (Peyron	   et	   al,	   2008).	   Moreover,	   these	   foamy	  
macrophages	  coexpress	  CD11c,	  CD205,	  have	  a	  low	  level	  of	  MHCII	  expression	  (Ordway	  et	  al,	  
2005)	  and	  are	  positive	  for	  Arg1	  (Schaale	  et	  al,	  2013).	  All	  of	  these	  characteristics	  are	  shared	  
with	  most	  of	  cells	  infected	  by	  Brucella	  in	  our	  model.	  






4. Perspectives	  and	  Final	  	  Conclusions	  
4.1. Primary	  immune	  response	  
After	   an	   intranasal	   (i.n.)	   infection	   of	   mice	   with	   Brucella	   melitensis,	   bacteria	   are	  
phagocytozed	   by	   alveolar	   macrophages	   before	   being	   transported	   to	   the	   draining	   lymph	  
nodes	  by	  alveolar	  macrophages	  and	  dendritic	  cells	  (Archambaud	  et	  al.,	  2010).	  The	  immune	  
system	   fails	   to	   neutralize	   Brucella	   because	   of	   bacterial	   properties	   that	   confer	   to	   the	  
pathogen	   a	   strong	   resistance	   to	   immune	   effectors.	   Escape	   mechanisms	   allow	   Brucella	   to	  
disseminate	   through	   the	   body	   of	   its	   host	   and	   establish	   a	   replicative	   niche.	   Fortunately,	  
bacteria	   do	   not	   remain	   undetectable	   by	   the	   immune	   system,	   and	   granulomas	   appear	  
progressively	   in	  the	  liver	  and	  spleen	  to	  surround	  infected	  cells	  after	  a	  week.	  After	  12	  days,	  
MHCII-­‐dependent	  antigen	  presentation	  to	  CD4+	  T	  lymphocytes	  appears	  to	  play	  a	  central	  role	  
in	  the	  control	  of	  the	  infection.	  These	  T	  cells	  begin	  to	  produce	  IFNγ	  which	  increases	  until	  50	  
days	   p.i..	   This	   pro-­‐inflammatory	   cytokine	   induces	   the	   production	   of	   nitric	   oxide	   by	   innate	  
immune	   cells	   that	   helps	   control	   the	   infection	   (Copin	   et	   al.,	   2007).	   This	   pro-­‐inflammatory	  
immune	  response	  developed	   in	   the	  spleen	  and	  the	   liver	   is	  sufficient	   to	  clear	  Brucella	   from	  
the	  liver	  by	  one	  month	  p.i.,	  but	  not	  from	  the	  spleen.	  In	  the	  lungs,	  the	  immune	  mechanisms	  
seems	   to	   be	   different;	   no	   recruitment	   is	   detectable	   but	   mucosal	   γδ	   T	   cells	   and	   IL-­‐17a	  
production	  help	  the	  Th1	  immune	  response	  in	  the	  early	  phase	  of	  infection.	  The	  local	  immune	  




- We	   have	   demonstrated	   that	   the	   lungs	   are	   infected	   3	   hours	   after	   intranasal	  
infection	   and	   that	   the	   bacterial	   load	   approximately	   corresponds	   to	   the	   infected	  
dose.	  At	  this	  time	  point	  bacteria	  have	  not	  replicated	  yet.	  However,	  infection	  of	  the	  
upper	   respiratory	   tract	   is	   not	   excluded	   since	   the	   exact	   number	   of	   inoculated	  
bacteria	   is	  not	  known.	  Analysis	  of	  the	  bacterial	   load	  in	  the	  upper	  respiratory	  tract	  
and	  the	  draining	  lymph	  nodes	  would	  indicate	  if	  Brucella	  infects	  these	  zones	  as	  well	  
as	   the	   lower	   respiratory	   tract.	   Utilization	   of	  whole	   body	   imaging	   could	   also	   be	   a	  
great	  method	  to	  observe	  the	  zones	  infected	  by	  Brucella	  after	  intranasal	  inoculation	  






- It	  would	  be	  interesting	  to	  study	  the	  infection	  in	  lymph	  nodes	  because	  we	  know	  that	  
mediastinal	   lymph	   nodes	   are	   rapidly	   infected	   after	   i.n.	   inoculation	   in	   the	   murin	  
model	  (Archambaud	  et	  al.,	  2010)	  but	  the	  kinetics	  of	  these	  infections	  have	  not	  been	  
investigated.	  We	  should	  analyse	  the	  immune	  response	  in	  this	  organ	  to	  compare	  the	  
protection	  with	  the	  one	  of	  lungs,	  spleen	  and	  liver.	  
- The	   pathway	   used	   by	  Brucella	   to	   reach	   deep	   organs	   has	   not	   been	   characterized.	  
With	  whole	  body	   imaging,	  we	  could	  also	  follow	  dissemination	  of	  the	  bacteria	  and	  
perhaps	   have	   a	   clue	   about	   the	   route	   of	   spread	   as	   has	   been	   demonstrated	   with	  
Bacillus	  anthracis	  (Glomski	  et	  al.,	  2007).	  
- We	  hypothesized	  that	  presence	  of	  bacteria	   in	  the	  red	  pulp	  of	  the	  spleen	  after	   i.p.	  
infection	   but	   not	   after	   an	   i.n.	   infection	   could	   be	   explained	   by	   the	   rapid	  
dissemination	  after	  i.p.	  infection.	  Brucella	  could	  be	  too	  abundant	  to	  all	  be	  trapped	  
by	   the	   macrophages	   of	   the	   marginal	   zone.	   It	   has	   been	   shown	   that	   depletion	   of	  
MZM	  and	  MMM	  in	  the	  spleen	  of	  mice	  impairs	  trapping	  of	  intravenous	  (i.v.)	  injected	  
microspheres	   and	   L.	   monocytogenes	   by	   the	   marginal	   zone.	   They	   are	   no	   more	  
retained	  and	  spread	  to	  the	  red	  pulp	  (Aichele	  et	  al.,	  2003).	  This	  experiment	  could	  be	  
an	   indication	   that	   if	   the	  amount	  of	   foreign	  particles	   is	   superior	   to	   the	  number	  of	  
macrophages	  in	  the	  marginal	  zone,	  they	  would	  not	  be	  retained	  and	  reach	  the	  red	  
pulp.	   Injection	  of	  high	  doses	  of	  microspheres	  could	  allow	  us	  to	  see	   if	  a	  portion	  of	  
them	  reaches	  the	  red	  pulp.	  	  	  
- In	  our	  study,	  IL-­‐17A	  production	  seems	  to	  be	  independent	  from	  IL-­‐23	  production.	  It	  
has	  already	  been	  demonstrated	  that	  its	  production	  can	  be	  independent	  from	  IL-­‐23	  
and	  that	  IL-­‐1β	  can	  substitute	  for	  IL-­‐23	  to	  induce	  IL-­‐17	  (Hasegawa	  et	  al.,	  2013).	  Our	  
model	  shows	  that	   IL-­‐1β-­‐deficient	  mice	  are	  also	  not	  susceptible	  to	  the	   infection.	   It	  
would	   be	   interesting	   to	   use	   double	   knockout	   IL-­‐23/IL-­‐1β	   mice	   in	   order	   to	   see	   if	  
these	  two	  cytokines	  have	  redundant	  activities.	  Moreover,	  other	  cytokines	  such	  as	  
IL-­‐6,	   IL-­‐18	   and	   TGFβ	   have	   also	   been	   implicated	   in	   promoting	   IL-­‐17	   production	  
(Veldhoen	  et	  al.,	  2006;	  Lalor	  et	  al.,	  2011).	  Their	  depletion	   in	  mice	  could	  also	  give	  
answers.	  
- IL-­‐17A	   participates	   in	   control	   of	   infection	   in	   the	   lungs,	   but	   we	   were	   not	   able	   to	  
detect	  production	  of	   	   this	  cytokine	  by	   flow	  cytometry.	  RT-­‐PCR	  or	   restimulation	  of	  






- We	   have	   tested	   the	   function	   of	   γδ	   T	   cells	   in	   the	   lungs	   during	   Brucella	   infection	  
because	   they	   are	   abundant	   in	   the	   mucosal	   environment,	   are	   important	   for	   the	  
control	  of	  	  infections	  in	  these	  zones,	  and	  are	  potential	  producers	  of	  IL-­‐17	  and	  IFNγ.	  
But	  other	  cell	  types,	  such	  as	  Natural	  Killer	  cells,	  NK	  T	  cells	  and	  innate	  lymphoid	  cells	  
(ILCs),	   are	   also	   able	   to	   produce	   these	   cytokines	   and	   participate	   in	   mucosal	  
immunity.	  Depletion	  of	  these	  cell	   types	   in	  mice	   is	  also	  a	  possibility	  to	  enlarge	  our	  
knowledge	  on	  cell	  populations	  playing	  a	  role	  in	  the	  control	  of	  i.n.	  infection.	  
- The	   reason	  why	   IFNγ-­‐deficient	  mice	  die	  was	   investigated	  as	  a	   side	  project	  during	  
the	   thesis.	   Massive	   inflammation	   due	   to	   neutrophil	   recruitment	   was	   observed.	  
Reduction	  of	  inflammation	  by	  an	  anti-­‐inflammatory	  treatment	  could	  be	  planned	  to	  
thwart	  the	  deleterious	  effects	  of	  inflammation.	  However,	  we	  have	  to	  keep	  in	  mind	  
that	  inhibition	  of	  global	  inflammation	  could	  also	  be	  detrimental	  for	  mice.	  Recently,	  
mice	   genetically	   deficient	   for	   neutrophils	   (Genista	   mice),	   have	   been	   generated	  
(Ordonez-­‐Rueda	   et	   al.,	   2012).	   Crossbreeding	   between	   these	   mice	   and	   IFNγ-­‐
deficient	   mice	   could	   generate	   double	   knockout	   mice	   that	   would	   not	   die	   if	  
inflammation	   due	   to	   neutrophilia	   were	   responsible	   for	   the	   death	   of	   mice.	   An	  
alternative	  is	  the	  utilization	  of	  Ly6G-­‐specific	  antibody	  (1A8)	  to	  deplete	  neutrophils	  
(Daley	   et	   al.,	   2008).	   Dr.	   Muraille	   has	   tested	   this	   antibody	   once	   in	   a	   model	   of	  
footpad	  infection,	  but	  he	  did	  not	  observe	  a	  reduction	  of	  neutrophils	   in	  the	  lesion.	  
We	   could	   nevertheless	   try	   the	   antibody	   in	   our	   model	   with	   different	   kinetics	   of	  
injection	  and	  different	  doses.	  
- IFNγ	   is	   essential	   for	   the	   survival	  of	  mice	  but	   it	   apparently	  has	   to	  be	  produced	  by	  
CD4+	   T	   cells	   for	   efficient	   control	   of	   the	   infection.	   Without	   this	   IFNγ-­‐producing	  
population	  (Th1),	  mice	  are	  more	  susceptible	  despite	  the	  fact	  that	  other	  cell	  types,	  
such	  as	  CD8+	  T	  cells	  or	  NK	  T	  cells,	  are	  able	  to	  produce	  this	  cytokine.	  This	  suggests	  
that	   these	   CD4+	   T	   cells	   have	   another	   function	   that	   is	   particularly	   effective	   for	  
controlling	  the	  infection.	  Th1	  cells	  not	  only	  produce	  IFNγ,	  so	  the	  expression	  of	  other	  
cytokines	  such	  as	  IL-­‐2	  and	  TNFα	  (Darrah	  et	  al.,	  2007)	  could	  also	  be	  studied	  to	  solve	  







4.2. Reservoir	  cells	  
After	   one	  month	   p.i.	   ,	   the	   spleen	   of	   	  wt	  mice	   is	   the	   last	   studied	   organ	   that	   is	   still	  
infected.	   This	   suggests	   that	   it	   contains	   a	   particularly	   favorable	   niche	   where	   Brucella	   can	  
persist	  for	  the	  long	  term.	  We	  had	  to	  investigate	  the	  question	  of	  the	  reservoir	  cells	  by	  using	  
susceptible	   IL12p40-­‐deficient	   mice	   because	   of	   the	   insufficient	   amount	   of	   bacteria	   in	   the	  
spleen	   of	   wt	   mice.	   In	   this	   model,	   Brucella	   is	   able	   to	   infect	  many	   cell	   types	   but	   its	   main	  
sanctuary	  is	  apparently	  similar	  to	  the	  ‘foamy’	  macrophages	  infected	  during	  Mycobacterium	  
tuberculosis	  persistence.	  These	  cells	  are	  CD11c+	  CD205+	  Bodipy+	  Arg1+	  and	  MHCII	  low/neg	  
and	  could	  constitute	  a	  niche	  with	  a	  nutrient	  source	  for	  the	  pathogen.	  The	  fact	  that	  deletion	  
of	  STAT6	   in	   IL12p40-­‐deficient	  mice	  does	  not	   influence	  the	   infected	  cell	   types	   in	  the	  spleen	  
and	   that	   they	  do	  not	   express	  M2	  markers	   such	   as	  CD301	  and	   Fizz	   let	   us	  hypothesize	   that	  
these	  cells	  are	  not	  classical	  M2	  macrophages.	   It	  also	  seems	  that	   infected	  MMM	  and	  MZM	  
migrate	  from	  the	  marginal	  zone	  to	  the	  white	  pulp	  because	  of	  the	  expression	  of	  MOMA-­‐1	  and	  
ERTR9	  on	  a	  portion	  of	  the	  infected	  cells.	  
	  
à	  Perspectives:	  	  
- Brucella	  are	  able	  to	  infect	  different	  cell	  types	  in	  vitro	  but	  our	  results	  show	  that	  one	  
cell	   type	   is	   mainly	   infected,	   or	   at	   least,	   different	   cell	   types	   that	   share	   common	  
markers.	   It	   could	   be	   interesting	   to	   target	   one	   of	   these	   markers	   with	   liposomes;	  
composed	  of	  a	  phospholipid	  membrane	  and	  an	  encapsulated	  aqueous	  phase,	  these	  
structures	  can	  contain	  a	  therapeutic	  agent	  (Sofou	  et	  al.,	  2008).	  We	  could	  conjugate	  
liposomes	  with	  a	  specific	  antibody	  (for	  example	  DEC205	  antibody)	  on	  their	  surface	  
to	   interact	   with	   the	   particular	   cell	   population	   positive	   for	   the	   marker	   (DEC205).	  
Once	  on	  the	  targeted	  cells,	   liposomes	  can	   fuse	  with	   the	  cellular	  membrane	  or	  be	  
internalized	  by	  endocytosis	  to	  deliver	  the	  drug.	  This	  approach	  could	  reduce	  or	  even	  
eliminate	  persistence	  of	  the	  bacterium	  in	  the	  spleens	  of	  mice.	  	  
- We	  were	  not	  able	  to	  characterize	  reservoir	  cells	   in	  wild	  type	  mice	  because	  of	  the	  
limit	  of	  detection	  (106	  CFU/spleen),	  but	  targeting	  of	  these	  cells	  with	  liposomes	  in	  wt	  
and	  IL12p40-­‐deficient	  mice	  could	  permit	  us	  to	  see	   if	  persistence	   is	  reduced	  in	  the	  







- We	  are	  not	  able	  to	  explain	  why	  mCherry-­‐Br	  colocalizes	  with	  markers	  usually	  located	  
on	  different	   cell	   types,	   such	  as	  MOMA-­‐1	  and	  DEC205.	  We	  hypothesized	   that	   it	   is	  
due	   to	   infection	   and	   migration	   of	   cells:	   during	   migration,	   infected	   cells	   could	  
acquire	   new	   markers	   and	   lose	   others.	   However,	   it	   is	   not	   excluded	   that	   it	   is	   a	  
technical	  artifact.	  Use	  of	  confocal	  microscopy	  could	  help	  to	  see	  if	  markers	  are	  only	  	  
present	  on	  one	  cell	  or	  if	  there	  is	  an	  overlap	  of	  two	  cell	  types.	  
- Study	  of	  the	  reservoir	  cell	  at	  later	  times	  would	  tell	  us	  if	  Brucella	  stays	  in	  the	  same	  
cell	   type	  during	   its	  persistence.	   In	  the	  susceptible	  mice	  used	  for	  our	  experiments,	  
CFUs	   slightly	   decrease	   at	   50	   days	   p.i.,	   but	   observation	   of	   infected	   cells	   remains	  
possible.	  	  
	  
4.3. Secondary	  immune	  response	  
Upon	  secondary	  i.n.	  infection,	  the	  experimented	  immune	  system	  of	  the	  mouse	  is	  able	  
to	  fight	  Brucella	  with	  a	  stronger	  specific	  response.	  But	  contrary	  to	  the	  i.p.	  model	  of	  infection,	  
specific	   circulating	   antibodies	   secreted	   by	   B	   lymphocytes	   do	   not	   play	   a	  major	   role	   in	   the	  
clearance	  of	  the	  challenge	  strain.	  It	  seems	  that	  effector	  memory	  T	  lymphocytes	  are	  sufficient	  
to	   coordinate	   bacterial	   clearance	   and	   provide	   a	   long-­‐term	   protection	   in	   organs.	   The	  
intracellular	   location	  of	  Brucella	  during	  systemic	  dissemination	   is	  probably	   the	   reason	  why	  
cell-­‐mediated	   immune	   response	   is	   the	  only	   protective	   immune	   response	   against	   a	   second	  
invasion	  by	  Brucella	  melitensis.	  	  
	  
à	  Perspectives	  
- We	   have	   only	   investigated	   the	   humoral	   immune	   response	   in	   the	   control	   of	  
secondary	   infection,	   but	   study	   of	   the	   cellular	   immunity	   should	   clearly	   be	  
interesting.	   It	   is	   known	   that	   primary	   and	   secondary	   immune	   effectors	   can	   be	  
different	  (Kirby	  et	  al.,	  2002).	  This	  would	  improve	  our	  knowledge	  of	  the	  protective	  
immune	   response	   following	   a	   challenge	   and	   could	   help	   to	   generate	   an	   effective	  
vaccine.	  








Taken	  together,	  our	  results	  improve	  our	  knowledge	  of	  the	  host	  immune	  response	  to	  	  
brucellosis.	   They	   highlight	   the	   importance	   of	   the	   model	   of	   infection	   and	   show	   that	   the	  
analyzed	  organ	  can	  influence	  the	  outcome.	  Our	  data	  also	  provide	  insight	  into	  the	  identity	  of	  	  
the	   reservoir	   cells	   inhabited	   by	   the	   brucellae	   during	   the	   chronic	   phase	   of	   infection	   in	  
susceptible	  mice.	   These	   findings	   could	   help	   to	   define	   an	   effective	   treatment	   by	   a	   specific	  
target	   of	   infected	   cells.	   Finally,	   differences	   observed	   between	   i.p.	   and	   i.n.	   model	   of	   a	  
secondary	   infection	   could	   help	   to	   define	   a	   rational	   strategy	   for	   the	   generation	   of	   new	  
vaccines	   against	   brucellosis.	   This	   thesis	   has	   laid	   a	   cornerstone	   in	   the	   building	   of	   the	  
knowledge	  on	  Brucella	  and	  the	  associated	  immune	  response	  but	  it	  has	  also	  shown	  that	  there	  
remains	  a	   lot	  of	  work	   in	  the	  future	  to	  elucidate	  the	  complete	  protective	   immune	  response	  
against	   Brucella	   and	   the	   mechanisms	   used	   by	   this	   pathogen	   to	   infect	   its	   host	   with	   such	  
efficiency.	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